Subject index  by unknown
600A SUBJECT INDEX JACC March 19, 2003 
Subject Index 
Ablation-catheter 
A Prospective Randomized Study Comparing 
Transvenous Cryoenergy and Radiofrequency 
Ablation in the Triangle of Koch: Preliminary Data 
1042.8.93A 
Acute and Long-Term Results of Radiofrequency 
Ablation of Common Atrial Flutter and the tnfluence of 
the Riaht Atrial Isthmus Ablation on the Occurrence 
of Atrial Fibrillation 1063.18.95A 
Acute Pulmonary Vein Reaction to Radiofrequency 
Catheter Ablation for Atrial Fibrillation: Assessment 
Using Intracardiac Ultrasound 1151-17669A 
Advanced Fast Electra-Anatomical Mapping to Guide 
Radiofrequency Catheter Ablation of Ventricular 
Tachycardia 1114-l 6.107A 
Assessment of Transmural Extent of Radiofreauencv 
Ablation With Magnetic Resonance Imaging’ 
1075A-MP-205.424A 
’ 
Atrial Mechanical Function Following an lntraoperative 
Linear Radiofrequency Procedure for Atrial 
Fibrillation 1113-20.106A 
B-Type Natriuretic Peptide Levels in Patients With 
Hypertrophic Obstructive Cardiomyopathy Treated 
With Alcohol Septal Ablation 1014-59.144A 
Can an Epicardial Origin of Idiopathic Left Ventricular 
Tachycardia Be Predicted From the Surface 
Electrocardioaram? 1114.15.107A 
Can the Left Atrial Appendage Be Safely Closed 
Without Removal? 121lMP-170.132A 
Characterization of lntraatrial Reentrant Tachycardia in 
Patients After Mustard Operation for Transposition of 
Great Arteries Using Electroanatomlc and 
Entrainment Mapping 1113.19.106A 
Coincident Right Ventncular Outflow Tract Tachycardia 
and Atrioventricutar Nodal Reentry Tachycardia: More 
Than a Random Association? 1114-14.107A 
Computed Tomographic Screening of Potential 
Complications of Percutaneous Pulmonary Vein 
Isolation With Cryoablation for the Treatment of Atrial 
Fibrillation 834-5.118A 
Concomitant Microwave Ablation Is a Superior Concept 
for Curative Treatment of Permanent Atrial Fibrillation 
in Comparison to Cardiosurgical Procedures Alone 
1042-7.92A 
Coronary Sinus Actwation Pattern in Patients With AV 
Nodal Reentrant Tachycardia 1163.8.120A 
Correlation of the Pathology and Physiology in 
Circumferential Pulmonarv Vein Isolation 
1063-l 1.94A 
Creation of a Mathematical Model to Define 
Circumferential Linear Lesion Length for Pulmonary 
Vein Isolation 1023.55.520A 
Cryoablation for Treatment of Paroxysmal Atrial 
Fibrillation: Initial Results of a Prospective Multwnter 
Clinical Trial 846.5.125A 
Cryoablation of the Pulmonary Veins Using a Novel 
Balloon Catheter 104%4Q2A 
Do All lschemic Ventricular Tachycardia Patients Need 
an Implantable Cardioverter Defibrillator? 
1212-18.133A 
Does the ClInical Presentation of Atrial Fibrillation 
Affect Long-Term Outcome After Catheter Ablation? 
1063-l 3.94A 
Early Recurrence of Atrial Fibrillation After 
Circumferential Pulmonary Vein Ablation: Is It 
Predictive of Long-Term Unsuccessful Outcome? 
846.4.124A 
Efficacy of Circumferential Pulmonary Vain Ablation in 
Patients With Atrial Fibrillation and Associated Heart 
Failure 846.6.125A 
Electrophysiological Characteristics of Tachycardtas 
Arising From the Apex of the Triangle of Koch 
1163.10.120A 
Elevated C-Reactive Protein Predicts Pulmonary Vein 
Narrowing Following Pulmonary Vein Ablation of 
Atrial Fibrillation 834-1.117A 
Feasibility of His Bundle Pacing Guided by Intracardiac 
Echocardiography 882.4.139A 
Identification of Endocardtal Trigger and Exit of Right 
Ventricular Outflow Tract Tachycardia: Implication for 
Radiofrequency Catheter Ablation 1212.18.134A 
Importance of the Right Inferior Pulmonary Vein in 
lnltiation and Recurrence of Atrial Fibrillation 
1211MP.164.131A 
Improvement in Quakty of Life Post Circular Mapping 
Guided Pulmonary Vein Isolation in Both Normal 
Heart and Low Ejection Fraction Patients 
1063.9.93A 
Improvement of Ventricular Function Following Catheter 
Ablakon of Frequent Ventricular Arrhythmias 
1114.18.108A 
Irrigated-Tip Versus 8-mm-Tip Catheter for 
Radiofrequency Ablation of Common Atnal Flutter in 
Patients With Cave-Tricuspid Isthmus Lengths > 35 
mm: Is the Catheter Selection or the Cave-Tricuwid 
Anatomy a Determinant Factor for Atrial Flutter 
Ablation? 1042-3.92A 
Is InducibiliN of Atrial Fibrillation With Burst Pacinq a 
Marker f&Atria1 Remodeling and Poor Outcome-After 
Successful Pulmonary Vein Isolation? 1063.12.94A 
Is the Use of a Saline-lrngated Ablation Electrode as 
Safe as the Conventional Solid Tip Electrode to 
Eliminate Pulmonarv Vein SDike Potentials for 
Catheter Ablation ofAtria Fibrillation? 834-4.118A 
Left Ventricular Function and Long-Term Right 
Ventricular Pacinq In Patients With Atrial Fibrillation 
Following Atrioventricular Node Ablation 862-2.139A 
Linear Ethanol Jet lniection for Suraical Treatment of 
Atrial Fibrillation: danme SurvlvajStudy 1042-6.92A 
Low Incidence of Pulmonary Vein Stenosis Following 
Ostial Pulmonary Vein Ablation 121 lMP-171.132A 
Magnetic Navigation System for Intracardiac Mapping 
of Supraventricular Tachycardia in Humans 
834-6.1lQA 
Magnetic Resonance Angiography of Pulmonary Veins: 
A New Gold Standard Prior and After Ablation of 
Atrial Fibrillation 1130A-MP-207.43SA 
Markers of Inflammation, Myocardial Damage, and 
Twue Healing After High-Energy Radiofrequency 
Ablahon of Atrial Arrhythmias 1211MP-172.132A 
Modification of the Atrial Substrate bv Left Atrial Linear 
Lesions in Symptomatic Patients After Pulmonary 
Vein Isolation 1063.10.94A 
Monitorina of Catheter Thrombus and Char Formation 
Using Phased Array Intracardiac Echo During 
Pulmonary Vein Isolation in Patients With Atrial 
Fibrillation 1166-47.449A 
Occurrence of Transient ST-Segment Elevation During 
Pulmonary Vein Ablation for Paroxysmal Atrial 
Fibrillation in a Prospective Multi-Center Study 
1063.1695A 
One-Year Clinical and Echocardioaraphic Follow-UP 
After Endocardfal Aadiofrequen~y Ablation for Airial 
Fibrillation During Mitral Valve Surgery 
1037~25.499A 
Ostial Locations of Pulmonary Vein Fasicles in Patients 
With Atrial Fibrillation 1063.17.95A 
Prospective Assessment After Pediatric Cardiac 
Ablation: Initial Results of the Multicenter Study 
815-5.483A 
Radiation Exposure on Paroxysmal Atrial Fibrillation 
Catheter Ablation 121 lMP-163.131A 
Randomized Study Comparing Radiofrequency 
Ablation With Cryoablahon for the Treatment of Atrial 
Flutter 1042.2.91A 
Recovery of Left Atrial Function Following Pulmonary 
Vein Isolation Using Radiofrequency Ablatton in 
Chronic Atrial Fibrillation: An Intracardiac Doppler 
Echocardiographlc Study 1166-46.448A 
Reduction in Mitral Regurgitation After Alcohol Septal 
Ablation in Pattents With Hypertrophtc Obstructive 
Cardiomyopathy 1014-83.146A 
Reentrv Within the Cavotricuspid Isthmus: A Novel 
Isthmus Dependent Circuit ‘I 163.3.119A 
Residual Atrial Se&l Defect Followino Dual 
Transseptal Catheterization: A Doppler Color Flow 
Imaging Follow-Up 1063.15.95A 
Sinus Rhythm Control in Atrial Fibrillation: Outcomes 
From a Controlled Long-Term Ablation Study 
803.5.103A 
Symptomatic Pulmonary Vein Stenosis After Catheter 
Ablation of Atrial Fibrillahon: Correlation With Number 
of Affected Veins 834.2.116A 
The Common Left Pulmonary Vein: Intracardiac 
Ultrasound Characteristics and Impact Upon 
Pulmonary Vein Isolation 846-2.124A 
Three-Dimensional Imaging of the Left Atrium and 
Pulmonary Veins: Computed Tomography or 
Magnetic Resonance Imaging? 12llMP-169.132A 
Three-Dimensional Intravascular Ultrasound 
Architecture of the Pulmonary Venous Wall: 
Implications for Radiofrequency Ablation of Atrial 
Fibrillation 846-3.124A 
Three-Dimensional Myocardial Contrast 
EchocardioaraDhv: A Novel Method to Assess 
Ablation Le&nsin Koch’s Tnangle in Humans 
1163-7.120A 
Transcatheter Angioplasty for Acquired Pulmonary Vein 
Stenosis Following Radiofrequency Ablation 
834-3.11 BA 
Treatment of Supraventricular Tachyarrhythmias With 
the CryoCorTM Cryoablation System: Worldwide 
Results 1042.l.QlA 
Accessory pathways 
A Prospective Randomtzed Study Comparing 
Transvenous Cryoenergy and Radiofrequency 
Ablation in the Triangle of Koch: Preliminary Data 
1042.8.93A 
ECG Differentiation of Typical AV Node Reentrant 
Tachycardia From Orthodromic AV Reciprocating 
Tachycardia Mediated by Concealed Accessory 
Pathway I” Children 1163-4.119A 
Accessory pathways, ablation 
Prospective Assessment After Pediatric Cardiac 
Ablation: Initial Results of the Multicenter Study 
815.5.483A 
Supraventricular Arrhythmias in Ebstein’s Anomaly: 
Management and Outcome 1113-2.106A 
ACE inhibitor 
A Comparison of Beta-Blockers and Angiotensin 
Converting Enzyme Inhibitors on Aortic Elastic 
Properties, Aortic Growth, and Left Ventricular Size 
and Function in Madan Patients 854-4.492A 
Additive Effects of Angiotensin Converting Enzyme 
Inhibitor Combined With Statin on Inflammation and 
Fibrinolysis in Hypercholesterolemic Patients With 
Coronary Artery Disease 1177.126.294A 
Addkive Effects of Ramipril and Atorvastatin on 
Inflammatory Cytokines Interferon-y, Tumor Necrosis 
Factor-a. Interleukin-6. and C-Reactive Protein in 
Diabetic Patients With Congestive Heart Failure 
1181.123.301A 
Additive Effects of Statin Combined Wtth Anaiotensin 
Converting Enzyme Inhibitor on Vasomoti& in 
Hypercholesterolemic Patients 1083.138.255A 
Adherence to Secondary Prevention Therapies 
Following Acute Coronary Syndromes: One-Year 
Results From the Canadian Acute Coronary 
Syndrome Registry 1171-109.362A 
Angiotensin Converting Enzyme Inhibition Improves 
Impaired Coronary Flow Reserve in Type 2 Diabetes 
Mellitus 1040.88.154A 
Angiotensin Converting Enzyme Inhibition Reduces 
Elevated C-Reactive Protein in Patients With 
Angiographic Coronary Artery Disease 
849FO-5.391A 
Angiotensin Converting Enzyme Inhibitor Therapy 
Reduces the Vascular Oxidative State in 
Normotenwe Patients With Newly Diagnosed Type 2 
Diabetes Mellitus 1152.126.285A _ 
Anaiotensin Convertina Enzvme Inhibitor Tissue Affinitv 
Is Not Associated With Different Risk of Myocardial . 
Infarction 1058-l 31.247A 
Anqiotensin Convertinq Enzvme Inhibitors Do Not 
Prevent Supraventri&larTachyarrhythmias: Evidence 
From the SOLVD Trial 12llMP-166.131A 
Angiotensin Converting Enzyme Inhibitors Stabilize Left 
Ventricular Remodeling in Chronic Aortic 
Regurgitahon Despite Abnormal Resting Mechanics 
1141.31.442A 
Antiinflammatory and Antiangiogenetic Effect of 
Ramiprilat: Angiotensin Converting Enzyme Inhibition 
in Monocytes Prevents Their Angiotensin II- and 
Hypoxia-Induced Cytokine Expression by 
Downregulation of AT-1 Receptor Expression and 
NF-kappaB Activation 875-5.3154 
Arterial Compliance Changes in Diabetic Normotensive 
Patients After Angiotensin Converting Enzyme 
Inhibition Therapy 1104-151.2631 
Beneficial Effects of Ramipril on Cardiovascular Events 
in High-Risk Patients Older Than 75 Years of Age: 
Secondary Outcomes From the HOPE Trial 
1040-87.154A 
Cardiovascular Outcomes After First-Ever Treatment of 
Hypertension With Angiotensin Converting Enzyme 
Inhibitors or Calcium Channel-Blockers in Primary 
Care 1058-124.246A 
Carvedilol Treatment Is as Well Tolerated as 
Angiotensin Converting Enzyme Inhibition in Patients 
With Chronic Heart Failure: Results of the CARMEN 
(Carvedilol ACE Inhibitor Remodelina Mild CHF 
EvaluatioN) Study 1184-70.2044 _ 
Comparative Effects of Aspirin With Angiotensin 
Converting Enzyme Inhibitor or Angiotensin Receptor 
Blocker on Myocardial Infarction and Vascular 
Function 1194.97.393A 
Differential Antiplatelet Effects of Angiotensin 
Convertina Enzvme Inhibitors: Ex Viva and In Vttro 
Studies Using I&hole Blood Aggregometry 
1131.145.272A 
DIscordant Prescriptton of Guideline-Dfrected Therapy 
for Heart Failure Between Subspecialties of 
Cardiology 1085-72.162A 
Do Patients Necessarily Have to Start With an 
Angiotension Converting Enzyme Inhibitor in the 
JACC March 19,2003 SUBJECT INDEX 601A 
Treatment of Heart Failure? Results of the CARMEN 
(Carvedilol ACE Inhibitor Remodeling Mild CHF 
EvaluatioN) Study 1085-74.162A 
Early Use of Beta-Blockade in Complicated Myccardial 
Infarcnon: The VALIANT Trial lOOl-106.322A 
Effect of the Angiotensin Converting Enzyme Inhibitor 
Trandolapril on Functional Status and Furcsemide 
Consumption in Patients With Reduced Left 
Ventricular Function After Myocardial Infarction 
1164-80.206A 
Electrcphysiologic Alterations Seen in Patients With 
Advanced Cardiac Failure After Angiotension 
Converting Enzyme Inhibitor Therapy 1065-78.163A 
In-Hospital and Discharge Utilization of Medications in 
Patients With and Without Heart Failure Presenting 
With Acute Coronary Syndromes: Insights From the 
PURSUIT Study 1171-107.362A 
fnhibrtion of P38 Mitogen-Activated Protein Kinase 
Protects the Heart Against Cardiac Remodeling III 
Mice Wtth Heart Failure Due to Myccardial Infarction 
1135~59.16OA 
Left Ventricular Systolic Function and Survival in a 
Contemporary Cohort of Patients With Heart Failure 
1036.68.147A 
Prevention of Renal Fibrosls With Dual ACE+NEP 
Inhibition With MDL 100,240 in aTransgenic Model of 
Angiotensin II-Dependent Hypertension 
1203-l 24.31 OA 
Pcor Treatment With Angiotensin Converting Enzyme 
Inhibitors Influences the Diurnal Variation III Acute 
Myccardial Infarction Onset 1035-148.237A 
Ramlpril Is Cost-Effective in Preventing Cardiovascular 
Events in Patients With Diabetes Mellitus 
1070.58.525A 
Replacement of Angiotensin Converting Enzyme 
Inhibition by Carvedilol Results in Long-Term 
Reversed Left Ventricular Remodeling in Mild Heart 
Failure and Is Well Tolerated: Results of the 
CARMEN (Carvedilol Ace-inhibitor Remodeling in 
Mild heart failure EvaluatioN) Study 1184-73.205A 
Routine Use of Ramipril Is Cost-Effective After 
Percutaneous Coronary Intervention 1070-57.524A 
Scintigraphic and lmmunohistochemical Evidence for 
Localization of Anqictensin Converting Enzyme to 
Myccytes in Human lschemic Cardiomyopaihy 
1093-35.427A 
Spircnolactone Improves Endothelial Function in 
Congestive Heart Failure Patients on Angiotensin 
Convertina Enzvme Inhibitors 1177-132.295A 
Utilization orACE: and P-blocker Therapy in Managed 
Care Patients With Heart Failure: NC ACE Proiect 
1184-77.206A 
Dietary Fish Oil Supplementation Improves Endothelial 
Function I” Patients With Congestive Heart Failure 
1184.83.207A 
Early Improvement in Endothelial-Dependent 
Relaxation Is Related to Decreased Macrcphage 
Infiltration and Plaque Formation in Experimental 
Atherosclerosis 1036-l 18.236A 
From Syndrome X to Coronary Artery Disease 
1148.89.376A 
Mwcardlal Perfusion Cold Pressor Test 99mT~ 
MIBI-SPECT Detects Both Microvascular and 
EpicardIaI Abnormal Reactivity in Patients With 
Endcthelial Dysfunction and Angicgraphically Normal 
Coronary Arteries With lntracoronary Acetylcholine 
Vasoconstriction 1142-37443A 
Sildenafil Selectively Improves Endothelium-Dependent 
Micrcc~rculat~cn 1131.135.271A 
Uncoupling of eNOS in Congestive Heart Failure 
1061-76.157A 
Adenosine 
Alpha-Blockade in Patients With Coronary Artery 
Disease: Implications for Fractional Flow Reserve 
Measurements 1051.191.17A 
Caffeine Decreases Coronary Flow Reserve at 
Exercise in Healthy Volunteers 858.2.460A 
Can Anatomic No-Reflow Be Prevented by 
Pharmacologic Treatment With Adenosine and 
Verapamil? 869-6.401A 
Ghromc Al and A2b Adenosine Receptor Blockade 
Improves Diabetes and Attenuates Renal and 
Cardiac Histopathology in Animals With the Metabolic 
Syndrome 1158-72.193A 
Comparative Diagnostic Value of Dipyridamole and 
Adencslne-Triphcsphate Stress First-Pass 
Myocardial Perfusion Magnetic Resonance Imaging 
for Detection of Coronary Artery Disease 
883-6.47OA 
Comparison of Adenosine and Dipyndamole in 
Detecting Coronary Artery Disease Using Tc-99m 
Sestamibi Single-Photon Emission Computed 
Tomography Imaging: A Randomized. Prospectwe 
Clinical Study 858.3.461A 
Comoarison of Vasodilation bv CVT-3146. a Novel A2A 
Receptor Agonist, and Adenosine in Different 
Vascular Beds in Awake Dcas 860-3.312A 
Effect of Hypoxia on Corcna~Microcirculation in 
Coronary Artery Disease Patients 1093.37.426A 
Effects of a New Selective A2a Adenosine Receptor 
Agonist on Thallium-201 and Tcm99-MIBI 
Biodistribution and Clearance: Implications for 
Optimizing Vasodilator Stress Perfusion Imaging 
858.4.461A 
Effects of ACAT Inhibition by Positron Emisston 
Tomography Measured Myccardial Blood Flow: A 
Double-Blind. Randomized, Multicenter Trial 
858-l 46OA 
Five Years of Adenosine Contrast Echocardiography: 
Lessons From 1,750 Consecutive Studies in a Single 
Center 819.4.432A 
Hyperemic Pulse Transmission Coefficient: A Novel 
Index for the Functional Assessment of Microvascular 
Integrity Following Percutaneous Gorcnary 
Interventions 1151-199.60A 
Intravascular Ultrasound-Derived Coronary Flow 
Reserve 1077-175.26A 
Myocardial Perfusion Imaging With a Novel Selective 
A2a Adenosine Receptor Agonist (CVT-3146): 
Important Differences in Radiotracer Behavior 
1142-38443A 
Possible Beneficial Effects of Adenosine as Adjuvant 
Therapy to Thrcmbolytic Treatment in Patients With 
an Acute Anterior Myccardial Infarction and 
Depressed Left Ventricular Function 1071-l 12.347A 
Prevention of Rheolvtic Thrombectcmv Induced 
Bradyartiythmlas.With Aminophylli& 1051-195.16A 
Reversal of Slow or No-Reflow Durina Percutaneous 
Transluminal Coronary Angioplasty”Using Boluses of 
lntracorcnary Adenosine aid Sodium Nicrcprusside 
in Combination 1101.201.39A 
Transthoracic Coronary Doppler Detects Severe Left 
Anterior Descending Coronary Artery Stenosis 
1092-47.426A 
Usefulness of Noninvasive Assessment of Coronary 
Flow Reserve Using Contrast Enhanced 
Transthoracic Color Doppler Echocardiography for 
Detecting Left Anterior Descending Stenosis With 
Comparison of Stress Thallium-201 Single-Photon 
Emission Computed Tomography 1117.39.435A 
Variant of Outflow Tract Tachycardia Associated With a 
Somatic Mutation of the Gai Switch 2 Region 
818-2.1054 
Aging 
Acute and Long-Term Outcomes of Multivessel Stenting 
in Patients Aged 80 Years 1112-88.160A 
Age Dependent Association Between High Sensitivity 
C-Reactive Protein and Tumor Necrosis Factor 
Functional Variants 840.2.262A 
Age Is Not a Factor in Survival of Patients Undergoing 
Left Ventricular Assist Device Placement as 
Destination Therapy: The REMATCH Experience 
1086-88.165A 
Characterizing the Young Patient With Aortic 
Dissection: kesults From the International Registry of 
Acrtic Dissection (IRADI 1081.154.253A 
Coronary Endothelial Fun&ion: The Impact of Aging I” 
a Matched Study Group With Normal Coronary 
Arteries 1131-141.272A 
Diastolic Dysfunction in Elderly Patients Referred to the 
Heart Failure Diaanostic Clinic 1162-82.200A 
Diastolic Left Vent&lar Filling Patterns in Diastolic 
Versus Systolic Congestive Heart Failure of the 
Elderlv: The Cardiovascular Heart Studv 
1162-84.200A 
Differences Between TIME (Trial of Invasive Versus 
Medical Therapy in Elderly Patients With Chronic 
Angina) and Registry Patients, and Impact on 
Outcome 1112.87.16OA 
Does Myccardial Function Decline With Age? 
1088-86.166A 
Effect of Age on Mitral Annular Velocities by Tissue 
Doppler Imaging in Healthy Subjects: A 
Population-Based Study 1140.27.440A 
Elderly Patients Have Better Functioning, Less Angina 
at One Year With Coronary Artery Bypass Graft 
887FO-6.22OA 
Favorable Right Heart Remodeling After Atrial Septal 
Defect Device Closure Even in the Over-80 Aae 
Group 1021-159.473A 
Gender-Related Differences in Neurchormonal Plasma 
Levels 1038-76.149A 
Impact of Age on Pathology. Treatment, and Outcome in 
Degenerative Mitral Valve Disease 806-l .502A 
Left Atrial Volume Is More Strongly Associated With 
Prevalent Conaestive Heart Failure and Predictive of 
Incident Congestive Heart Failure in the Elderly Than 
Doppler Mitral Inflow Velocities or Deceleration Time 
1038.69.146A 
Mitctic Cell Death as a Result of Cell Cycle Re-Entry Is 
a Unique Option for Senescent Cardiomyocytes in 
Addition to Apoptosis and Mitosis 1183-65.263A 
Outcomes of an Elderly Population Undergoing 
Maximal MedIcal Therapy 1040.83.153A 
Plasma Levels of Inflammatory C-Reactive Protein and 
Interleukln-6 Predict Outcome in Elderly Patients 
With Stroke 1162-85.200A 
Prognostic Value of Stress Testing in Patients Above 75 
YearsofAge 1161-61.198A 
Pulmonary Artery Systolic Pressure in 
Echocardiographically Normal Subjects 81 l-1.257A 
Raloxifene Effect on Endothelial Function Depends on 
Duration of Menopause and Previous Hormone Use 
1035.147.236A 
Reduced Aortic Distensibility and Congestive Heart 
Failure Among the Elderly in a Population-Based 
Study: The Cardiovascular Health Study 
887F04.220A 
Risk Stratification and Prognosis in Octogenarians: A 
Stress Echocardiographic Study 1019~34.409A 
Skeletal Muscle Remodeling and Exercise Intolerance 
in Elderly Patients With Diastolic Heart Failure 
1088-87.166A 
The Effect of Age on Early Death and Stroke Rates in 
Patients With Heart Failure After Acute Myocardlal 
Infarction 1112.85179A 
The Impact of Diabetes on Clinical and Economic 
Outcomes of Percutaneous Coronary Intervention in 
the Elderly: A Population-Based Analysis 
1070-54.524A 
The Modifying Effect of Age on Risk Factors for Stroke: 
The Manitoba Follow-Up Study 887FO-5.220A 
The Prevalence and Risk Factors of Peripheral Arterial 
Occlusive Disease in the Elderly Chinese Pcpulation- 
Wanshoul” Study 886-2.317A 
Thrombolytic Therapy but Not Primary Angioplasty Is 
Associated With an Early Hazard in Patients >75 
Years Old With Acute Myccardial Infarction: Results 
of the PPRIMM75 Registry 1040~64.153A 
Upregulation of Arginase Mediates Endothelial 
Dysfunction in Aging Blood Vessels 
1130MP-171.270A 
Alcohol 
B-Type Natriuretic Peptide Levels in Patients With 
Hypertrcphic Obstructive Cardiomyopathy Treated 
With Alcohol Septal Ablation 1014-59.144A 
Comoarison of Novel Stratecv Theraoies for 
Obstructive Hypertrcphic &rdicm~cpathy: Relation 
of Relief of Left Ventricular Outflow Obstruction to 
Improved Symptoms and Health-Related Quality of 
Life Parameters 1014-82.145A 
Heart Block After Alcohol Septal Ablation: Predictors 
and Consequences 1206-77.212A 
Injury Size and Location Induced by Percutaneous 
Transluminal Septal Myccardial Ablation in 
Hypertrophic Obstructive Cardiomyopathy: Effect on 
Gradient Reduction 1014-85.146A 
Myccardial Injury After Percutaneous Transluminal 
Septal Myocardial Ablation in Hypertrcphic 
Obstructive Cardiomyopathy: Evaluation by Magnetic 
Resonance Imaging 1167~44452A 
Prognosis of Patients With Hypertrcphic Obstructwe 
Cardiomyopathy After Transcoronary Ablation of 
Septal Hypertrophy 807.3.169A 
Reduction in Mitral Regurgitation After Alcohol Septal 
Ablation in Patients With Hypertrcphic Obstructive 
Cardiomyopathy 1014-83.146A 
Aldosterone 
Altered Aldostercne Disposition in P-Glycoprotein 
Knockout Mice 1183-82.203A 
High Prevalence of Functioning Adrenccortical Lesions 
in Low Renin Arterial Hypertension 1058-132.247A 
Long-Term Effect of Aldostercne Inhibition on Cardiac 
Structural Abnormality as Assessed With Analysis of 
Ultrasonic Radio Frequency Signals 1044-44.417A 
Mineralocorticoid Receptor Antagonism Attenuates 
Thrombotic Response to Injury I” Atherosclerosis 
Through Favorable Effects on Nitric Oxide 
Bioavailability 1032.129.232A 
Serum Aldcsterone Is Associated With Left Ventricular 
Remodeling in Women but Not Men: FramIngham 
Heart Study 1159MP.168.195A 
Spircnolactone Improves Endothelial Function in 
Congestive Heart Failure Patients on Angiotensln 
Converting Enzyme Inhibitors 1177.132.295A 
Spironolactone Induced Renal Impairment and 
Hyperkalemia in Patients With Heart Failure: Can We 
Predict These Side Effects? 1085.73.162A 
Treatment With Eplerenone, an Aldostercne Antagonist 
Improved Ventricular Remodeling and Function Post 
Myocardial Infarction 1135-88.162A 
Valsartan Produces a Sustained Decrease in Plasma 
Aldostercne Independent of Age, Gender, or Race: 
Results From Val-HeFT 1106.124.265A 
Alpha-adrenergic receptor blockers 
Alpha-Blockade in Patients With Coronary Artery 
Disease: Implications for Fractlcnal Flow Reserve 
Measurements 1051-191.17A 
KEY: Abstract Title, Session-abstract numbeppage number 
602A SUBJECT INDEX JACC March 19,2003 
Ambulatorv blood oressure , . 
A Low Pulse Pressure Is an Independent Predictor of 
Mortalitv in Heart Failure: Data From a Lame 
Nationwide Cardiology Database (IN-CHF kegistry) 
1038-80.150A 
A Programing Library for Transparent Access to 
Physiological Signals 1023-58.521A 
Blood Pressure Response Durina ABPM and Exercise 
and Cardiac Alternations 1058-130.247A 
Evaluation of the Extent and Duration of the ABPM 
Effect in Patients With Essential Hypertension 
1058-I 28.246A 
The Influence of Body Weight on Blood Pressure 
Response to Exercise in Patients With Normotensive 
ABPM Values 101 l-145.2301\ 
Ambulatory ECG 
A Programing Library for Transparent Access to 
Physiological Signals 1023-58.52lA 
A Randomized Study of Three Tilt Test Protocols With 
Long-Term Follow-Up by Implantable Loop Recorder 
1090-20.102A 
Evaluation of Heart Rate Variability, Late Ventricular 
Potentials, and lnducibility of Ventricular Tachycardia 
in Patients With Myotonic Dystrophy Type 1 
1164-14.122A 
Halter Monitoring and Treadmill Testing Assist I” 
Prediction of Future Events in Patients With Classic 
Mitral Valve Prolxxe 1205-24.615A 
Influence of Specific Sleep Stages and Autonomic 
Nervous System on QT Interval and Repolarization 
Dynamicity (QT/RR) in Healthy Volunteers 
1164-20.123A 
ISAR HRT Substudv: Prediction of Mortalitv bv 
Beat-to-Beat Variability Parameters 121%6:134A 
lschemia During Daily Activities Is Associated With 
Impaired Endothelium-Dependent and 
Endothelium-Independent Brachial Artery Dilation in 
Patients With Chronic Coronarv Arterv Disease , I 
1148.90.376A 
QT-RR Dynamics in Coronary Artery Disease by 
Gender 1164.15.122A 
Rapid Detection of Atrial Tachyarrhythmia in Pacemaker 
Patients Using Home Monitoring 1090-19.102A 
The Use of Implantable Loop Recorders in the 
Diagnosis and Management of Syncope 
1090-3.lOOA 
Valsartan Improves Early Morning and 24-Hour Heart 
Rate Variability 1115.8.109A 
Amiodarone 
A Randomized Double Blind Placebo Controlled Trial of 
the Effect of Amiodarona Compared to Placebo 
Before, During, and After Elecirical Cardioversion for 
Persistent Atrial Fibrillation 1089-9.96A 
Amiodarone Increases Transmural Heterogeneity of 
Repolarization in Patients With Cardiac Death 
1115-10.109A 
Double Blind, Placebo-Controlled Study of Long-Term 
Intermittent Dobutamine Infusion With Concomitant 
Oral Amiodarone for End Stage Heart Failure 
1085.75.162A 
Intravenous Amiodarone in Cardioversion of 
New-Onset Atrial Fibrillation 1015-13.65A 
Lack of QT Prolongation With Amicdarone Increases 
Arrhythmic Risk 814-1.103A 
Rapid Load Oral Amiodarone Reduces Incidence of 
Postooerative Atrial Fibrillation and Atrial Flutter 
1037.22.496A 
Recurrence Rate of Atrial Fibrillatton in Patients After 
the First Relapse: A Comparison Between Metoprolol 
CR/XL, Sotalol, and Amiodarone 1089-10.96A 
Unpredicted Amiodarone and Warfarin Interaction at 
the 17th to 20th Week After the lnibation of 
Amiodarone 1009-153.226A 
Aneurysms 
Are Thoracic Aortic Aneurysms a Genetic Disease? 
1154.141.267A 
Coarctation of the Aorta: Prevalence of Intracranial 
Aneuwsm 1192-I 60.49OA 
ContrasiEnhanced Duplex Ultrasound Improves 
Endoleak Detection Following Endovascular 
Abdominal Aortic Aneurysm Repair 1100-l 99.39A 
Influence of Chronobiolooical Variation in the Risk of 
Acute Aortic Dissectionon In-Hospital Mortality 
1154-l 44.266A 
Lack of Association Between Chlamydia Pneumoniae 
Seropositivity and Thoracic Aortic Dilatation: A 
Population-Based Transesophageal 
Echocardiographic Study With Implications for 
Thoracic Aortic Aneurysm Formation 1105.153.264A 
The Effect of Left Ventricular Surgical Remodeling on 
Three-Dimensional Myocyte OGentation Using- 
Maanetic Resonance Diffusion Tensor lmaaino 
120-&21~514A 
- _ 
The Frequency and Consequences of Angiographic 
Aneurysms After Sirolimus-Eluting Stems: Results 
From SIRIUS 1030-181.13A 
Transluminal Endovascular Graft Placement With 
INOUE Stent Graft Is Effective for Many Types of 
Aneurysms and Dissections 1199-197.76A 
Angina pectoris 
A Combination of Pro-BNP Och Troponin T at Baseline 
Provide the Best Prediction of Risk of Death and 
Myocardial Infarction Early After Acute Coronary 
Syndrome 810-4.353A 
Abciximab Treatment Does Not Influence Levels of 
Inflammatory Markers in Patients With Acute 
Coronary Syndrome 849FO-3.396A 
Abciximab Upregulates the Number of Glycoprotein Ilb/ 
llla Receotors In Viw 867-5.76A 
Atrial Fib&&ion Does Not Degrade the Clinical 
Benefits From Enhanced External Counterpulsation 
Theraov in Pabents With Chronic Anaina: Results 
From iie International EECP Patient-Registry 
1148-l 14.379A 
C(-260)+T Polvmoruhism in the Promoter of CD14 
kecdptor Gene &Associated With the Risk of Acute 
Coronarv Events in Patients With Anaina Pectoris 
1132-l 36.275A 
C-Reactive Protein, Clinical Presentation, and lschemic 
Activitv in Patients With Chest Pain and Normal 
Coro&ry Angiograms 1054-I 38.239A 
Can Taoered-Tio Guidewires lmorove the Success Rate 
of Percutaneous Coronary Intervention in Chronic 
Total Occlusion? 1127-188.46A 
Clinical Effects of Spinal Cord Stimulation in Patients 
With Refractory Angina Pectoris: Results From a 
Prospecbve It&an Registry 829.5.37lA 
Comparison Between the Flow Velocitv: Pressure 
Gradient Relation and the Coronarysnd Fractional 
Flow Reserve in the Assessment of Coronary 
S&noses 1131-143.272A 
Comparison of Culprit Lesions Showing Negative 
Remodeling Between Acute Coronary Syndrome and 
Stable Angina Pectoris 1102-I 82.42A 
Effect of Roxithromycin on Clinical Cardiovascular 
Events in Patients Undergoing Coronary Angioplasty 
1026-100.335A 
Efficacy and Safety of a Chronotherapeutic 
Graded-Release Diltiazem Hydrochloride 
Formulation Dosed at Bedtime Compared to Placebo 
and to Morning Dosing in Chronic Stable Angina 
Pectoris 1026-102.335A 
Enhanced External Counterpulsation for the Relief of 
Angina in Patients With Diabetes: A One-Year Clinical 
Outcome Study 1148-l 15.379A 
Enhanced External Counteroulsation Improves 
Endothelial Function in Paiients With doronary Artery 
Disease 829-3.370A 
External Counterpulsation Therapy Improves 
Endothelial Function in PatientsWith Refractory 
Anaina Pectoris 1130MP-166.269A 
How ‘Valuable Is Real-Time Myocardial Contrast 
Echocardiography for Pharmacological Stress 
Testing? 819-3.432A 
Influence of Depression on Disease Specific Functional 
Status Recovery Following Coronary Bypass Surgery 
1074-98.352A 
Influence of Guidelines and Results From Major Clinical 
Trials on Medical Practice: Findinas From the Global 
Registry of Acute Coronary Eve& (GRACE) 
1022MP-169.516A 
Is Enhanced External Counterpulsation Effective for 
Angina Relief in Diabetic Paiients Who Are Not 
Candidates for Transcatheter Intervention? 
1003.89.326A 
Is Enhanced External Counterpulsation the Preferred 
Treatment for Chronic Stable Anaina I” Select 
Patients 75 Years and Older? 1762s86.200A 
Maior Bleedino Incidence After Coronatv Arterv Bvoass 
drafting in catients With Unstable An&w/Nbn-gT 
Elevabon Myocardial Infarction Based on Coronary 
Artery Bypass Graft Timing in TACTICS-TIMI- 
1146-107.374A 
N-T Pro-BNP Is a Powerful Predictor of Outcome in 
Patients With Stable Angina: A Substudy of the IONA 
Trial 1098-I 15.360A 
Prediction of Maior Coronary Events in Stable Angina: 
The IONA St&y 1050.100.344A 
Preserved Benefit of Enhanced External 
Counterpulsation in End Stage lschemic Heart 
Disease 829-4.37OA 
Prevalence of Hypogonadism in Men With Coronary 
Artery Disease 1050-l 03.344A 
Prodromal Anaina Favorably Alters RelatIonshiD 
Between Time to Rep&&ion and Outcomes in 
Patients With a First Anterior Acute Mvocardial 
Infarction 1195-93.396A 
Prolonged but Reversible Sarcolemmal Phosphatidyl 
Serine Expression in Myocardial lschemla 
Represents lschemic Memory and Can Be 
Noninvasivelv Detected bv Radiolabeled Annexin-V 
Imaging 835.5446A 
Ranolazine Increases Exercise Performance and 
Decreases Hemoglobin AIC in Angina Patients With 
Diabetes 1148s91.376A 
Statin Promotes Coronary Collateral Circulation and 
Induces the Regression of Left Ventricular Mass in 
Patients With Angina 1181-124.302A 
The Effect of Vardenafil. a Selective PDE5 Inhibitor, on 
lschemic Threshold, Exercise Tolerance, and 
Circulatory Responses During Treadmill Exercise in 
Men With Stable Angina Pectoris 1026-104.336A 
The Neurohumoral Response to Exercise in Coronary 
Heart Disease and the Relationship With Inducible 
lschemia 1098-89.359A 
Two-Year Outcomes After Enhanced External 
Counterpulsation: Data From the International EECP 
Patient Registry 1148-I 16.379A 
Unstable Versus Stable Angina in the Current Era: 
Comparison of Percutaneous Coronary Intervention 
Outcomes in the NHLBI Dynamic Registry 
1005188.lA 
Women With Cardiac Syndrome X Exhibit Features of 
the Insulin Resistance Syndrome and Impaired 
Peripheral Microvascular Functton 1177.131.295A 
Angiocardiography 
Acute Coronary Syndrome Patients With ST-Segment 
Deoression Have Substantial Mortalitv Rates but 
U&ergo Less Aggressive Management Strategies: 
Insights From the Global Registry of Acute Coronary 
Events (GRACE) 1002-103.326A 
Angiogradhic and Hemodynamic Correlates of 
Low-Dose Positive Dobutamine Stress 
Echocardiography 1092-48.4271 
Small Coronary Arteries Predict Long-Term Outcome in 
Patients Without Previous Revascularlzation 
1104-I 50.263A 
Angiogenesis 
A Randomized Double Blind Placebo Controlled 
Multicenter Pilot Study of the Safety and Feasibility of 
Ad~vVEGFl21.10 via an lntramyocardial Injection 
Catheter in Patients With Advanced Coronary Artery 
Disease 1053.173.21A 
Acute Dynamic Exercise Increases Circulating 
Endothelial Progenitor Cells 1178-l 37.296A 
Angiogenesis Induced by Human Hepatocyte Growth 
Factor Gene Without Nitric Oxide Synthesis in a Rat 
lschemic Hindlimb Model 1178-143.297A 
Angiogenic Potential of Subcutaneous Adipose Stromal 
Cells for Autologous Cell Therapy 1201-152.306A 
Antiinflammatory and Antiangiogenetic Effect of 
Ramiprilat: Angiotensin Converting Enzyme Inhibition 
I” Monocytes Prevents Their Angiotensin II- and 
Hypoxia-Induced Cyloklne Expression by 
Downregulation of AT-I Receptor Expression and 
NF-kappaB Activation 875.5.315A 
Arteriogenesis Is Reduced in CD44 Knockout Mice 
1055-I 54.242A 
Caldesmon Regulates Apoptosis and Cell Cycle 
Progression in Capillary Endothelial Cells and Inhibits 
Angiogenesis In Vitro 1176-140.297A 
Can Vascular Endothelial Growth Factor Improve Blood 
Flow in Diabetes? 1178-I 41.297A 
Concerted Action of Various Angiogenic Factors During 
Acute Myocardial Infarction in Patients: The Three 
Lines of Defense 881 FO-5405A 
Constltutive Overexpression of Hypoxia Inducible 
Factor-IaNP-16 Enhances the In Vitro AnaioaenicI 
Arteriogenic Effects of Mesenchymal Stro&lCells 
830.3.279A 
Detection of Unique Factors Involved in Coronary 
Collateral Growth: Analysis 01 the Cardiac Interstitial 
Subproteome 1055-153.242A 
Effect bf Exercise Training in Patients With Coronary 
Artery Disease on Circulating Endothelial Progenitor 
Cells 875-6.315A 
Enhanced Mobilization of Circulating Endothelial 
Progenitor Cells in Hypercholesterolemic Patients by 
3-Hydroxy-3.Methylglutaryl Co-A Reductase Inhibitor: 
View Point to Two Different Tvoes of Endothelial 
Progenitor Calls f 131.136.Z?lA 
Estrogen Augments Incorporation of Bone 
Marrow-Derived Endothelial Progenitor Cells Into 
Sites of Myocardial Neovascular~zation 407-3.542A 
Evaluation of the Porcine Ameroid ConstrIctor Model of 
Chronic Myocardial lschemia for Therapeutic 
Angiogenesis Studies 1024-I 11.331A 
Exercise-Induced Expression of Angiogenic Cyiokines 
in Normal and Infarcted Hearts 1161-64.199A 
Exposure to Second Hand Smoke Stimulates 
Angiogenesis in Tumors 830.5.26OA 
First Expewnce With Noncavitabonal Ultrasound 
Enhancement of Selective Cellular Delivery of Liquid 
Perfluorocarbon Nanooarticles to Anaiwenlc Sites _ _ 
1151-175.59A 
Functional Myocardial Angiogenesis Resulting From 
Persistent Systolic Perfusion 1004.94.327A 
KEY: Abstract Title, Session-abstract number-page number 
JACC March 19,2003 SUBJECT INDEX 603A 
Genetic Background Is a Major Determinant of 
Arteriogenesis After Femoral Artery Ligation in Inbred 
Mice 830-l .279A 
Genetic Determinants of Nicotine-Induced 
Angiogenesis 804.2.256A 
Glycoprotem 130 Mediated Induction of Vascular 
Endothelial Growth Factor in Human Adult Cardiac 
Myocytes 1132-l 32.275A 
Improvement in Global and Segmental Left Ventricular 
Contractility Following Autologous Bone Marrow Cell 
Transplantation in Humans With Severe lschemic 
Heart Failure 874-5219A 
Improvement in Symptoms and Exercise Capacity at 
Eight Weeks I” a Controlled Study of Autologous 
Bone Marrow Cell Transplant in Humans With Severe 
lschemic Heart Failure 823.144A 
Inhibition of Angiogenesls and Wound Healing by 
Adenowrus-Mediated Gene Transfer of a Soluble 
Form of Vascular Endothelial Growth Factor Receptor 
in Mice IZOl-120.307A 
lntracoronary Delivery of Bone Marrow-Derived CD34+ 
Mononucl&r Cells Increases Vascular Density in 
Infarcted Mvocardium 878.54Q3A 
Intramyocard&l Delivery of Bone Marrow-Derived 
Mesenchymal Stem Cells Improves Myocardial 
Contractility in a Chrontc lschemic Model 
1178-i 38.296A 
Llpophilic Statin-Induced Antiangiogenesis Requires 
the Inhibition of Ras Farnesylation in Human 
Coronary Artery Endothelial Cells 1177.128.294A 
Matrix-Immobilized Fibroblast Growth Factor Genes 
Promoted Angiogenesis in a Porcine Model of 
Chrome Myocardial lschemla 1055.152.242A 
MCP-1 Induces a Sustained Arteriogenic Response in 
ApoE Mice but Accelerates Atherosclerotic Plaque 
Development 830.4.26OA 
Mesenchymal Stromal Cell Transplantation Contributes 
to Collateral Response I” Tissue lschemia Through 
Release of Arteriogenic Cytokines 1176-i 73.67A 
Neovasculature of the Infarct Scar: Need to Expand 
Anglogenic and Vasculogenic Components 
1194-103.394A 
Noninvasive Assessment of Angiogenesis by Contrast 
Ultrasound Imaging With Microbubbles Targeted to 
Alpha-V lntegrins 802.i.430A 
Percutaneous Endocardial Versus Selective Coronarv 
Venous Cellular Delivery: Comparisons of Transplant 
Efficiency, Distnbution, and Efficacy in Reducing 
Infarct Size and Improving Myocardial Function 
1176.174.67A 
RelationshIp of Soluble Angiopoietin Receptor Tie-2 to 
Tissue Factor, Endothelial Dysfunction, and Vascular 
Endothelial Growth Factor in Hypertension 
832.5.261A 
Rupture of the External Elastic Lamina Increases 
Plaque Neovascularization AHer Coronary 
Anqioplastv in the Swine Model 1149.194.55A 
Safe6 of Autblogous Bone Marrow Cell Injection in 
Humans With Severe lschemic Heart Failure 
1176.176.67A 
Sequential Changes in Indices of Anglogenesis, 
Endothelial Damage/Dysfunction and 
Thrombogenesis in Acute Coronary Syndromes 
1173-l 15.367A 
Site-Specific Imaging of Tumor Anglogenesis Using 
Contrast-Enhanced Ultrasound Imaging With 
Microbubbles Targeted to Alpha-V Beta-3 
802.4.431A 
Statin Promotes Coronarv Collateral Circulation and 
Induces the Regrassioi of Left Ventricular Mass in 
Patients With Angina 1181-124.302A 
Surgical Implantation of Bone Marrow Cells May 
Reverse Perfusion and Wall Motion Abnormalities in 
Patients With Previous Myocardial Infarction and 
Dominance of Scar 1004.98.326A 
The Clinical Signifkxnce of Circulating Levels of 
GranulocytelMacrophage-Colony Stimulating Factor 
in Acute Myocardial Infarction Patients 
1049-l 11.343A 
The Early Growth Response-l (EGR-1) Gene Is CritIcal 
to Reperfusion Following Acute Vascular Obstruction: 
Results From a Knockout Mouse lschemia Model 
830.2.279A 
Transeplcardial Autologous Bone Marrow 
Transplantation in a Porcine Nonreperfused 
Myocardial InfarctIon Model: Angiogenesis or 
Myogenesis? 1176-l 39.296A 
Transfection With DNA of Soluble VCAM-1 Causes 
Monocyte Chemotaxls and Increased Endotheltal 
Cell Staining: A New Gene-Therapeutic Approach for 
Angiogenesis? 117%145.296A 
Treatment of Experimental Heart Failure With 
Hepatocyte Growth Factor 409-5.544A 
Tumor Necrosis Factor Signaling Not Important for 
Arteriogenws but for Angiogenesis 1201-l 53.306A 
Vascular Endothelial Growth Factor Induces Both 
Anglogenesls and Arteriogenesis Independently of 
Nitric Oxide 630.6260A 
Angiography 
A New Endpoint to Evaluate the Success of 
Reperfusion Therapy Following ST-Elevation 
Myocardial Infarction 853.3.392A 
A Prospective, Randomized Placebo-Controlled 
Multicenter Trial Evaluatino Fenoldopam Mesvlate for 
the Prevention of Contrastlnduced f&phropaihy: The 
CONTRAST Trial 880FO-3.63A 
Adaptive Coronarv Vessel Remodeling Following 
S&gical Coronary Artery-to-Left Ventricle Stent 
(VSTENTTM) lmplantatlon 1004.96.326A 
Aggressive Treatment Aimed at Raising High-Density 
Lipoprotein Cholesterol in Stable Patients With 
Anoioaraohicallv Evident Coronan, Disease Prevents 
St&o&‘Progr&sion and Reduces Cardiovascular 
Events 878.1.315A 
Angiographic Assessment of Repeffusion in Acute 
Myocardial Infarction by Myocardial Blush Grade 
1049-108.342A 
Angiographic Predictors of Left Ventricular Ejection 
Fraction After Successful Angioplasty in Acute 
Myocardial Infarction: An Angiographic Risk Score for 
Use in the Catheterization Laboratory 1191.29.366A 
Can Changing Referral Patterns Based on ACCiAHA 
Practice Guidelines for Coronary Angiography Be 
Measured? Validation of a Decision Analysis Model of 
Test Appropriateness in Coronary Artery Disease 
Patients 1095.58.526A 
Changing Sex Differences in Invasive Cardiac 
Procedure Rates Following Acute Myocardial 
Infarction 1121.58.527A 
Combined Computed Tomography-Anglogram and 
Positron Emission Tomography Perfusion Imaging for 
Assessment of Coronary Artery Disease in a Novel 
PET/CT: A Pilot Feasibility Study 
1130A-MP-203.439A 
Comparison of the Importance of Increasing Pathogen 
Burden, Elevated C-Reactive Protein, and the 
Presence of AntibodIes to Heat Shock Protein 60 on 
Myocardial Infarction or Death 889.2.408A 
Coronary Ectasia in Pediatric Heart Transplant 
Recipients 1143-160.466A 
Correlation of Coronary Flow Reserve Measured by 
Myocardial Contrast Echocardlography and Coronary 
Angiography 1043-45.413A 
Deceptive Ostlal Coronary Lesions: Lack of 
Relationship Between Imaging and Physiology 
1149.190.54A 
Differences in Outcome of Primary Angloplasty for 
Acute Myocardial Infarction During Routine Duty 
Hours Versus During Off-Hours: Is It the Patient or Is 
It Care? 1097.96.357A 
Divx Compression Allows Medically Lossless lntranet 
or Internet Exchange of Coronary Angiograms 
868-4.536A 
Does Coronary Angioplasty Lead to Accelerated 
Progression-of Non-Criti&l Coronary Artery 
S&noses? 1005A-214.4A 
Elective Coronary Angioplasty and Percutaneous 
Coronary Intervention Dunng Uninterrupted Warfarin 
Therapy 1174-190.63A 
Endothel&l Function and Slow Coronary Flow 
1177-l 30.294A 
Gadolinium Enhanced Coronary Anglography in 
Patients With Impaired Renal Function: A Pilot Study 
1174-193.63A 
Higher Platelet Counts Are Associated With Greater 
Thrombus Burden in Patent Arteries Followina 
Thrombolytic Administration: A TIMI Angiograbhic 
Substudy 1001.109.322A 
ImDrOved Functional Status and Qualitv of Life After 
invasive Management of Non-ST-Segment Elevatfon 
Acute Mvocardial InfarctIon 1196.109.396A 
Incidence and Outcomes of Heparin-Induced 
Thrombocytopenia Following Acute Coronary 
Syndromes 1174-187.62/L 
Incidence of Renal Artery Stenosis in 2,111 Patients 
Undergoing Coronary Angiography: A Model of 
Predictive Risk of Renal Artery Stenosis 
1007-l 73.7A 
Increased Risk of Adverse Outcomes With Proximal 
Culpnt Artery Lesions in Acute Myocardial Infarction 
lOOl-108.322A 
lntracoronary Thermwraphv Provides On-Line lmaqmq 
of the Te&perature Heterogeneity of Atheroscler~tic~ 
Plaoues in Human Beinas 1005.187.1A 
Is the incidence of Coron&y Heart Disease Changing 
Over Time? 1121.51.527A 
Low Socioeconomic Status Is More Predictive of 
Increased Hazard in Women Than Men After 
Angiographic Diagnosis of Coronary Artery Disease 
1169-52.531A 
Mediterranean and Low Fat Diets Are Associated With 
Similar Lipid Levels at 12 Months in Patients With 
Coronary Heart Disease on Statin Therapy 
1056-l 22.243A 
Micro Transducers to Profile Pulsatile Shear Stress 
With Vascular lnflammatorv Rewonses 
1023.51.519A 
Multiple Complex Unstable Plaques Associated With 
Svstemic Inflammation and Adverse Cardiovascular 
dutcomes 1048-89.336A 
Multislice Computed Tomography for Noninvasive 
Coronary Angiography: Diagnostic Accuracy of 
Volume Rendering Versus Maximum Intensity 
Proiection Reconstructions 1067.35.421A 
Nonin~aswe Coronary Angiography by Retrospectively 
Electrocardiographically-Gated, Thin-Slice 
Multidetector-Array Computed Tomography 
870-2.466A 
Predictors of Short- and Long-Term Adverse Outcomes 
Following Saphenous Vein Graft Percutaneous 
Coronary Intervention 1127-194.47A 
Prevention of Renal Function Worsening After Coronary 
Angioplasty: The Role of Acetylcysteine 
1051.192.16A 
Prophylactic Acetvlcysteine Is Not Effective III 
Pr&enting Contrast-Induced Nephropathy Following 
Coronarv AnqioaraDhv 880FO-6.64A 
Pulse Pre&ureat%&y~Stages of Exercise Predicts 
Angiographlcally Determined Coronary Artery 
Disease Severity 1161.60.196A 
Qp/Qs in Atrial Septal Defects by Cardiac Magnetic 
Resonance imaging Is Comparable to QplQs by 
Cardiac Catheterization 1130A-MP-205.439A 
Randomized Comparison of Fenoldopam and 
N-Acetylcysteine to Saline in the Prevention of 
Radio-Contrast Induced Nephropathy 
1003.115.327A 
Role of Cardiac Troponin-I for the DetectIon of Early 
Graft Occlusion Following Coronary Artery Bypass 
Graftina 1182-25.5134 
ST Elevaion Myocardial Infarction Caused by 
Spontaneous Distal Embolizatlon From Unstable 
Lesions: Frequency and Sequelae of a Distinct 
Pathophyslological Entity 1170.104.361A 
Statin Promotes Coronarv Collateral Circulation and 
Induces the Regression of Left Ventricular Mass in 
Patients With Angina 1181.124.302A 
Svstemlc Inflammation: Independent Predictor of 
.Contrast Induced Nephrop’athy 1200-l 41.306A 
The Accuracv of Multislice Soiral Comouted 
Tomography Using a Nova\ ECG-Gaied Image 
Recor%truction M&hod for the Assessment of 
Coronarv Artery Stenosis 1067.36.421A 
The Angio&aphi&l Stenotic Flow Reserve Compared 
to lntracoronary Hemodynamic Parameters for 
Evaluation of Coronary Lesion Severity 
1077-202.3OA 
The Effects of Sirolimus-Elutina Stents on In-Stent and 
Peri-Stent Restenosis: An Aigiographic Subanalysis 
From the SIRIUS Trial 1030.186.14A 
The Role of Acetylcysteine in Preventing 
Contrast-Induced Nephropathy Following Cardiac 
Catheterization in Patients With Acute and Chronic 
Renal Failure 1075MP-16423A 
Warfann Therapy Improves Clinical Outcome of 
Kawasaki Disease Patients With Giant Coronarv 
Aneurysm 1143.155.465A 
What Is the Frequency, Functional, and Clinical 
Significance of Complex Lesions in 
Noninfarct-Related Arteries in Acute ST-Segment 
Elevation Myocardial Infarction? 1172-99.365A 
Angioplasty 
A Hiqher Vascular lniurv Index Is Associated With a 
Higher Incidence df l&Zsnt Restenosis: Insights 
From the PRESTO Trial 667-4.76A 
A Mathematical Model of Preventing Plaque Rupture 
With Drug-Eluting Stents Based tipon Distance From 
the Ostium to the Culorit Lesion in ST Elevation 
Myocardial Infarction ‘1052.18520A 
A Prospective Randomized Multicenter Trial Comparing 
Distal Protection Durinq Saphenous Vein Graft 
Intervention With a F&Based Dewe Compared to 
Balloon Occlusion and Asoiration: The FIRE Trial 
820-4.43A 
A Prospective, Randomized Placebo-Controlled 
Multlcenter Tnal Evaluatlna Fenoldooam Mesvlate for 
the Prevention of Contrast-induced tiephropaihy: The 
CONTRAST Trial 880FO-3.63A 
A Prospective, Randomized Tnal of 
Thromboatherectomy During Intervention of 
Thrombotic Native Coronary Arteries and Saphenous 
Vein Grafts: The X-TRACT Trial 820-l .43A 
A Randomized Comparison of Dalteparin Versus 
Unfractionated Heparin During Percutaneous 
Coronary Interventions 1176-201.66A 
A Risk Score for Prediction of Contrast Induced 
Nephropathy After Percutaneous Coronary 
Intervention 1099.192.37A 
Abciximab F&administration: Ftnal Results of the 
Reopro@ Readmimstration Registry 887.2.77A 
Accelerated Transplant Vasculopathy Portends 
Proliferative Restenosis After Percutaneous Coronary 
Intervention in Cardiac Transplant Patients 
1052.178.19A 
KEY: Abstract Title, Session-abstract number-page number 
604A SUBJECT INDEX JACC March 19,2003 
Adjunct& Porous Filter Protection From Distal 
Embolizatlon in Primary Percutaneous Intervention 
for Acute Mvocardial Infarction 1127-18946A 
Adventitial Response and Expansive Remodeling After 
Intravascular Brachylherapy in a Rabbit Model of 
Restenosis 1099-191.37A 
Angiographic and Clinical Outcomes of Patients Treated 
With Primary or Rescue Angioplasty in Saphenous 
Vein Gran for Acute Myocardial Infarction 
1172-98.366A 
Angiographic Assessment of Reperfusion in Acute 
Myocardial Infarction by Myocardial Blush Grade 
1049-l 08.342A 
Angiographic Predictors of Left Ventricular Ejection 
Fraction After Successful Angioplasty in Acute 
Mvocardial Infarction: An Anoioaraohic Risk Score for 
U6e in the Catheterization Gb&iory 1191-29.388A 
Angioplasty Versus Coronary Artery Bypass Surgery !n 
Patients With Chronic Kidney Disease 1051-194.18A 
Assessment of Anticoagulation Using Activated Clotting 
Times in Patients Receiving Intravenous Enoxaparin 
During Percutaneous Coronary Intervention 
1176.200.68A 
Assessment of Health-Related Qualitv of Life Amona 
Patients Undergoing Peripheral P&cutaneous - 
Intervention: The ALEVE [Assessment of Lower 
Extremity reYasc”larizatio~outcornEs) Study 
1047-57.522A 
Baseline C-Reactive Protein and Cardiac Troponin I as 
Predictors of Outcome Following Percutaneous 
Coronary Intervention in Stable and Unstable 
Coronary Disease 1029-189.1OA 
Baseline features and Climcal Results in Patients 
Excluded From Randomization From a Laroe 
lnternatlonal Trial of Repeffusion Strategieg in Acute 
Myocardial Infarction: The CADILLAC Registry 
827-2.368A 
Baseline Hemoglobin Is a Novel Predictor of Mortality 
After Percutaneous Coronary Intervention 
1029-188.10A 
Baseline Plasma Creatinine Is an Independent 
Predictor of In-Hospital Mortal& After Percutaneous 
Coronary Intewent/on 1005A-il5.4A 
Baseline Serum Creatinine Level Strongly Predicts Risk 
of Procedural Failure of Percutaneous Coronary 
Intervention in Patients With Acute Myocardial 
Infarction: Results From the Jaoanese Multicenter 
AMI Registry (JAMI) 1172.94.&A 
Benefit of Clopidogrel in Pabents Undergoing 
Percutaneous Coronarv Intervention in the CURE 
Trial Receiving and Noi Receiving an lntracoronary 
Stent 823.6.45A 
Benefits and Risks of Abciximab Use in Primary 
Angioplasty for Acute Myocardial Infarction: ?he 
CADILLAC Trial 1097-95.357A 
Bifurcational Coronary Artery Lesion Treatment With 
Rapamicine-Elutlng Stents: Results From a Single 
Center Experience 639FO-3.53A 
Bivalirudin Prowdes Increasing Benefit With Declining 
Renal Function in Percutaneous Coronary 
Intervention: A Meta-Analysis of 5,035 Patients 
Enrolled in Three Randomized Trials 880FO-2.83A 
Bivalirudin Reduces Hemorrhagic Complications and 
Glycoproteln IIB/IIIA Inhibitor Usage in Coronary 
Intervention: Results From the NYU Bivalirudin 
Registry 1005A-219.5A 
Bivalirudin Reduces lschemic and Hemorrhagic 
Complications of Percutaneous Coronary 
Intervention: Pooled Data From 10 Prospective 
Studies in 6,134 Patients 1075MP-170.26A 
Can Preinfarction Angina Limit Infarct Size in Patients 
With a First Q-Wave Myocardial Infarction 
Undergoing Primary Percutaneous Coronary 
Angioplasty? 1096-l 11.355A 
Can Tapered-Tip Guidewires improve the Success Rate 
of Percutaneous Coronary Intervention in Chronic 
Total Occlusion? 1127.166.46A 
Cardloprotective Effect of Chronic Treatment With 
Statins Prior to Percutaneous Coronary Intervention 
1075MP-166.24A 
Cerebrovascular Accidents After Percutaneous 
Coronary Interventions: Incidence, Predictors, and 
Outcomes 1005192.2A 
Changing Sex Differences in Invasive Cardiac 
Procedure Rates Following Acute Myocardial 
Infarction liZI-56.527A 
Chronic Kidney Disease: The Silent Killer After 
Coronary Angioplasty 1149.189.54A 
Circadian Fluctuations in Thrombogenicity in Patients 
Undergoing Primary Angloplastyfor Acute Myocardial 
Infarction 1172.32.384A 
Clinical and Angiographic Effects of DirectIonal 
Atherectomy in De Nova Coronary Artery Lesions 
Located at the Ostium of the Left Anterior 
Descending Artery 1076-189.26A 
Clinical Outcome After Prehospital Thrombolysis 
Versus Percutaneous Coronary Intervention for ST 
Elevation Myocardial Infarction: Results of the START 
in Berlin Pilot Study 1197-194.72A 
Clinical Outcomes After Percutaneous Coronary 
Intervention in Right Ventricular Infarction 
1127.193.47A 
Clopidogrel Pretreatment Prior to Percutaneous 
Coronary Intervention Attenuates Periprocedural 
Rise of C-Reactive Protein 1075MP-165.24A 
Clopidogrel Pretreatment Reduces Platelet 
Inflammatory Marker Expression in Patients 
Undergoing Percutaneous Coronary Intervention 
823-5.45A 
Combination of a Direct Thrombin Inhibitor, Argatroban. 
and Glycoprotein Ilb/llla Inhibitor Is Effective and 
Safe in Patients Undergoing Percutaneous Coronary 
Intervention 1176-197.68A 
Combined Angioplasty and Robotic Coronary Bypass 
Surgery in Multivessel Coronary Artery Disease 
646FO-6.380A 
Common Femoral Artery Percutaneous Intervention. 
Feasibilitx Safe&. and Clinical Outcomes 
1199-Z& .77A 
Coronary Artery Bypass Graft Surgery Rates Are 
Decreasing: An Analysis of Trends in Surgery and 
Percutaneous Coronary Intervention Rates in 
Washington State From 1987-2001 1121-52.527A 
Coronary Brachytherapy Is an Effective Treatment for 
Chrome In-Stent Total Occlusions 1128-179.48A 
Coronary Flow Pattern in the Left Anterior Descending 
Artery Could Predict Systolic Function Recovery After 
Primary Angioplasty: A Transthoracic Doppler 
Echocardiography Study 1117.40.435A 
Coronary Interventions in 1,070 Consecutive 
Octogenarians: Complication Rates in Diabetic 
Versus Nondiabetic Patients 1162.87.20lA 
Correlation Between Statin Theraov Before 
Percutaneous Coronary Interve%on, Periprocedural 
Creatine Kinase-MB Release, and Mortality at 
Follow-Up 867-l .77A 
Current Status of Percutaneous Coronary InterVentiOh: 
Results From a Large International Trial 
1075MP.163.23A 
Cutting Balloon Angioplasty Versus RotatIonal 
Atherectomv for Treatment of Diffuse In-Stent 
Restenosis:‘Multicenter Registry in Japan 
l OSS-189.36A 
Cuttina Balloon Atherotomv Is Associated With 
Decreased Stent Utilizat;on 1149.191.56A 
Diabetes Does Not Add to the Increased %-Month 
Mortality Associated With Increase in CK-MB After 
Percutaneous Coronary Intervention 1149-192.55A 
Diabetes Mellitus and Long-Term Impact on Renal 
Function in Patients With Renal Artery Stenosis 
Receiving Percutaneous Translominal Renal 
Angioplasty and Stent Placement 1199-177.76A 
Diabetics Achieve Lower Activated Clotting Time When 
Given the Same Dose of Heoarin as NondIabetics 
During Percutaneous Coron&y lnterventlon 
102%196.12A 
Differences in OutCOme Of Primaw AnaloDlastv fOr 
Acute Myocardlal InfarctIon During Rbiine buty 
Hours Versus Durina Off-Hours: Is It the Patient or Is 
It Care? 1097.96.3g7A 
Differential Proliferative Index of Resident Smooth 
Muscle Ceils and Infiltrating Leukocytes After Balloon 
Angioplasty and Stenting of Swine Coronary Arteries 
1054-141.24OA 
Direct Physiological Evidence of Damage to Collaterals 
During Primary Coronary Angioplasty for Acute 
Myocardial Infarction 1123-l 13.363A 
Distal Myocardial Protection With lntracoronary 
Propranolol During Percutaneous Coronary 
Intervention Is Widely Applicable 1051.188.17A 
Do Good Collaterals increase the Risk of Reocclusion 
After Recanaliration of a Chronic Coronary 
Occlusion? 1175181.65A 
Do Overlapping Multiple Sirolimus-Eluting Slents 
Impact Angiographic and ClinIcal Outcomes? Insights 
From the SIRIUS Trial 805~533A 
Do the Ethnic Differences in Presentation and 
Treatment Strategy Influence Outcomes of 
Contemporary Percutaneous Coronary Intervention? 
A Report From the National Heart, Lung, and Blood 
Institute Dynamic Registry 1051-f93.18A 
Does a Thrombotic Lesion Detected by Coronary 
Angiography Always Contain a Thrombus? An 
Intravascular Ultrasound Study 1007-201.9A 
Does Coronary Angioplasty Lead to Accelerated 
Progression of Non-Critical Coronary Artery 
Stenoses? 1005A-214.4A 
Does Genetic Polymorphism for Platelet Glycoprotein 
llla Impact Early and Long-Term Outcomes After 
Elective Percutaneous Coronary Interventions? 
1029-195.124 
Does Pretreatment With Statins Before Percutaneus 
Coronary Intervention Reduce Myonecrosis? 
1083-143.256A 
Early Fluvastatin Treatment Reduces the Long-Term 
Incidence of Major Adverse Cardiovascular Events 
Following Successful First Percutaneous Coronary 
Intervention With or Without the Use of Stent: The 
LescolB Intervention Prevention Study 
lOlO-146.227A 
Economic and ClInical Analysis of Elective 
Percutaneous Coronary Intervention Without On-Site 
Cardiac Surgery 820.5.44A 
Effect of a Novel Pharmacological Strategy to 
Counteract Shivering During Endovascular Cooling 
for Acute Myocardial Infarction 1197-196.72A 
Effect of Creatine Kinase Elevation Following 
Percutaneous Coronary Intervention on Long-Term 
Mortality 1029.192.llA 
Effect of Diabetes Mellitus on the Predictwe Value of 
Myocardial Fractional Flow Reserve 100%210.2A 
Effect of Distal ProtectIon or Thrombectomy on 
Corrected Thrombolysis in Myocardial Infarction 
Frame Counts in Stenting for Acute Myocardial 
Infarction 1097~94.356A 
Effect of Ethnicity on Long-Term Outcomes Following 
Percutaneous Coronary Intervention in a Setting With 
Universal Access to Health Care 1169.53.531A 
Effect of Gender According to Age on In-Hospital 
Mortality in Patients With Acute Myocardial Infarctjon 
in the ACC-National Cardiovascular Data Registry 
885.3.54OA 
Effect of Highly Dosed Molsidomlne on Restenosis 
Rate After Coronary Angioplasty: A Randomized 
Placebo-Controlled Double-Blind Trial 867.3.78A 
Effect of Intravenous Glycoprotein Ilb/llla Receptor 
Antagonists on Survival in Percutaneous Coronary 
Interventions: A Meta-Analysis 823-3.45A 
Effect of Roxithromycin on Clinical Cardiovascular 
Events in Patients Undergoing Coronary Angioplasty 
1026.100.335A 
Effect of Simvastatin on the Inflammatory Response to 
Coronarv Awoplastv 1053-139.22A 
Effective Sient-eased Delivery of Tissue Inhibitor of 
Metalloproteinase 3 to Porcine Coronary Arteries 
Using a Novel Biosynthetic Stent Coating 
1053-174.21A 
Embolic Volume Retrieved Durina Native Coronarv 
Percutaneous Coronary lnterv&tion With Distai 
Protection Is Far Lower Than During Saphenous Vein 
Graft Percutaneous Coronary Intervention 
Regardless of Plaque Burden 1197-189.71A 
Edifibatlde Blocks C-Reactive Protein Increase After 
‘Coronary Angloplasty 1032-l 32.233A 
Estimating the Cost-Effectiveness of Tirofiban for Acute 
Coronary Syndrome Patients Managed in a Relatively 
Low Interventional Setting: The United Kingdom 
1070.55.524A 
Estradlol Coated Stents for the Prevention of 
Restenosis in Native Coronary Arteries: Results From 
the Randomized Multicentric Studv EASTER 
1150.179.56A 
Excessive Body Weight Does Not Increase the Risk of 
Complications Following Percutaneous Coronary 
Interventions 1075MP.171.25A 
Fastina Plasma Insulin Is an lndeoendent Predictor of 
Cardiac Events at One-Year Atier Percutaneous 
Coronary Revasculariration 1053.20123A 
Final Anglographic and Climcal Results of the Latin 
Amenca Small Vessel Randomized Study (LASMAL 
Trial) 1076-l 85.26A 
First-in-Human Study of Angiopeptln-Eluting Stents: A 
Quantitative Coronary Angiography and Volumetric 
Intravascular Ultrasound Study 1006.182.6A 
Follow-Up Results of Cutting Balloon Angloplasty for 
Pulmonary Artery Stenosis in Children 
1168.162.489A 
Four-Year Clinical Experience With Ad Hoc Fractional 
Flow Reserve Measurement to Guide 
Revascularization Strategy 1077-200.30A 
Functional Health Predicts Future Intervention for 
Coronary Artery Disease 1047-51.52lA 
Gender-Based Differences in Long-Term Outcome 
Following Percutaneous Coronary Intervention 
1127-l 90.46A 
Genetic Risk Diagnosis System for Restenosis After 
Percutaneous Coronary Intervention 820-6.44A 
Glycoprotein Ilb/llla Inhibitors After Full Dose 
Thrombolysis in Rescue Angioplasty for Acute 
Myocardiai Infarction: To Give or Not Gwe? 
1097.101.358A 
Hemoglobin Level Is an Independent Predictor of 
Mortality in Patients Undergoing Percutaneous 
Coronary Artery Interventions 1005A-213.4A 
Hospital Percutaneous Coronary Intervention Volume 
and Patient Mortality: Is the ACC/AHA Volume 
Minimum Appropriate? 671.6.539A 
How Important Is Time to Treatment With Primary 
Percutaneous Coronary lntewention for Acute 
Myocardial Infarctron? Results From the CADILLAC 
Trial 827-l .368A 
Hyperemic Pulse Transmission Coefficient: A i wel 
Index for the Functional Assessment of Microvascular 
Integrity Following Percutaneous Coronary 
Interventions 1151.199.60A 
Hypnosis but Not Drug Sedation Selectively Abolishes 
the Increase in Cardiac Sympathetic Activity 
Associated With Myocardial lschemla During 
KEY: Abstract Title, Session-abstract number-page number 
JACC March 19,2003 SUBJECT INDEX 605A 
Percutaneous Transluminal Coronary Angioplasty 
11642.122A 
Impact of Multivessel Coronary Artery Disease on 
In-Hospital Outcome in Patients Treated by 
Immediate Angioplasty for Acute Myocardial 
Infarction 1097~98.357A 
Impact of Multivessel Disease on Recovery of Left 
Ventricular Function After Primary Angioplasty for 
Acute Myocardial Infarction l lSl-49389A 
Improved Clinical Outcomes With Abciximab Therapy in 
Acute Myocardial Infarction: A Systematic Overview 
of Randomized Clinical Trials 1025MP-166.333A 
Improved Efficiency in Both Inkrat Reperfusion Therapy 
and Subsequent Acute Myocardial Infarction Care 
Through Commitment to Emergency 
Department-Initiated Primary Percutaneous 
Coronarv Intervention 1001-l 13.323A 
In-Hospitai and One-Year Outcomes Accordrng to 
ST-Seament Resolution in Hiah-Risk Patients With 
AcuteMywardial Infarction TFeated With Primary 
Angioplasty or Thrombolysis: Date From the 
MISTRAL Study 1147~99378A 
Incidence and Outcomes of Heparin-Induced 
Thrombocytopenia Following Acute Coronary 
Syndromes 1174-187.62A 
Incidence, Management, and Outcomes of Coronary 
Perforation: An Analvsis of 16,298 Patients 
1197.193.72A 
Mechanical Disruption of Atherosclerohc Plaques 
During Percutaneous Coronary Intervention Results 
rn Acute Plasma Increases in Oxidized Low-Densky 
Lipoprotein and Lp(a): Implications for Understanding 
Vulnerable Plaques 1054-137.239A 
Mechanisms of Lumen Enlargement Durina Stentina of 
Acute Myocardial Infarctionlesions: A V&netric 
Intravascular Ultrasound Study 642-4.6lA 
Mid-Term Results of Thrombus Extraction in Patients 
With ST Elevation Myocardial Infarction: One Center 
Experience With the X-SIZER Catheter System 
1097.93.356A 
Prevention of Rheolytic Thrombectomy Induced 
Bradyarrhythmias With Aminophylfine 1051-195.18A 
Primary Angioplasty Reduces Mortality in Elderly 
Patients With Right Ventricular Infarctron 
1071.114.348A 
Primary Angioplasty Under D&al Protection Is a Useful 
Strategy to Obtain Optimal Myocardial Reperfusion 
Compnred to the Primary Angioplasty With 
Thrombectomy Device in Acute Myocardial Infarction 
Patients 1049-l 12343A 
Primary Coronary Angioplasty After Transfer Versus 
On- Site Thrombolysis in Acute Myocardial Infarction: 
A Mete-Analysis 1172~95.384A 
Pnmarv Percutaneous intervention in Patients With 
Prio;Coronary Artery Bypass Grafting Admitted With 
Acute Myocardial Infarction: Results of the 
ALKK-Reaistrv 1197.187.71A 
Primary Use of the Cutting Balloon Results in Fewer 
Maior Adverse Cardiovascular Events at Six Months 
Than Balloon Angioplasty in a Subgroup of Patients 
With Ostial/Bifurcation or Small Vessel Lesrons 
1005A-2175A 
Mobilized Bone Marrow Stem Cells Accelerate 
Reendothelialization. Reduce Vascular Inflammation. 
and Prevent &stenosis After Intravascular Radiation 
80.5133A 
Multiple Lesion Coronary Intervention Is Associated 
With Hrgher Mortality in Primary Angioplasty for 
Acute Mvocardial infarction: The Stent PAMI Trial 
827-4.3&A 
Multivessel Percutaneous lnterventron for ST-Segment 
Elevation Mvocardial Infarction: The Mew Clinic 
Experien&1001-208.324A 
Neither Periprocedural Pregnancy-Associated Plasma 
Protein A nor C-Reactive Protein Levels Predict 
Restenosis 1053.200.22A 
No Mortalitv Benefit of Primary Anaioplastv Over 
Thromboiytic Therapy in Patient~V\iith N&anterior 
Myocardial Infarction at Long-Term Follow-Up: 
Results of the Zwolle Trial 627-5.369A 
Obligate Role of Macrophage Colony-Stimulating 
Factor for the Development of Neointrmal Thickenina 
Following Arterial Inj”ry 608.5.34A 
One-Year Follow-Up of the SIRIUS Study: A 
Randomized Study With the Sirolimus-Elutina Bx 
VELOCITY TM in the Treatment of Patients With De- 
NOVO Native Coronarv Arterv Lesions 805-3.32A 
Oral Sirolimus to Prevent Restenosts After Stenting De 
Nova Coronary Lesions 1075MP-16924A 
Outcome After Urgent Percutaneous Coronary 
Interventions in ASSENT-3 1 lSl-46389A 
Outcome of Patients With Acute Myocardial Infarction 
Admitted to Hospitals With and Without Facilities for 
Primary Percutaneous Coronary Intervention: Data 
From the AMI-Florence Reaistrv 1097.102.358A 
Outcomes in Patients Requrrgg Bail-Out Abciximab 
Dunng Primary Intervention in Acute Myocardial 
Infarction: Analysis From the CADILLAC Trial 
1025MP-169.333A 
Prognostic Value of the Absolute Degree of 
ST-Segment Elevation of the ECG at Baseline and 
After Primary Angioplasty: Analysis From the 
CADILLAC Trial 1001-l 12.323A 
Prolonged Antiplatelet Therapy After Coronary 
Brachytherapy: When Is It Safe to Stop Cloprdogrel? 
1128-163.49A 
Prospective Study of Primarv Percutaneous 
Intervention and Abciximab in Patrents With ST 
Elevation Myocardial Infarction Complicated by 
Cardiogenic Shock 1196-l 07.398A 
Protection Against Reperfusion Injury With ITF-1697 rn 
Acute Mvocardial Infarction: The PARI-MI Trial 
881 FO-3.404A 
Incremental Cost-Effectiveness of Early and Long-Term 
Clopidogrel in Patients Undergoing Percutaneous 
Coronary Infarction in the CURE Trial: The 
PCI-CURE Economic Analysis 1171-I 12.383A 
influence of Diabetic Treatment Status on Survival After 
Successful Percutaneous Coronary Intervention 
1197-l 92.72A 
Injection of Monteplase Priorto Percutaneous Coronary 
Intervention Maintains Left Ventricular Function and 
Prevents Left Ventricular Remodeling in Acute 
Myocardial Infarction Combining Monteplase With 
Angioplasty, COMA Tnal 1191.28.387A 
Interferon Gamma Receptor 1 88 GIA Polymorphism 
and Restenosis Following Coronary Artery Stenting 
107%179.3lA 
International Trends in the Use of Primary 
Percutaneous Coronaw Intervention 1005A-216.4A 
lntracoronary Beta-Blocker Protects the Distal 
Myocardium During Percutaneous Coronary 
Intervention 88OFO-4.84A 
lntracoronary Beta-Irradiation 24 Hours After 
Percutaneous Coronary Interventions: A Serral 
Volumetric Intravascular Ultrasound Study 
1099-l 96.36A 
Randomized Trial of Balloon Angioplasty Versus 
Stenting for the Treatment of Long Coronary Lesions 
1052-l 64.20A 
Randomized Trial of Pnmarv Anaioolastv Versus 
Prehospital Hibrinolysis in Acuie ‘Myooardial 
Infarction: One-Year Survival Results 827.6.369A 
Reduction in Hospital Mortality by First Day 
Percutaneous Coronary Intervention for Non-ST 
Elevation Myocardial Infarction rn Diabetics: Results 
of the ACOS-Registry 1196-108.398A 
Reduction of Restenosis in Percutaneous Coronary 
Interventions by Hyperbaric Oxygen Therapy 
1051-189.17A 
Regional Variations in Treatments and Outcomes of 
Reinfarction in the HERO-2 Trial 1071-l 11.347A 
Relationship Between Time-toReperfusion and 30-Day 
Mortality in Patrents With ST-Seament Elevatron 
Myocardial Infarction Treated With Primary 
Angioplasty 827-3.368A 
Renal Angroplasty and Stenting Under Distal Protection 
86%6.80A 
lntracoronary Calcrum Channel-Blocker Is Associated 
With Earlier Release of Cardiac Enzymes After 
Comnary Intervention 1053-198.22A 
lntracoronary Gamma Radiation for Elderly Patients 
1128-i 80.46A 
lntracoronary Hyperoxemrc Blood Infusion Following 
Primary Percutaneous Coronary Intervention in 
Anterior Acute Myocardial Infarctron Patients: Positive 
Effects on Cardiac Enzyme Kinetic, ST-Segment 
Changes. and Left Ventricular Functron Recovery 
1049-l 13.343A 
Is Insulin Resistance Associated With One-Year Target 
Vessel Revasculanzation Rates Results From 
CREDO IRS? 1174.195.64A 
Percutaneous Coronary Intervention and Very Low 
Dose of Heparin: ACT Anti-Xa and Creatine Kinase 
Monitoring 1005A-218.5A 
Percutaneous Coronarv Intervention Durina the Index 
Hospitalization Is As&ciated With Reduced 
Recurrent Myocardial Infarction and Improved 
Survival Following Thrombolytic Administration 
1196-l 06.396A 
Percutaneous Intervention of Common Femoral Artery 
for the Treatment of Limb lschemia 1199202.77A 
Percutaneous Transluminal Angioplasty of lnfrapoplrteal 
Arteries in Patients With Intermittent Claudication: 
Acute and One-Year Results 1199-19976A 
Persistent Benefit of Coronary Artery Stenting Versus 
Balloon Angioplasty for Isolated Stenosis of the 
Proximal Left Anterior Descending Coronary Artery: 
Five-Year Clinical Follow-Up 1052-183.2OA 
Pilot Study With Oral Rapamycin in Patients 
Undergoing Stenting in Coronary Arteries: Buenos 
Aires Experience (ORAR Trial) 87%3&ZA 
Predictors of Adverse Events Complicating Carotid 
Artery Stentina in the Era of Distal Protection Devices 
1129:199.52~ 
Renal lnsuffrciency and Anemia in Patients Undergoing 
Percutaneous Coronary Interventions: A Double 
Jeopardy 1029-193.1 iA 
Renal lnsufficiencv Is an lndeoendent Predictor of 
Mortality After Percutaneoui Coronary Interventron: 
Current Results From the NHLBI Dynamic Registry 
1005-189.lA 
Restenosrs Is Not Increased in Mild or Moderate 
Chronic Kidnev Disease: Results From the PRESTO 
Trial 1075MP1167.24A Left Ventricular Ejection Fraction, Enzyme Release, and 
Stent lmplantaton Are Independent Predictors of 
Late Clinical Outcome After Late Opening of 
Infarct-Related Occlusion 1196-l 10.399A 
Left Ventricular Function in the Stent or Surgery Tnal 
One Year After Randomization to Coronary Artery 
Bypass Graft Surgery or Stem Percutaneous 
Coronary Intervention 1076-184.25A 
Left Ventricular Remodeling Is the Most Common 
Cause of Svstolic Dvsfunction After Acute Mvocardial 
Infarction: Findings irom the Stent-PAMI St;dy 
1159MP-166.194A 
Restoration of Normal Coronary Flow After No-Reflow 
Phenomenon Does Not Improve Post-Procedural 
Myocardial Infarction in Patients Without ST-Segment 
Elevation Myocardial Infarction 1029.190.10A 
Results of the PIXEL Study: Randomized Multicenter 
Trial Comparing Direct and Conventional Predilation 
Stenting in Small Vessels 1076-186.26A 
Reversal of Slow or No-Reflow During Percutaneous 
Transluminal Coronary Angioplasty Using Boluses of 
lntracoronaw Adenosine and Sodium Nitroprussrde 
rn Combinakon 1101.201.39A 
Role of AKT (Protein Krnase B) in Modulating Vascular 
Response to Injury 1031.197.15A 
Safety and Efficacy of Subcutaneous Enoxaparin in 
Early Invasive Strategy of Unstable Angina 
1176.199.66A 
Predictors of Neointimal Regression Six Months After 
Intravascular Brachytherapy for In-Stent Restenosis 
1007-199.9A 
Predictors of Short- and Long-Term Adverse Outcomes 
Following Saphenous Vein Graft Percutaneous 
Coronary Intervention 1127-194.47A 
Predictors of Treatment Delav in Patients With Acute 
Myocardial Infarction Undergoing Primary 
Anaioolastv: An Analvsis From the CADILLAC Trial 
I I i7-b3.3+6~ ’ 
Long-Term Follow-Up (15.Year) Results of Balloon 
Coarctation Angioplasty in the Adolescent and Adult 
Patient 1168.158.488A 
Safetv of Adiunctive Glvcoorotern Ilb/llla Blockade 
D&g R&cue/Early’Pe~cuteneous Coronary 
Intervention Following Full-Dose Fibrinolykc Therapy 
for Acute Myocardral Infarctron 1025MP-163.332A 
Safety of Percutaneous Coronary Interventions Without 
On-Site Cardiac Surgery: A Recent IO-Year 
Experience of 5,909 Cases 1052-180.19A 
Serum Levels of Hiah-Sensitive C-Reactive Protern 
Predict Rester& After Stent Implantation in 
Patients With Unstable Angina 813-5.36A 
Should Sirokmus-Eluting Stents Be the New Standard 
for Left Antenor Descending Therapy? A SIRIUS 
Substudy 1198-l 7973A 
Sirolimus-Eluting Stent for Treatment of In-Stent 
Restenosis: One-Year Angiographic and Intravascular 
Ultrasound Follow-Up 1030-178.12A 
Lower Preprocedural Hemoglobin Level Is Associated 
With Increased Risk of In-Hospital Mortality Followrng 
Percutaneous Coronary Intervention 871.5.539A 
Magnitude and Impact of After Hours Treatment Delay 
in Patients Undergoing Primary Angioplasty for Acute 
Myocardial Infarction. The CADILLAC Trial 
1005lSO.lA 
Management and In-Hospital Outcome for Patrents 
With Acute Myocardial Infarction in Contemporary 
Practice: Japan Acute Myocardral Infarction (JAMI) 
Study--Prospective Multicenter Observatronal Cohort 
Study in Japan 1193-56.533A 
Marked Mortality Risk of Renal Insufficiency in Patrents 
Undergoing Primary Angioplasty for Acute Myocardial 
Infarction 1172.93.364A 
Marked Survival Benefit Associated With Statin 
Pretreatment Pnor to Percutaneous Coronary 
Intervention Is Dependent Upon the Preproceduraf 
Inflammatory Status 880FO-5.64A 
Prehospital Thrombolysis Accelerates Myocerdial 
Reperfusion Compared to Percutaneous Coronary 
Intervention for ST-Segment Elevation Myocardial 
Infarction: Results of the START in Berlin Pilot Study 
1172~97.385A 
Preinterventional Levels of C-Reactive Protern and 
Platelet Function in Patients With Stable Angina 
1175-l 78.64A 
Preprocedural Lesion Morphology es Assessed by 
Intravascular Ultrasound Predicts Thrombolysis in 
Myocardial infarction Frame Counts Following 
Percutaneous Coronary Intervention for the 
Infarct-Related Artery 842.2.61A 
Preprocedure Inflammatory State Predicts 
Periprocedural Myocardial Infarction After Elective 
Percutaneous Coronary Intervention: An EPIC 
Substudy 1051.190.17A 
KEY: Abstract Title, Session-abstract numberpage number 
606A SUBJECT INDEX JACC March 19,2003 
ST Elevation Myocardial Infarction Caused by 
Spontaneous Distal Emboliration From Unstable 
Lesions: Freauencv and Sequelae of a Distinct 
PathophysiologicaiEnttty 1 t70-104.38lA 
Stentina After Cuttino Balloon Versus Plain Old Balloon 
Angilplasty: Inter& Results of the REDUCE Ill Trial 
1099-l 90.37A 
Subacute Stent Thrombosis After Sirolimus-Eluting 
Stent implantation in Daily Practice: Results From the 
Rapamycin Eluting-Stent Evaluated 6t Rotterdam 
Hospital (Research) Registry 1053-20223A 
SucceosfufLate Reperfusion by Primary Angioplasty 
Reduces Risk of Mechanical Complication in Patients 
With Acute Myocardial Infarction i029-194.llA 
Survival Following Percutaneous Coronary 
Interventions Versus Coronary Artery Bypass Graft in 
Northern New England 1005A-210.3A 
Temporal Trends of One-Year Reinfarction and Mortality 
Rates Following Primary Angioplasty I” High-Rrsk 
Acute Myocardial infarction Patients 1174-196.64A 
The Effect of lschemic Preconditioning Is Preserved on 
QT Oispersfon in Elderly Patients Undergoing 
Coronarv Anoioolastv 1115-9.109A 
The French Regisiry oiLaft Main Coronary Artery 
Treatment: Preliminary Results 1127-167.46A 
The Frequency and Consequences of Angiographic 
Aneurysms After Sirolimus-Eluting Stents: Results 
From SIRIUS 1030-161.13A 
The Impact of Srrolrmus-Eluting Stents in Diabetics: 
Results From the SIRIUS Trial 839FO-6.64A 
The Impact of Srrolimus-Eluting Stents on the Outcome 
of Patients With Bifurcatton Lesrons 1030-160.12A 
The tmportance of Combined Pressure and Flow 
Velocity Measurements to Evaluate the 
Hemodynamic Effect of Percutaneous Coronary 
Interventions 1149-i 96.56A 
The importance of Microvascular Resistance In 
Restoration of Coronary Perfusion After 
Percutaneous Coronarv Intervention 1197.191.7lA 
The Influence of Baseline Thrombocytopenia on the 
Outcomes of Percutaneous Coronary Interventions 
1174.191.63A 
The Outcome of Percutaneous Coronary Interventions 
of Saohenous Vein Grafts in Diabetic Patients 
Compared to Nondiabetic Patients 1127-l 92.47A 
The Role of Myocardial Revascularization Surgery and 
Percutaneous Coronary lnterventfon in the 
Long-Term Follow-Up of Elderly Patients With 
Myocardial Infarction 1112.62.179A 
The Smoker’s Paradox I” Patients Undergoing 
Percutaneous Coronary Intervention: A Report From 
the Dynamic Registry 10.61.167.16A 
Tirofiban Does Not Attenuate the Acute Inflammatory 
Response Triggered by Percutaneous Coronary 
lnterventrons 1174.169.63A 
Tissue Factor Predicts Long-Term Outcome After 
Percutaneous Coronary Revascularizatro” 
1176-202.69A 
Transcatheter Angioplasty for Acquired Pulmonary Vein 
Stenosrs Followrng Radiofrequency Ablation 
6343.118A 
Treatment of Saohenous Vefn Bvoass Grafts With 
Ultrasound Thrombolysis: A Randomized Study 
620.2.43A 
Trends in Door to Balloon Times Among Hugh-Rusk 
Patients Undergoing Primary Angioplasty 
100%211.2A 
Triple Antiplatelet Therapy Does Not Increase Femoral 
Access Bleeding With Vascular Closure Devices: 
Results From TARGET 1051.196.18A 
Troponrn I Elevation Following Percutaneous Coronary 
lnterventron Does Not Predict Future Adverse 
Outcomes 1193-52.532A 
Unfractionated Hepann Increases Platelet-Monocyte 
Binding In Vrtro and in Patients Undergoing 
Percutaneous Coronary lnterventro” 1176.196.68A 
Unstable Versus Stable Angrna in the Current Era: 
Comoarison of Percutaneous Coronary Intervention 
Outcomes in the NHLBI Dynamrc R&try 
1005.1661A 
Vascular Acoustic Emission Parameters Better Identify 
and Characterize Angioplasty-Induced Injury 
1005.191.2A 
Vascular Disease Independently Predicts Worse 
Outcome After Percutaneous Coronary Intervention. 
Results From the NHLBI Dynamic Registry 
1005A-211.3A 
Angioscopy 
Are Multiple Plaque Disruptions More Common in 
Patients With Acute Coronary Syndrome Than in 
Patients With Stable lschemic Heart Drsease? 
1102-176.41A 
Association Between Angroscopically Determined 
Parameters of Atherosclerosis and Classical Risk 
Factors of Myocardial Infarction IOEO-123.251A 
Reductfon of Hospital Mortality in Patients With ST 
Elevation Myocardial Infarction Receivmg 
Glycoprotei” Ilb/llla Antagonlsts: Results of the 
ACOS Regrstry 1025MP-168.333A 
Use of Glycoprotein llbillla Receptor Blockers Before 
and During Percutaneous Coronary Intervention for 
Acute Coronary Syndromes Versus Stable Angina in 
Consecutive Patrents in Europe: Results of the 
International SHAKESPEARE Registry 
1001-l 11.323A 
Angiotensin II 
Altered Angiotensin II-Induced Activation of Intracellular 
Signalling Pathways in Failing Human Ventricular 
Myocytes 1156.73.193A 
Angiotensin II Type-l Receptor Antagonist Inhibits 
Vascular Phenotypic Change and Remodeling in 
Intramyocardial Arteries by Reducing Oxidativa 
Stress Through Upregulation of Superoxide 
Dismutase 1177-l 29.294A 
Angiotensi” ReceptorType 1 (AT,) Independent Growth 
Effects of Intracellular Angiotensrn II (Ang II) in 
Cardiac Myocytes 1132-121.273A 
Antiinflammatory and Antiangiogenetic Effect of 
Ramiprilat: Angtotensin Converting Enzyme Inhibition 
in Monocytes Prevents Their Angiotensin II- and 
Hypoxia-Induced Cytokine Expressron by 
Downregulation of AT-1 Receptor Expression and 
NF-kappaB Activation 675.5.315A 
Cardiovascular Morbidity and Mortality in Hypertensive 
Patients With Atrial Fibrillation: The LIFE Study 
1133-147.2761 
Chronic Oral Endothelin-A Receptor Antagonism 
Activates the Renin-Angiotensin-System With 
Persrsting Sodium Retention in Experimental Heart 
Farlure 1156-69.192A 
Effect of Candesarla” Cilexetil on Left Ventricular 
Remodeling in Mitral Regurgitation: A Randomized 
Clinical Trial 1064.25.501A 
Effects of Metoprolol on Oxidant Stress Parameters and 
Nrtnc Oxide Broavailabrlity in Angiotensi” II Induced 
Hypertension 1177.134.295A 
Effects of Valsartan and Valery1 btlydroxy Valsartan on 
Human Platelets: A Possible Missing Link to Explain 
Reduction of Acute Vascular Events With Angiotensin 
II Receptor Blockers 1203-125.310A 
Inhibition of Plasmrnoge” Activator Inhibitor Type-l 
Expressron in Human Adipose Tissue: An 
Anttthrombotic and Antiatheroaenic Effect of ANP 
CNP, and BNP 1032.133.233i 
Interactive Effects of the ACE DD Polymorphism With 
the NOS Ill Homozvaous G649T (Glu296-Asp) 
Variant I” Determinf~g Endothelial Function in 
Coronary Artery Disease 1202-149.309A 
People at Increased Risk of Cardiovascular Disease 
Screened for the NAVIGATOR Trial Frequently Have 
Undiaonosed Diabetes or Impaired Glucose 
Tolerance 1169-51.5308 
Rapid Electrical Stimulation of Contraction Modulates 
Gap-Junction Protein in Cultured Neonatal Rat 
Cardiomyocytes: Involvement of Mitogen-Activated 
Protein Kinases and Effects of Anaiotensin II 
Receptor Antagonist 6.256-tl3i 
Relation Between Angiotensfn-Converting Enzyme II 
Genotvoe and Cardfovascular Events in Patients With 
Hyperirophic Cardiomyopathy 1014.62.146A 
Role of Kinins and Anaiotensin II Tvoe 2 Receptors in 
the Cardioprotective”Effect of Angiotensin II ‘Type 1 
Receptor Antagonists in Brow” Norway 
Kininogen-Deficrent Rats 1156.70.192A 
Scintigraphic and lmmunohistochemical Evidence for 
Localization of Angiotensin Converting Enzyme to 
Myocytes in Human lschemic Cardiomyopathy 
1093-35.427A 
The Effect of Losartan Versus Atenolol on Aortic Valve 
Sclerosis: A LIFE Study 1109MP-t66.505A 
Valsartan Improves Early Morning and 24.Hour Heart 
Rate Variabflity 1115.6.109A 
Valsarta” Produces a Sustained Decrease in Plasma 
Aldosterone Independent of Age, Gender, or Race: 
Results From Val-HeFT 1106-124.265A 
Antiarrhythmia agents 
Antiarrhythmic Agents May Decrease Long-Term 
Survival in Patrents With Implantable Defibrillators 
1064-6.96A 
Beat-To-Beat Variability Is an Independent and Early 
Indicator for d-Sotalol-Induced Arrhythmias In VIVO 
1041.17.9tA 
Effects of Intravenous lbutilide on the Complexity of 
Activation and the Incidence of Reentry During 
Ventricular Fibnllation I” Pigs 1166.3.125A 
Is Dofetilide Safe to Use in Patrents Wrth Implantable 
Cardioverter Defibnllators? 1064-t 9.97A 
Metanalysis of Antiarrhythmic Drugs for Conversion of 
Atrial Fibrillation and the Marntenance of Srnus 
Rhythm: Combining Efficacy and Adverse Effects 
1217.52.536A 
Oral Bolus of IC Antiarrhythmic Drugs for Atrial 
Frbrillation: Outpatient Versus Inpatient 
Administration 1069.11.98A 
Antibodies 
Antrbody Levels Against Chlamydia Pnsumoniae and 
Outcome of Roxithromycin Therapy: Results From a 
Substudy of the Randomized Antibiotic Therapy in 
Acute Myocardial Infarction (ANTIBIO) Trial 
1196.111.399A 
Comparison of the Importance of Increasing Pathogen 
Burden, Elevated C-Reactive Protein, and the 
Presence of Antibodies to Heat Shock Protein 60 on 
Myocardial Infarction or Death 869-2.400A 
Elevated Titre of Antihuman Heat Shock Protein 60 
Predicts a” Adverse Medium-Term Prognosis in 
Patients With Unstable Angina 1173-91.386A 
Enhanced Coronary Artery Disease Risk Prediction by 
Combining Indices Reflecting Pathogen Burden, 
C-Reactive Protein, and Heat-Shock Protein 
Antibodies 669-4.319A 
Importance of Methodology in Chlamydia Pneumoniae 
Serology 1054.139.240A 
Anticoagulants 
Assessment of Anticoagulation Usrng Activated Clotting 
Times in Patients Receiving Intravenous Enoxaparin 
Dunng Percutaneous Coronary Intervention 
1176-200.66A 
Association of Major Bleeding With Adverse Clinical 
Outcomes and Length of Stay: A TACTICS TIMI 16 
Substudy 1 t 46-l 06.375A 
Bivafirudin as Sole Anticoagulant in Peripheral Vascular 
Dwase: A Safety and Feasible AlternatIve in Renal 
and Iliac Interventions 112%201.52A 
Bivalirudin Provides Increasing Benefit With Declrning 
Renal Function in Percutaneous Coronary 
Intervention: A Me&r-Analysis of 5,035 Patients 
Enrolled in Three Randomized Trials 880FO-283A 
Bivalirudin Reduces Hemorrhagic Complications and 
Glycoprotei” IIB/IIIA Inhibitor Usage in Coronary 
Intervention: Results From the NYU Bivalfrudin 
Registry 1005A-219.5A 
Bivalirudi” Reduces lschemic and Hemorrhagic 
Complications of Percutaneous Coronary 
Intervention: Pooled Data From 10 Prospectrve 
Studies in 6,134 Patients 1075MP.170.25A 
Bleeding Complications From Combinations of Aspirer. 
Warfarin, and Thienopyridine Derivatives I” Elderly 
Patients Following Myocardial Infarction 
1040-66.154A 
Bosentan Increases Warfarfn Dosrng Requirements in 
Pulmonary Hypertension tOO6-131.225A 
Combrnatio” of a Direct Thrombin Inhibitor, Argatroba”, 
and Glycoprotein Ifb/llla Inhibitor Is Effective and 
Safe in Patients Undergoing Percutaneous Coronary 
lnterventron 1176-I 97.66A 
Comparison of the Safety and Efficacy of Enoxaparin 
With Unfractionated Heparin and Phenprocoumo” as 
Anticoagulation in Cardioversion of Nonvalvular Atrfal 
Fibrillation t015-1685A 
DALTON Study: A Randomized Study Comparing 
Outpatient Daltepari” Administration to Inpatient 
Heparin for the Initiation of AntIcoagulation I” Atrial 
Fibrillatron tOt5-t4.65A 
Demographic and Cllnical Predictors of Excesswe 
Anticoagulation Following Initiation of Warfarin 
Therapy 1009-152.226A 
Early Decreased Interfeukin-6 but Persistently Elevated 
van Wiilebrand Factor During Long-Term Dalteparin 
Treatment in Unstable Coronary Artery Disease 
1046-l 15.34lA 
Enoxaparin Is Superior to Unfractionated Heparin After 
Fibrinolysis I” Acute Myocardial Infarction: 
Meta-Analysis of ASSENT-3, HARTII. and 
ENTIRE-TIMl-23 Trials 1025MP-171.334A 
Incidence and Outcomes of Heparin-Induced 
Thrombocytopenia Following Acute Coronary 
Syndromes 1174.167.62A 
Incremental Cost-Effectiveness of Early and Long-Term 
Clopidogrel in Patients Undergoing PerCUtanaOUS 
Coronary Infarction I” the CURE Trial: The 
PCI-CURE Economic Analysis 1171-l t2.383A 
Influence of CYP2C9 Polymorphrsm on Fluindione 
Dose Requirement and Anticoagulation 
1079-l 26248A 
Kinetrcs of Intravenously Adminrstered Dalteparin 
1075MP-172.25A 
Low Molecular Werght Heparin I” Atrial Fibrillatron Prior 
to Cardioversion: Short-Term Safety and Efficacy in a 
Transesophageal Echocardiography Prospective 
Study 1214.34.462A 
Low-Molecular-Weight Heparin Alone and With Ilb/llla 
Inhibitors in Patients With Renal Failure and Non-ST 
Elevation Acute Coronary Syndromes: insights From 
the Global Regrstry of Acute Coronary Events 
1026.101.335A 
Natronal Trends of Lower Target Intensity Among 
Elderly Patients Takfng Warfarin: The Anticoagulation 
Consortium lo improve Outcomes Nationally 
(ACTION) Study 1040~85.153A 
Percutaneous Left Atrial Appendage Transcatheter 
Occlusion (PLAATOTM) to Prevent Stroke I” Pabents 
KEY: Abstract Title, Sessfon-abstract number-page number 
JACC March 19,2003 SUBJECT INDEX 607A 
With Atrial Fibrillation: lnitlal Results of the 
Multicenter Feasibility Trial 866.1.79A 
Rapid Cycle Interventions by Integrated Teams Can 
Effectively Improve Anticoagulation Clinical Care in a 
Safety Net Hospital 1217-57537A 
Safety and Efficacy of an Accelerated Streptokmase 
Regimen in Combmation With Enoxaparin in the 
Prehospital Management of the ST Acute Myocardial 
Infarctton (ASENOX-2) Study 1196.112.399A 
Safety and Efficacy of Subcutaneous Enoxaparin in 
Early Invasive Strategy of Unstable Angina 
1176-i 99.66A 
Safety of Low Molecular Weight Heparm After 
Transesophageal Echocardiographic Guided 
Cardioversion as Bridging Therapy 1214.33.462A 
Secondary Prevention of Cerebrovascular Events in 
Patients With Patent Foramen Ovale and Cryptogenic 
Stroke: AUSTRIAN-PFO-Registry 891.5.496A 
Short-Term Effect of Oral Anticoagulant Therapy on 
Documented Left Atrial Thrombi in Candidates for 
Percutaneous Transvenous Mitral Commissurotomy 
1032~130.233A 
Statins Potentiste the Anticoagulant Effects of Low 
Molecular Weight Heparin 1083.144.266A 
Superior Efficacy of Low Molecular Weight Heparin 
Versus Unfractionated Heparin in Acute Coronary 
Syndromes Without ST Elevation 1 i71-106.362A 
There Is Synergism of Aspirinltleparin With Low 
Frequency Ultrasound for Clot Lysis: Potential for 
Clmical Application m Acute Coronary Syndromes 
IOOI-209.324A 
Underuse of Reperfusion Therapy in Female Patients: 
Insights From the TETAMI Study and Registry (The 
Safety and Efficacy of Subcutaneous Enoxaparin 
Versus Intravenous Unfractionated Heparin and of 
Tirofiban Versus Placebo in the Treatment of Acute 
Myocardial Infarction) 1097.99.368A 
Unfractionated Heparin Increases Platelet-Monocyte 
Binding In Vitro and in Patients Undergoing 
Percutaneous Coronary Intervention 1176-l 96.66A 
Unpredicted Amiodarone and Warfarm Interaction at 
the 17th to 20th Week After the Initiation of 
Amiodarone 1009-l 53.226A 
Use of Reperfusion Therapy in Patients Presenting With 
ST Elevation Myocardial Infarction: Findings From 
The TETAMI Study and TETAMI Registry (The Safety 
and Efficacy of Subcutaneous Enoxaparin Versus 
Intravenous Unfractionated Heparin and of Tirofiban 
Versus Placebo in the Treatment of Acute Myocardml 
Infarction) 1147-97.377A 
Antihypertensive therapy 
Cardiovascular Safety of Vardenafil in Patients 
Receiving Antihypertensive Medications: A Post-Hoc 
Analysisbf Five-Placebo-Controlled Clinical Trials 
1133.146.276A 
Effects of Valsartan and Valery1 4.Hydroxy Valsartan on 
Human Platelets: A Possible Missmg Link to Explain 
Reduction of Acute Vascular Events With Anqiotensin 
- II Receptor Blockers 1203-125310A 
First Demonstration in Humans of Svstemic Neutral 
Endopeptidase and Endothelin Cdnverting Enzyme 
Inhibitnon Usmg a New Orally Active Dual 
Metalloprotease Inhibitor SLV 306 1106.122.266A 
The Effect of Losartan Versus Atenolol on Aortic Valve 
Sclerosts: A LIFE Study 1109MP-166.606A 
Antioxidants 
Ascorbic Acid Accelerates Left Atrial Mechanical 
Recovery Following a Brief Duration of Atria1 
Fibrillation 1214-44.464A 
Beta Carotene Increases All-Cause Mortality and 
Cardiovascular Death: A Pooled Analysis bf 
Randomized Trials 1169.58.532A 
Blood Glutathione Detects Metabolic Patterns 
Associated With Atherothrombotic Vascular Events in 
Patients With Mild Hyperhomocysteinemia 
1104.147.262A 
Comparison of Effect of Thiazolidinediones on 
Atherosclerosis in Apolipoprotein E-Deficient Mice 
1155-150.289A 
Dietary Green Tea Intake Preserves and Improves 
Arterial Compliance and Endothelial Function 
1131-136.271A 
Dyspnea-Induced Training of the Diaphragm Augments 
Local Antioxidative Enzyme Activih/ in an Animal 
Model of Heart Failure: Implications for Aerobic 
Metabolism 1060-69.156A 
Effect of Green Tea Intake on the Development of 
Coronary Artery Disease 1169-55.531A 
Elevated Plasma Xanthine Oxidase Actwity m Chronic 
Heart Failure: Source of Increased Oxygen Radical 
Load and Effect of Allopurinol in a Placebo 
Controlled, Double Blmded Treatment Study 
1184-81.207A 
Green Tea Derived Polvphenol AntioxIdant. EGCG. 
Differentially Modulat& Developing Compared to 
Mature Atherosclerotic Lesions in ADO E -/- Mice 
1200-136.305A 
Heme Oxygenase-1 Is Repressed by Bachl: A Novel 
Heme-Binding Transcriptional Repressor in Smooth 
Muscle Cells and Macrophages 875-4.314A 
Improved Lipid Profile and Reduced Liptd Peroxidation 
With Soy Milk in Patients With Primary 
Hypercholesterolemia 1057.150.244A 
Modification of Endothelial Function, Serum Levels of 
Adhesion Molecules, and Lipid Hydroperoxides by 
Antioxidant Treatment Wtth Vitamins C and E in 
Chronic Smokers 1035.150.237A 
Motexafin Gadolinium Decreases Vascular 
Inflammation in a Rabbit Model of Atherosclerosis in 
the Presence of Ascorbate 812.5.269A 
Opposing Effects of Vitamins and Statins on Lipoprotein 
Subclasses in Children With Familial 
Hypercholesterolemia 1083-137.264A 
Oral N-Acetylcysieine Administered Immediately Prior 
to Routine Percutaneous Coronary Procedures 
Ameliorates Contrast-Induced Nephrotoxicity 
1174-188.62A 
Oxidatw Damage and Repair System in Spinal Cord 
lschemia and Repeifusion Injury 1180-152.300A 
Oxygen Free Radical Scavengers Reverse Alterations 
to Multiple Proteins Observed Following Myocardial 
Stunning 1145.102.373A 
Plasma Glutathione Redox State: A Novel Marker of 
Oxidative Stress, Correlates With Early 
Atherosclerosis in Humans 847-6.293A 
Reactive Oxygen Species Contribute to Inflammation- 
Induced Endothelial Dysfunction 1054-140.24OA 
Rosuvastatm Improves Endothelial Cell Function in 
Glutathione Peroxidase Deficient Mice 
1152-132.286A 
Statins Promote Systemic Antioxidant Effects Through 
Specific Inflammatory Pathways 1181.120.3OlA 
Superoxide Dismutase Reduces 
Reoxygenation-Induced Cardiopulmonary 
Dysfunction in the Immature Heart 1046-158.475A 
The Relationship of Oxidaiive Stress to Vascular Health 
in Humans 1131.142.272A 
Aorta 
A Comparison of Beta-Blockers and Angiotensin 
Converting Enzyme Inhibitors on Aortic Eiastic 
Properties, Aortic Growth, and Lefl Ventricular Size 
and Function in Marfan Patients 854-4.492A 
A Comparison of Noninvasive ad Invasive Aortic Pulse 
Wave Velocity 1105-I 19.284A 
Aortic Stiffness Is Related With an Increased Turnover 
of Extracellular Matrix in Patients With Dilated 
Cardiomyopathy 1179-I 51299A 
Association of Echocardiographic Aortic Root Dilatation 
With Aortic Dissection: A Case Control Study 
861-3.467A 
Characterizing the Young Patient With Aortic 
Dissection: Results From the International Registry of 
Aortic Dissection (IRAD) 1081-154.263A 
Combined Transasophageal and Surface Magnetcc 
Resonance Imaging Provides Optimal Imaging of 
Aortlc Atherosclerosis 1190MP.172.458A 
Contrast Enhanced Duplex Ultrasound Improves 
Endoleak Detection Following Endovascular 
Abdominal Aortic Aneurysm Repair 1100-l 99.39A 
Culprit Coronary Lesion Location Correlates Closely 
With Aortic Rwt Mechanics Early After Acute 
Myocardial Infarction 1 t 53-l 36.286A 
E-Selectin and P-Selectm Are Markers of Aortic Plaque 
Burden as Measured by Transesophageal Magnetic 
Resource Imaging 812.2.259A 
Greater Error in Noninvasive Transfer Function-Derived 
Central Aortic Systolic Pressure in Type 2 Diabetes 
Mellitus 1058-126.246A 
Hospital Volume and Mortality in Acute Aortic 
Dissection: Does Low Volume Predict Worse 
Outcome? 857.2.304A 
Identifying Early Changes in Children at Risk for 
Cardiovascular Disease: Echo-Doppler Assessment 
of the Biophysics1 Properties of the Aorta in Children 
Born Small for Gestational Age 1153-134.286A 
Is Aortic Stiffness as Measured by Pulse Wave Velocity 
a Predictor of Coronary Atherosclerosts? 
1105-l l8.263A 
Is Central Aortic Systolic Pressure Augmentation Solely 
Due to Pressure Wave Reflection? 1058.125.246A 
Lack of Association Between Chlamydia Pneumonia? 
Seropositivity and Thoracic Aortic Dilatation: A 
Population-Based Transesophageal 
Echocardiographlc Study With Implications for 
Thoracic Aortic Aneurysm Formation 1105-I 53.264A 
Mechanical and Elastic Properties of the Normal and 
Aneurysmal Ascending Aorta by lntraoperative 
Epmortic Echocardiography 1182-24.513A 
More Favorable Improvement of Arterial Wall 
Characteristics by Renal Transplantation Than by 
Hemodialysis 1179-146.298A 
Real-Time Magnetic Resonance Imaging Guidance for 
Endograft Delivery in a Porcine Model of Abdominal 
Aortic Aneurysm 1 IGO-198.38A 
Reduced Aortic Distensibility and Congestive Heart 
Failure Amona the Elderlv in a Pooulation-Based 
Study: The C&diovascul& Health’ Study 
887FO-2.220A 
Refractory Systemic Hypertension in Patients With 
Chronic Aortic Dissection 1153-138.287A 
Surgical Intervention Is Superior to Medical Therapy in 
the Management of Type A Aortic Intramural 
Hematoma 1034-l 40.236A 
Ultrasonic Tissue Characterirat!on Defines the Specific 
Role of Elastin in Maintaining Aortic Structural 
lntegrlty and Compliance 861-4.4871 
Aortic coarctation 
Aortic Root Dilatation and Progression cn Patients With 
Bicuspid Aortic Valve 1068MP-168.477A 
Coarctation of the Aorta: Prevalence of Intracranial 
Aneurysm 1192.160.499A 
Fate of Infants With Severe Coarctatton of Aorta 
Treated Early With Balloon Angioplasty: A 19.Year 
Study 1168-I 69.486A 
Long-Term Follow-Up (15Year) Results of Balloon 
Coarctstion Angioplasty in the Adolescent and Adult 
Patient 1168-I 58.488A 
Mitral Valve Z-Score Predicts Need to Close Atrial 
Shunts at Time of Coarctation Repair 
1094-161.481A 
Pulse Pressure Propagation Changes in the Aorta With 
a Stent: An In Vitro Study Simulating an Adequate 
Result of Coarctation Treatment With a Stem in Place 
1168.l6l.469A 
Repair of Aortic Cosrctation in Infants. Results of a 
Tailored Surgical Approach in the Modem Era 
1069-I 58.48OA 
Aortic diseases 
Aortic Regurgitation: Long-Term Survival m Patients 
With Different Degrees of Left Ventricular Function 
Undergoing Surgical Treatment 1157-22.5llA 
Aortic Root Dilatation and Progression in Patients With 
Bicuspid Aortic Valve 1066MP-168.477A 
Aortic Valve Sparing Procedures in Young Adults With 
Marfan Syndrome and Annuloaortic Ectasia: Serial 
Echocardiographic Assessment of PostoperatIve 
Valve Function 859-1.515A 
Are Thoractc Aortic Aneuwsms a Genetic Disease? 
1154-141.287A I 
Characterizing the Young Patient With Aortlc 
Dissection: Results From the lnternatlonal Reaistrv of 
- ’ Aortic DissectIon (IRAD) 1081-I 54.253A 
Clinical and Echocardiographic Indicators for Surgery in 
Pediatric Patients With Aorlic Valve Regurgitation: A 
Multicenter Study 1068MP-171.477A 
Disproportional Upregulation of Matrix 
Metalloproteinase to Tissue Inhibitor of 
Metalloproteinase Genes in Abdominal Aortic 
Aneurysm: Results From Quantitative Real-Time 
RT-PCR Method 1154-142.287A 
Do Left-Sided Echo Contrast Aoents lmorove 
Diagnostic Accuracy of Tran&sopha~eal 
Echocardiography in Pahents With Suspected Aortic 
Dissection? 861.2.467A 
Endovascular Stent-Graft Repair of Descending 
Thoracic Aortic Penetrating Atherosclerotic Ulcers: 
Mid-Term Results 1034-143.236A 
Hospital Volume and Mortality in Acute Aortic 
Dissection: Does Low Volume Predict Worse 
Outcome? 857.2.304A 
Influence of Chronobiological Variation in the Risk of 
Acute Aortic Dissection on In-Hospital Mortality 
1154.144.288A 
Magnetic Resonance Anglography of Coronary Arteries 
and Peripheral Arteries III Infants and Young Children 
With Kawasaki Disease 891-l .495A 
Management of Bicuspid Aortic Valves I” Patients 
Having Repair or Replacement of Ascending Aortic 
Aneurvsm 1068MP.169.4TIA 
Mecha&al and Elastic Properties of the Normal and 
Aneurysmal Ascending Aorta by lntraoperative 
Epiaortic Echocardiography 1182-24.513A 
Penetrating Aortic Ulcer Treatment by Endovascular 
Stent-Grafl Placement 1199-I 98.76A 
Preoperative Predictive Risk Model for Mortality in 
Patients With Acute Type A Aortlc Dissection 
Undergoing Surgery: Lessons From the International 
Registry of Acute Aoriic Dissection (IRAD) 
1182-21.512A 
Renal Failure on Presentation Predicts Morbidity and 
Mortality in Aortic Dissection 1034-142.235A 
Surgfcal Intervention Is Superior to Medical Therapy in 
the Management of Type A Aortic Intramural 
Hematoma 1034.140.235A 
Transluminal Endovascular Graft Placement With 
INOUE Stent Graft Is Effective for Many Types of 
Aneurysms and Dissections 1199-i 97.76A 
Trends in Management and Outcomes of Acute Aortic 
Dissection: Lessons Learned From the First 1,000 
Patients Enrolled in the International Registry of 
Acute Aortic Dissection (IRAD) 1144-51.529A 
KEY: Abstract Title, Session-abstract numbwpage number 
608A SUBJECT INDEX JACC March 19, 2003 
Aortic regurgitation 
Angrotensin Converting Enzyme inhibitors Stabilize Left 
Ventncular Remodeling in Chronic Aortic 
Regurgitation Despite Abnormal Resting Mechanics 
1141.31442A 
Aortic Regurgitation: Long-Term Survival in Patients 
With Different Degrees of Left Ventricular Function 
Underaoina Surqical Treatment 1157-22.511A 
Aortic V&e Prolapse and Aortic Insufficiency in 
Subaortic Ventricular Septal Defects 
1068MP-170.477A 
Autocrine-Paracrine Factors Released by Cardiac 
Fibroblasts Stimulate Abnormal Mvocardial 
Fibronectin Synthesis in Aortic Re9urgitation 
1059~22499A 
C-Reactive Protein Is Increased in Aortic Stenosrs but 
Not Aortic Regurgitation 1012-24.497A 
Clinical and Echwardiographic Indicators for Surgery in 
Pediatnc Patients Wrth Aortic Valve Regurgitation: A 
Multicenter Study 1066MP-171.477A 
Delayed-Enhanced Magnetic Resonance lmaglng 
Detects Myocardial Fibrosis in Patients With Chronic 
Aortic Valve Disease 1167.38.450A 
Echocardiographic Predrctors of Aortic Valve Repair in 
Patients With Bicuspid Valves and Aortic 
Reouraitation 859.2516A 
lmpa~t 07 Systolic Hypertension and Impedance 
Lowerino Druas on Clinical Outcomes in Chronic 
Severe iortickegurgitation 1109MP-170596A 
Inhibitron of the c-Jun N-Terminal Kinase Pathway 
Minimizes Collagen Remodeling in Aorhc Regurgitant 
Hearts 1084.23.501A 
Left Ventricular Remodeling Differs in Chronic Aortic 
lnsufficiencv and Mitral Regurgitation Following 
Surgical Correction 1084-26.502A 
Mrld Aortic Valve Insufficiencv: A Mid-Term 
Complication of Percutaneous Closure of Atnal 
Septal Defects and Patent Foramen Ovale 
891-6.496A 
Selective Activahon of Frbrogenetic Growth Factors 
Addresses the Pattern of Hypertrophy in Human 
Aortic Valve Disease 1059.23.5WA 
Survival After Valve Replacement for Aortlc 
Regurgitation: Prediction From Noninvasive 
Contractikty Measurement and Comparison With 
Census-Expected Survival 1157-21.511A 
Aortic valve 
Accuracy of Aortic Valve Area Calculation Using a 
Computer-Based Planimetry System in the 
Catheterization Laboratory 1023-56.520A 
Aortic Root Dilatation and Prowession in Patients With 
Bicuspid Aortic Valve 1068MP-168.477A 
Aortic Valve Soarina Procedures in Youno Adults With 
Marfan Syndromeand Annuloaortic Eciasia: Serial 
Echocardiographic Assessment of Postoperative 
Valve Function 859.1.515A 
Assessment of the 3-D Flow Pattern in the Sinuses of 
Valsalva 1118.34.437A 
Brain Natriuretic Peptide Predicts Severity of Aortic 
Stenosis 847-2.5lOA 
C-Reactive Protein Is Increased rn Aortrc Sterwsis but 
Not Aortic Regurgitation 1012-24.497A 
Calcified Rheumatic Heart Valves Are Associated With 
Osteooontin Bone Matrix Expression 1059255oOA 
Do St.&s Really Slow the Progression of Aortic Valve 
Stenosis? A Need for a Prospective Randomized Tnal 
1012-23.497A 
Does Aorhc Valve Sclerosis Predict Cardiovascular 
Events lndeoendentlv of Albuminuria rn 
Hypertens&? A LIFE Study 841.4.51OA 
Hypercholesterolemlc Valvulopathy as an Aspect of 
Malianant Atherosclerosis 1012-22~4978. 
Left Ventricular Volume Shifts During fsovolumic 
Contraction Contrrbute to Dvnamic Openina of the 
Aortic Valve 1182.22.513A. - 
Len-Sided Valvuiar Disease in Carcinoid Syndrome: 
Underestimation Without Repetitive 
Echocardfographies 1109MP-172.507A 
Management of Bicuspid Aortic Valves in Patients 
Having Reparr or Replacement of Ascending Aortic 
Aneurysm 1068MP-169.477A 
Matrix Remodeling in Human Aortic Valve Disease 
824FO-5.506A 
N-Terminal Pro-BNP as a Biochemical Marker for 
Assessing Severity of Aortic Stenosis 1134-22.506A 
Natriuretic Peptide Plasma Levels Remain Elevated SIX 
Months After Aortic Valve Replacement for Severe 
Aortic Stenosis 1134-21.506A 
Patients With Degenerative Aortic Valve Stenoses Have 
Increased Thermal Heterogeneity in the Stenotic 
Valve 1059.24.500A 
Percutaneous Aortic Valve Replacement in the Beating 
Heart: Fwt Animal Results 1180-l 533OOA 
Performance of Bioprostheses and Mechanical 
Prostheses Assessed by Composites of 
Valve-Related Complications at 15 Years for Aortic 
Valve Replacement 859-3.516A 
Subclinical Aortic Valve Sclerosis Associates With Early 
Atherosclerotic Changes of Carotid Artery 
1109MP-165.5054. 
The Effect of Losartan Versus Atenolol on Aortic Valve 
Sclerosis: A LIFE Study 1109MP-166.505A 
The Risks and Benefits of Reoperation Aortic Valve 
Replacement 859-4.516A 
Aortic valve stenosis 
Accuracy of Aortic Valve Area Calculation Using a 
Computer-Based Planimetry System in the 
Catheterization Laboratory 1023-56.520A 
Association of Cardiovascular Risk Factors to Aortic 
Valve Calcification as Quantified by Electron Beam 
Tomography 1109MP-167.606A 
Atorvastatin Inhibits Aortic Valve Calciffcation in an 
Experimental Model of Chronic Hypercholesterolemia 
via Nonlioid Lowerina Effects 824FO-2.507A 
Balloon Dff&ion of Severe Aortic Stenosis in the Fetus: 
Technical Ac’vances 891-3.496A 
Brain Natriuretic Peptide Predicts Severity of Aortfc 
Stenosis 841.2&0A 
C-Reactive Protein Is increased in Aortic Stenosis but 
Not Aortic Regurgitation 1012.24.497A 
Cardiovascular Risk Factors in Patients With Aortic 
Stenosis Are Associated With the Prevalence of 
Coronary Artery Disease, but Not the Prevalence of 
Aortic Stenosis 1012.25.497A 
Deqeneratwe Aortic Stenosis: An Arteriosclerotic 
&ease 1012.26.496A 
D&wed-Enhanced Maanetic Resonance lmaaing 
Detects Myocardial Fybrosis in Patients WithChronic 
Aortic Valve Disease 1167.38.450A 
Do Statins Really Slow the Progression of Aortic Valve 
Stenosis? A Need for a Prospective Randomized Trial 
1012.23.497A 
Heteroqeneitv of Response to Pressure Overload in 
Aortic Stenosis 1084.24.501A 
Increased Presence of Pathogen Burden and of 
Circulatory Precursor Cells in Prosthetic Compared to 
Native Degenerated Aortic Valves 1059.21.499A 
lnterleukin 1 Beta Induces Matrix Metalloproternase 
Expression rn Human Aortic Valve Myofibroblasts In 
Vitro and Promotes Cell Proliferation 1059-2656OA 
Matrix Remodeling in Human Aortic Valve Disease 
824FO-5.506A 
Natriuretic Peotide Plasma Levels Remain Elevated Six 
Months After Aortic Valve Replacement for Severe 
Aortic Stenosis 1134.21.506A 
Patfents With Degenerative Aortic Valve Stenoses Have 
Increased Thermal Heterogeneity in the Stenotic 
Valve 1059.24.500A 
Percutaneous Implantation of Prosthetic Heart Valves: 
From Animal Model to First Human Implantation in 
Calcific Aortic Stenosis 624FO-6.506A 
Presence of Mitral Annular Calcification Predicts 
lmorovement in Mitral Reauraitation After Aortic Valve 
Replacement for Severe no& Stenosis 806-2.502A 
Relation of Aortic Valve Calcification With 
Cardiovascular Risk Factors and Antiinflammatory 
Gene Polymorphisms in Patients With Degenerative 
Calcific Aortic Stenosis 824FO-4.507A 
Risk Stratification in Mild and Moderate Aortic Steno% 
by Assessment of Aortic Valve Calcification 
1109MP-168.506A 
Selective Activation of Fibrogenetic Growth Factors 
Addresses the Pattern of Hypertrophy in Human 
Aortic Valve Disease 1059.23.5OOA 
Systemic Arterial Compliance in Patients With Aortic 
Stenosfs: Relationship With Drastolic Dysfunction 
1012.21.497A 
Tumor Necrosis Factor Alpha Induces Calcification of 
Aortic Valve Myofibroblasts 824FO-3.507A 
Aortocoronary bypass 
Angiographic and Clinical Outcomes of Patients Treated 
With Primary or Rescue Angioplasty in Saphenous 
Vein Graft for Acute Mvocardial Infarction 
1172-98.385A . 
Cardiac Outcome and Cost-Effectiveness One Year 
After Off-Pump and On-Pump Coronary Artery 
Bypass Surgery: Results From a Randomized Study 
648FO-4.360A 
Clinical Outcomes of Over 800 Radial Artery Grafts 
Used in Coronary Bypass Surgery 848FO-2.379A 
Different Cell Death Rates Determine Growth of 
Vascular Smooth Muscle Cells From Human 
Aortccoronary Bypass Vessels: Implications for 
Patency of Radial Artery Grafts 1054-143.241A 
Four-Pixel Velocitv Analvsis Is the Preferential 
Approach in Evaluating Magnetic Resonance Velocity 
Maos of Coronarv Arterv Bvpass Grafts 870-5.466A 
Funciional Health Predicts’ Future Intervention for 
Coronary Artery Disease 1047-51.521A 
Initial U.S. Experience With Membrane-Covered Stents 
in the Treatment of Saphenous Vein Graft Lesions: 
Roll-fn Phase of the BARRICADE Trial 879.1.62A 
Major Bleeding Incidence After Coronary Artery Bypass 
Grafting in Patients With Unstable AngmaiNon-ST 
Elevation Myocardial Infarction Based on Coronary 
Artery Bypass Graft Timing in TACTICS-TIMI- 
1146.107374A 
Minimally Invasive Coronary Bypass Grafting of the Left 
Anterior Descending Coronary Artery Improves 
Myocardial Perfusion in the Nonrevascularired 
Second Vessel Territory in Two-Vessel Coronary 
Artery Disease 1028-97.338A 
Safety and Feasibility of Autologous Myoblast 
Transplantahon in Patients Undergoing Coronary 
Artery Bypass Grafting: Results From the United 
States Experience 848FO-5.360A 
The Radiance P-32 RDX Balloon I” Saphenous Vein 
Grafts: A Comparison of De-Nova and InStent 
Restenotic Lesions in the SVG Brite Trial 650-4.7OA 
The Role of Myocardial Revascularization Surgery and 
Percutaneous Coronary Intervention in the 
Long-Term Follow-Up of Elderly Patients With 
Myocardial Infarctron 1112.82.179A 
Thrombin Potentiates Platelet-Derived Growth Factor 
Induced Vascular Smooth Muscle Cell Proliferation 
wa PI3 Kinase Activation and p27 Downregulation 
1032-l 26.232A 
Apolipoproteins 
Endothefiaf and Hepatic Lipase Gene Polymorphisms 
Are Associated With Plasma Levels of High-Density 
Lipoprotein Cholesterol in Lipoprotein Coronary 
Atherosclerosis Study 1107-l 38.266A 
Higher Restenosis Rates Among Apo E4 Versus Apo 
E2 Patients After Coronary Stenting: A Potentral 
Genetfc Etiology for Restenosis 1175-l 8666A 
Obesity Is Associated With Systemic Inflammation 
Independent of Metabolic Cardiac Risk Factors in 
Healthy Young Adults 1033.138.234A 
9gMTC-Annexln V Imaging for Detection of 
Atherosclerotic Lesions in Porcine Coronary Artery 
835-3.445A 
A Functional Erythropoietin Receptor in a Rat Heart Is 
Lrnked to Anti-Apoptotic Effects 1024.106330A 
Abciximab Modulates Apoptosrs of Circulating 
Neutrophils in Patients With Unstable Angina 
1096.109.355A 
Adventitfal Response and Expansive Remodeling After 
Intravascular Brachytherapy in a Rabbit Model of 
Restenosis 1099.191.37A 
Apoptosis and DNA Damage Markers in Human Left 
Ventricular Samples Under Controlled lschemia and 
Repedusion 878-4.403A 
Aspirin Protects Cardiac Myocytes From Apoptosis by 
Modulating Mitogen-Activated Protein Kinases 
665.4.313A 
Bag-l Relocates Within Cardiac Myocytes Following 
IschemfalReperfusion and Prevents Myocyte 
Apoptosis by Interaction With Hsc70 1145105.374A 
Caldesmon Regulates Apoptosis and Cell Cycle 
Progression in Capillary Endothelial Cells and Inhibits 
Angiogenesis In Vitro 1178.140.297A 
Downregulation of Insulin-Like Growth Factor-l 
Receptor in Atherosclerotic Plaque: Role of Oxidized 
Low-Density Lipoprotein and PPARy 1152-l 20.263A 
Downregulation of Microfilament Expression in 
Atherosclerotic Plaque Is Mediated by Oxidized 
Low-Density Lipoprotein 1200.137.305A 
Erythropoietin Augments Cardiomyocyte Survival and 
Left Ventncular Functron After Hypoxia 
1196-l 13.399A 
Genetic Determinants of Nicotine-Induced 
Anoroaenesis 804-2.256A 
High-kigk Clinical Features Predict Enhanced 
Post-Infarction Myocardial Apaptosis and the Need to 
Achieve Infarct-Related Artery Patency 410-2.544A 
Identification of Apoptosis-lnduong Factor Expression 
rn Human Coronary Artery Endothelial Cells and Its 
Upregulation by Ox-Low-Density Lipoprotein 
1152-l 29.265A 
In Monocyte Culture Apoptosis and Tissue-Factor 
Expression Are Induced by Oxidized Low-Density 
Lipoprotein and Can Be Attenuated by 
Caspase-lnhibrtion 875.2.314A 
Increased Tc-99m-Annexin Uptake !n Doxorubrcfn 
Induced Myocardial Apoptosis 1142.40.444A 
Mechanism of Activation of Myocardial Apoptosis in the 
Post-Cardtoplegic Neonatal Lamb Heart 863-4.495A 
Mitotic Cell Death as a Result of Cell Cycle Re-Entry Is 
a Unique Option for Senescent Cardiomyocytes in 
Addition to Apoptosis and Mitosis 118365.203A 
Oxidative Damage and Repair System rn Spinal Cord 
lschemia and Repelfusion Injury 1180-152.300A 
Platelet-Activating Factor-Like Lrpids Mediate 
Endothelial Cell Apoptosis Induced by 
Hypercholesterolemic Low-Density Lipoprotein 
1056-l 20.243A 
Prolonged but Reversible Sarcolemmal Phosphatidyl 
Serine Expression in Myocardial lschemia 
Represents lschemic Memory and Can Be 
KEY: Abstract Title, Session-abstract number-page number 
JACC March 19,2003 SUBJECT INDEX 609A 
Noninvaswely Detected by Radlolabeled Annexin-V 
Imaging 835.5446A 
Receptor Activator of NF-kB (RANK) and Its Ligand 
RANK-L Coincide With Exoression of Raoamvcin 
Receptor FKBPIP in Neoi&imal Dendritic Cefis 
1031-173.14A 
Reduced Post-Infarction Myocardial Apoptosis in 
Women: A Clue to Thew Different Clinical Course? 
1170-102.38lA 
Treatment of Expenmental Heart Fallure With 
Hepatwyte Growth Factor 409-5.544A 
Warm Blood Cardioplegia Induces 
Mitochondria-Initiated Myocyte Apoptosis Which Is 
Ameliorated by Overexpression of Endogenous 
Urocortin 1204-22.514A 
Arrhythmias 
A DNA Microarray Survey for Gene Expression 
Changes I” At& Fibrillation 1132.li7.274A 
A New Perspective on the Pharmacolooical Treatment 
of Vagal Induced Atrial Fibrillation: C&bined 
Inhibition of Muscarnic Potassium Current and IKr 
860.4.312A 
Alpha,,-Adrenergic Receptor Polymorphism Influences 
Baroreflex Sensitivity and Nonsustained Ventricular 
Tachycardla in Idiopathic Dilated Cardiomyopathy 
1132.1213.274A 
Amiodarone Increases Transmural Heterogeneity of 
Reoolarization in Patients With Cardiac Death 
lli5.10.109A 
Beat-To-Beat Variablkty Is an Independent and Early 
lndlcator for d-Sotalol-Induced Arrhythmias In Vivo 
1041.17.9lA 
Characterization of lntraatrial Reentrant Tachycardia m 
Patients After Mustard Operation for Transposition of 
Great Arteries Using Electroanatomic and 
Entrainment Mappina 1113-I 9.106A 
Chronic Subthreshdld &trical Stimulation of the Left 
Stellate Ganglion and a Canine Model of Sudden 
Cardiac Death 
825.4.112A 
Clinical Features of Minority Patients in the AFFIRM 
Study 1210.20.13OA 
Determinants and Cknical Implications of the Lack of 
Palpitations During Regular Wide QRS Complex 
Tachycardia 1212.17.133A 
Dilated Cardiomyopathy and Cardiac Arrhythmias I” the 
Transgenlc Mice Overexpressing Mouse Cardiac 
Junctate-1 865.1.313A 
Does the Cox-Maze Procedure Impact Quality of Life m 
the Late Postoperaiive Period? 1037.24.498A 
Electrophysiologcc and Electroanatomic 
Characterization of the Atria in Sinus Node Disease: 
Evidence of Diffuse Atrial Remodeling 1163-l 1.12lA 
Exercise Performance After Fontan Conversion to Total 
Cavopulmonary Connection 1068MP-163.476A 
Extrinsic Rapid Electrical Stimulation Modulates 
Sarcoplasmtc Reticulum Cazt Regulatory Proteins in 
Cultured Rat Cardiomyocyies 1132.131.275A 
Frequency of Implantable Cardioverter Fibrillator 
Discharges in New York Following the World Trade 
Center Attack 1016.10.66A 
Heterogeneity of Ventocular Reuolarization Is 
Increased in First Degree Relatives of Patients With 
Arrhythmogenic Right Ventricular Cardiomyopathy 
1207.83.213A 
Is Atrlal Fibrillation an Inflammatory Disease Reflected 
by Elevated C-Reactwe Protein? 1089-17.99A 
lschemia Precipitates Ventricular Tachyarrhflhmias in 
Transgenic Mice Overexpressmg 
Calcium-Independent Phospholipase A2p (IPLAZP) 
That Are Ablated by Mechanism-Based Inhibition of 
Phospholipase AZ Activitv 1186.8.126A 
Lack of QT Prolongation With Amiodarone Increases 
ArrhVthmic Risk 814-l .103A 
Medium-Term Outcome After Atrial Arrhythmia Surgery 
in Adult Patients With Congenital Heart Disease 
831-I .486A 
Plasma Amino-Terminal Pro-B-Type Natriuretic Peptide 
Predicts Postcardioversion Reversion to Atrial 
Fibrillatlon 1089.15.99A 
Prolonged QRS Duration and Cardiac Death in 
Postinfarction Patients 1213-3.134A 
Safety and Feasibility of Dobutamme-Atropme Stress 
Echocardiography for the Evaluation of Myocardial 
lschemia in Patients With Implantable Cardioverter 
Defibrillators 1139.19.117A 
SCN5A Mutations in the S5-S6 Reaion Cause Bruaada 
Syndrome and Cardiac Conduct& Disturbances 
821-3.lllA 
Supraventricular Arrhythmias rn the U.S. Population: A 
Raptdly Accelerating Epldemlc in the Elderly 
121lMP-167.13lA 
The Association of Left Ventricular Ejection Fraction, 
Mortality, and Cause of Death I” Stable Patients With 
Heart Failure 874.6.219A 
Arrhythmias, treatment of 
A Defibrillator With Constant Effectiveness Over 
Impedance 1139.1.115A 
A Multicenter Study of Heart Failure as a Predictor for 
Internal Cardioverter Defibrillator Shocks 
1064-l .%A 
A Prospectwe Randomized Study Comparing 
Transvenous Cryoenergy and Radiofrequency 
Ablation in the Triangle of Koch: Preliminary Data 
1042.8.93A 
A Randomized Double Blind Placebo Controlled Trial of 
the Effect of Amiodarone Compared to Placebo 
Before, During, and After Electrical Cardloversion for 
Persistent Atrial Fibrillation 1089-9.98A 
Acute Pulmonary Vein Reaction to Radiofrequency 
Catheter Ablation for Atrial Fibrillation: Assessment 
Using Intracardiac Ultrasound 1151.176.59A 
Advanced Fast Electra-Anatomical Mapping to Guide 
Radiofreauencv Catheter Ablation of Ventricular 
Tachycarbia 1 i 14.16.107A 
Antiarrhythmic Agents May Decrease Long-Term 
Surwval in Patients With implantable Defibrillators 
1064~6.96A 
Assessment of Transmural Extent of Radiofrequency 
Ablation With Magnetic Resonance Imaging 
1075A-MP-205.424A 
Atrial Tachyarrhythmia Recurrence: Temporal Patterns 
1163-9.12OA 
Can the Left Atrial Appendage Be Safely Closed 
Without Removal? 121 lMP-170.132A 
CliniCal Features of Minority Patients in the AFFIRM 
Study 1210.20.130A 
Concomitant Microwave Ablation Is a Superior Concept 
for Curative Treatment of Permanent Atrial Fibrillatlon 
ln Comparison to Cardlosurgical Procedures Alone 
1042-7.92A 
Cost Analysis of Implantable Cardioverter Defibrillators 
in Patients With lschemic Heart Disease, Decreased 
Left Ventricular Function, and Nonsustained 
Ventricular Tachvcardia: Selective or Wldesoread 
Use? 873.5.13aA 
Creation of a Mathematical Model to Define 
Circumferential Linear Lesion Length for Pulmonary 
Vein Isolation 1023~55.620A 
Ciyoablatlon of the Pulmonary Veins Using a Novel 
Balloon Catheter 1042-4.92A 
Detection and Discrimination Performance of an 
Automatic External Defibrillator in Ambulatorv 
Patients During Treadmill Exercise 1073.91.j60A 
Does the Cox-Maze Procedure Impact Quality of Life in 
the Late Postoperative Period? 1037-24.498A 
Electrophysiological Charactewtics of Tachycardias 
Arising From the Apex of the Trianale of Koch 
1163.iO.12OA 
Frequency and Timing of Defibrillator Events in Patients 
Without Documented Arrhythmias: Who Is at Highest 
Risk? 873.3.137A 
Identification of Endocardial Trigger and Exit of Right 
Ventricular Outflow Tract Tachycardia: Implication for 
Radiofrequency Catheter Ablation 1212.18.134A 
Immediate Defibrillation Predicts Probability of 
Defibrillation Curve Width for External Defibrillation 
Waveforms 1073.95.36lA 
Impact of Prevention Pacing Algorithms on Atrial 
Tachyarrhythmia Recurr&ePattems in Patients 
Sufferina From Bradv-Tachv Form of Sick Sinus 
Syndrome: A Randomized Study 1017.2.87A 
Implications of Anatomical Location on Successful 
Electrical Isolation of Pulmonic Veins by Lasso 
Catheter Guided Subtotal Circumferential Ostial 
Ablation 1042.20.93A 
Improvement of Ventricular Function Following Catheter 
Ablation of Frequent Ventricular Arrhythmias 
1114.18.108A 
Irrigated-Tip Versus B-mm-Tip Catheter for 
Radiofreauencv Ablation of Common Atrial Flutter in 
Patients With davo-Tricuspid Isthmus Lengths z 35 
mm: Is the Catheter Selection or the Cave-Tricuspid 
Anatomy a Determinant Factor for Atrial Flutter 
Ablation? 1042.3.92A 
Is the Use of a Saline-Irrigated Ablation Electrode as 
Safe as the Conventional Solid Tip Electrode to 
Eliminate Pulmonary Vein Spike Potentials for 
Catheter Ablation of Atrial Fibrillation? 834-4.118A 
Long-Term Outcome Aner Ablation of Postoperative 
Atrial Reentrant Tachycardias Is Complicated by 
Atrial Fibrillation 116%5.119A 
Minimizing Ionizing Radiation: A New Alternative 
Method for Mmimally lnvaswe Surgical Biventrlcular 
Resynchronizatlon 113E7.114A 
Modification of the Atrial Substrate by Left Atrial Linear 
Lesions in Symptomatic Patients After Pulmonary 
Vein lsolatlon 1063.10.94A 
Monitoring of Catheter Thrombus and Char Formation 
Using Phased Array Intracardiac Echo During 
Pulmonary Vein Isolation in Patients With Atrial 
Fibrillation 1166.47.449A 
Natural History and Outcome of Patients With Late 
Onset and Recurrent Atrial Arrhythmias After Fontan 
Surgery 1068MP-164.476A 
Oral Bolus of IC Antiarrhythmic Drugs for Atrlal 
Fibrillation: Outpatient Versus Inpatient 
Administration 1089.11.98A 
Prevention of Rheolytic Thrombectomy Induced 
BradyarrhythmIas With Amlnophylline 1051-195.18A 
Prospective Assessment After Pediatric Cardiac 
Ablation: Initial Results of the Multicenter Study 
815.5.483A 
Prospective Multicenter Clinical Trial of Surgical 
Pulmonary Vein Isolation for the Treatment of Atrtal 
Fibrillation 1037-21.498A 
Rapid Electrical Stimulation of Contraction Modulates 
Gap-Junction Protein !n Cultured Neonatal Rat 
Cardiomyocytes: Involvement of Mitogen-Activated 
Protein Kinases and Effects of Angiotensin II 
Receptor AntagonIst 8256.113A 
Surgical Ablation of Atrial Fibrillation. Clinical Results 
and Predictors of Success 1113.1.106A 
The HMG-CoA Reductase Inhibitor Atorvastatin 
Prevents Atrial Fibrillation by Inhibitlog lnflammatlon 
in the Canme Sterile Pericarditis Model 1041-15.904 
The Increase in Women Receiving Implantable 
Cardwerter Defibrillators: Changes in 
Characteristics or Indications? 1139.15.116A 
Three-Dimensional Intravascular Ultrasound 
Architecture of the Pulmonary Venous Wall: 
Implications for Radiofrequency Ablation of Atrial 
Fibrillation 846.3.124A 
Three-Dimensional Myocardial Contrast 
Echocardiography: A Novel Method to Assess 
Ablation Lesions in Koch’s Triangle in Humans 
1163-7.120A 
Three-Dimensional Noncontact Mapping Demonstrates 
Synergistic Electrophysiologic Effects of Multisite 
Atrial Pacing and Linear Atrial Ablation in Patients 
With Refractory Atrial Fibrillation 1017.3.88A 
Treatment of Supraventricular Tachyarrhylhmias With 
the CryoCorTM Cryoablation System: Worldwide 
Results 1042-I .91A 
Arteries 
Aldosterone Antagonism Improves Endothelial 
Dependent Vasorelaxation in Heart Failure via a Nitric 
Oxide Mediated Mechanism 1024-l 10.330A 
Atherosclerotic Plaque and Dose Attenuation of 
Different Vascular Brachytherapy Sources: An Ex 
Vivo Dosimetry Study 107%177.30A 
Anenuated Neointimal Formation After Arterial Injury in 
a Murine Model of Obestty and Diabetes 
1031-177.15A 
Brachial Artery Compliance in Hypertension: Effect of 
Losartan and Atenolol After One-Year of 
Treatment--A LIFE Substudy 1105.152.264A 
Clmical Outcomes of Over 800 Radial Artery Grafts 
Used in Coronary Bypass Surgery 848FO-2.379A 
Conduit Arterial Stiffness Is Associated With Impaired 
Left Ventricular Subendocardial Function 
843.5.453A 
Culprit Coronary Lesion LocatIon Correlates Closely 
With Aortic Root Mechanics Early After Acute 
Myocardial Infarction 1153-l 36.286A 
Effect of Caffeine on Arterial Stiffness and Endothelial 
Function 1131.137.271A 
Elevated Brain Natriuretic Peptide Levels Are Related to 
Impaired Small Artery Elasticity 1153.135.286A 
Endothelial Function and Inflammatory Process in 
Young Patients With Beta-Thalassemia Major 
1130MP.164.268A 
Noninvasive Pulse Contour Analysis Associated With 
Mlcroalbuminuria 1104-149.263A 
Reseated Exposure to Caffeine Increases Arterial 
Stiffness 1.133-l 17.275A 
The Thvroid Hormone Analoo. 3 5 Diiodothyropropionlc 
Acid (DITPA) Restores DIminished Vascular 
Beta-Adrenergic and Endothelial Medlated 
Vasorelaxation in Heart Failure 87%2.403A 
Arteriosclerosis 
99MTC-Annex~n V Imaging for Detection of 
Atherosclerotic Lesions in Porcine Coronary Artery 
835.3.445A 
A Prospective Case-Control Study of Tobacco 
Dependence in Thromboangiitis Obliterans 
(Buerger’s Disease) 857-6.304A 
Combined Intense Lifestyle and Pharmacologic Lipid 
Treatment Further Reduce Coronary Events and 
Myocardial Perfusion Abnormalities Compared to 
Usual Care Cholesterol Lowering Drugs I” Coronary 
Artery Disease 829.1.370A 
Comparison of Color Coded Duplex Sonography and 
Intravascular Ultrasound for the Evaluation of 
Femoral Artery Atenoses 1105-i 17.263A 
Comparison of Effect of Thiazolidinediones on 
Atherosclerosis in Apolipoprolein E-Deficient Mice 
1155-l 50.289A 
Coronary Artery Inflammation Is Associated With In 
VivoTemperature Elevation: Quantitation in a Porcine 
Coronary Model 1102.i75.40A 
KEY: Abstract Title. Session-abstract numberpage number 
610A SUBJECT INDEX JACC March 19, 2003 
Correlation of Peripheral Arterial Compliance and 
Framingham Coronary Heart Dtsease Risk 
Evaluation 1103.135.262A 
Cytcmegalcvirus Infection Negatively tnfluences 
Corcnarv Remodelina Modalities in Heart Transplant 
Recipieits: A Prospective Study 1137-67.1&A 
Diabetes and Progression of Coronary Calcium Score 
Using Electron Beam Tomography 
1190MP-170.456A 
Dietary Green Tea Intake Preserves and Improves 
Arterial Compliance and Endothelial Function 
1131~136.271A 
Difference Between Positive Remodeling and Negative 
Remodeling at the Coronary Culprit Lesion in Acute 
Coronary Syndromes 1002.104.325A 
Does Coronary Angioplasty Lead to Accelerated 
Progression of Non-Critical Coronary Artery 
Stenoses? 1005A-214.4A 
Endcthelin-1 Induces Expression of Functional CD40 
on Human Vascular Smooth Muscle Cells 
804-4.257A 
Fibrinolytic Activity and Protein Gene Polymorphisms: 
Association With Coronary Artery Disease 
1032-i 24.231 A 
Heme Oxygenase-1 Is Repressed by Bachl: A Novel 
Heme-Binding Transcriptional Repressor in Smooth 
Muscle Cells and Macrcphages 875-4.314A 
Hemoglobin Level Is an Independent Predictor of 
Mortality in Patients Undergoing Percutaneous 
Corona& Artery Interventions iOO5A-213.4A 
Impact of Insulin ResIstawe and Hyperinsulin 
Response on Arterial Stiffness 1202-146.309A 
Impact of Multiple Cardiovascular Disease Risk Factors 
on Brachial Artery Distensibility in Young Adults: The 
Bogalusa Heart Study 1156-l 19.29’JA 
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1153-l 39.287A 
Clopidogrel Pretreatment Reduces Platelet 
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Can the Left Atrial Appendage Be Safely Closed 
Without Removal? 12llMP-170.132A 
Roxithromycln Inhibits Plaque Formation Induced by 
Recurrent Lipopolysaccharide lnflammatlon In Viva 
1152.127.285A 
Short-Term Therapy With Gatifioxacin or Azithromycin 
Prevents the Acceleration of Atherosclerosis After 
Infection With Chlamydia Pneumoniae nn a Rabbit 
Model but Does Not Eradicate the Organism From 
Plaque 1155-l 49.289A 
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Flow Reserve Measurement to Guide 
Revascularization Strategy 1077.200.30A 
Marked Reduction in No-Reflow With Late Initiation of 
Hypothermia in a Rabbit Myocardial Infarct Model 
1170-105.38lA 
Measurement of Renal Blood Flow Using 
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Site-Specific Imaging of Tumor Angiogenesis Using 
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Extrinsic Rapid Electrical Stimulation Modulates 
Sarcoplasmic Reticulum Ca2+ Regulatory Proteins I” 
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Participate in the Establishment of Membrane 
Potential and Cell Growth 1186-4.125A 
Extrinsic Rapid Electrical Stimulation Modulates 
Sarcoplasmic Reticulum Ca2+ Regulatory Proteins in 
Cultured Rat Cardiomyocytes 1132.131.276A 
IL-6 Is Produced by Splenocytes Dewed From 
CMV-Infected Mice in Response to CMV Antigens, 
and Induces MCP-1 Production by Endothelial Cells: 
A New Mechanistic Paradigm for Infection-Induced 
Atheroaenesis 1178-l 42.297A 
Prognoscc Value of Monocyte Cell Markers Early After 
Acute Myocardial Infarction 1194-l 01.394A 
Raloxifene Acutely Suppresses Ventricular MyoCyte 
Contractility Through Inhibition of the L-Type Calcium 
Current 1082151.254A 
Regulation of Estrogen Receptor Subtypes on Vascular 
Cells 107%136.269A 
Sex Differences rn the Response of Cardiac Myocytes 
to the Phytoestrogen, Genistein 1082-150.254A 
Transmural Action Potential Repolarization 
Heterogeneity Develops Postnatally in the Rabbit 
825.1.112A 
Tyrosine Kinases Inhibit Availability and Open 
Probability of Single L-Type Calcium Channels in 
Human Atrial Myocytes 1041-1490A 
Cells 
Acute Dynamic Exercise Increases Circulating 
Endothelial Progenitor Cells 117%137.296A 
Angiogenic Potential of Subcutaneous Adipose Stromal 
Cells for Autologous Cell Therapy 1201-l 52.306A 
Antifibrotic Prooertv of Brain Natriuretic Peotide in 
Cardiac Fib&blasts: Cross-Talk Action tiith 
Endothelin-I and Tumor Necrosis Factor on the 
Induction of Matrix Metalloproteinases 409-2.543A 
Biological Ex-Viva Pre Differentiation of Adult Bone 
Marrow-Derived Mesenchvmal Stem Cells for 
Cardiac Repair in a Chronic Dog Model of Myocardial 
Infarction 809.4.171A 
Bone Marrow Derived Cardiomyocytes Are Present in 
Adult Human Heart 410-1544A 
Combination of Mesenchymal Stem Cell 
Transplantation and Anqiogenic Gene Transfer for 
Myocardial Regeneration and Therapeutic 
Anaioaenesis 1185-86.208A 
Cons&ive Overexpression of Hypoxia Inducible 
Factor-laNP-16 Enhances the In Vitro Angiogenicl 
Arteriogenic Effects of Mesenchymal Stromal Cells 
630-3.279A 
Erythropoietin Augments Cardiomyocyte Survival and 
Left Ventricular Function After Hypoxia 
1196-113.399A 
First Experience With Noncavitational Ultrasound 
Enhancement of Selective Cellular Delivery of Liquid 
Perfluorocarbon Nanooarticles to Anaiooenic Sites 
1151-175.69A 
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Hammerhead Ribozymes Directed Against Cyclin E 
and E2Fl as Tools to Prevent InStent Restenosis 
1055-117.241A 
Impact of Autologous Skeletal Myoblast Transplantation 
on Hemodynamics and Left Ventricular Function in 
Repeated Coronary Microembolization-Induced 
Heart Failure in Awake Dogs 1135.84.161A 
Improvement in Global and Segmental Left Ventricular 
Contractility Following Autologous Bone Marrow Cell 
Transolantation in Humans With Severe lschemic 
Heart Failure 674-5.219A 
Improvement in Symptoms and Exercise Capacity at 
Eight Weeks in a Controlled Study of Autologous 
Bone Marrow Cell Transplant in Humans With Severe 
lschemic Heart Failure 823-1.44A 
Mechanisms Underlying the Putative Role of 
Transforming Growth Factor Beta-l in Pathological 
Collagen Deposition in Chronic Heart Failure 
1060-67.155A 
Noncultured Autologous Skeletal Muscle Cells Can 
Successfully Engraft in Ovine Myocardium 
1185~85.206A 
Overexpression of Tumor Necrosis Factor-a in 
Cardiomyocytes Migrates Embryonic Stem Cells 
865-3.313A 
Percutaneous Endocardial Versus Selective Coronary 
Venous Cellular Delivery: Comparisons of Transplant 
Efficrency, Distribution, and Efficacy in Reducing 
Infarct Size and Improving Myocardial Function 
1176-l 74.67A 
Real-Time Magnetic Resonance Imaging for Integrated 
Identification, Targeting, and Injection of Labeled 
Stem Ceils to Porcine Myocardial Infarction 
407.2542A 
Receptor Activator of NF-kB (RANK) and Its Ligand 
RANK-L Coincide With Expression of Rapamycin 
Receptor FKBP12 in Neointimal Dendritic Cells 
1031-173.14A 
Safety and Feasibility of Autologous Myoblast 
Transplantation in Patients Undergoing Coronary 
Artery Bypass Grafting: Results From the United 
States Experience 846FO-5.360A 
Safety of Autologous Bone Marrow Cell Injection in 
Humans With Severe lschemic Heart Failure 
1176-i 76.67A 
Site Specific Systemic Delivery of Rapamycin With 
Perfluorobutane Gas Microbubble Carrier Reduced 
Neointimal Formation in the Porcine Coronary 
Restenosis Model 1031-200.16A 
Statins Inhibit Calcification of Aortic Valve Interstitial 
Cells 1177.136.296A 
The Coronary Sinus: A Safe and Effective Route for 
Percutaneous Myoblast Transplantation 
1176-177.67A 
Transplantation of Autologous Endothelial Cells Induces 
Angiogenesis in a Sheep Model of Chronic lschemia 
1201-l 22.306A 
Ventricular Arrhythmias Following Autologous Skeletal 
Myoblast Implantation 11 IO-78.176A 
Central nervous system 
B-Type Natriuretic Peptide Predicts Cardiac Injury and 
Dysfunction After Subarachnoid Hemorrhage 
1062.61.166A 
Diastolic Dysfunction After Neurocardiogentc Injury: 
Prevalence and Association With Pulmonary Edema 
1207.85.214A 
lschemic Stroke Causes Regional Denervation in Rat 
Myocardium 1142.42.444A 
Markers of Central Modification of the Sympathetic 
Nervous System Activity in Humans 1115-l 1 .llOA 
Persistant Myocardial Sympathetic Denervation in 
Patients With Neurocardiogenic Injury 1142-43.444A 
Cerebrovascular circulation 
Vascular Disease Independently Predicts Worse 
Outcome After Percutaneous Coronary Intervention: 
Results From the NHLBI Dynamic Registry 
1005A-211.3A 
Cholesterol 
Atoivastatin Inhibits Aortic Valve Calcification in an 
Experimental Model of Chronic Hypercholesterolemia 
via Nonlipid Lowering Effects 824FO-2597A 
Blood Pressure, Weight, and Cholesterol 890-2.32OA 
Cholesteryl Ester Transfer Protein Variants Are 
Associated With Plasma Levels of High-Density 
Lipoprotein Cholesterol but Not the Severity or 
Progression of Coronary Atherosclerosis or 
Response to Therapy 1107-137.266A 
Endothelial and Hepatic Lipase Gene Polymorphisms 
Are Associated With Plasma Levels of High-Density 
Lipoprotein Cholesterol in Lipoprotein Coronary 
Atherosclerosis Study 1107.138.266A 
Enhanced Mobilization of Circulating Endothelial 
Progenitor Cells in Hypercholesterolemic Patients by 
3-Hydroxy-3-Methylglutaryl Co-A Reductase Inhibitor: 
View Point to Two Different Types of Endothelial 
Progenitor Cells 1131-138.27lA 
Improved Lipid Profile and Reduced Lipid Peroxrdation 
With Soy Milk in Patients With Primary 
Hypercholesterolemia 1057-150.244A 
Internet-Based Continuing Medical Education 
Instruction and Live Interactive CME Workshops 
Produce Similar Knowledge Gains of National 
Cholesterol Education Program: Adult Treatment 
Panel Ill Guidelines 1122-57.5264 
Mediterranean and Low Fat Diets Are Associated With 
Similar Lipid Levels at 12 Months in Patients With 
Coronary Heart Disease on Statrn Therapy 
1056.122.243A 
On-Line Detection of Cholesterol and Calcrfication by 
Catheter-Based Raman Spectroscopy in Human 
Atherosclerotic Plaque Ex Viva 1102-l 774OA 
On-Treatment Increments in Serum High-Density 
Lipoprotein Levels Are Associated With Improved 
Survival in Patients With Coronary Heart Disease: An 
Extended Follow-Up of the Bezafibrate Infarction 
Prevention Trial 876.3.316A 
Post-Prandial Lipid and Lipoprotein Responses in 
Patients Taking HIV Protease Inhibitors 
1057.149.244A 
Preventing Coronary Events by Control of Lrpids and 
Blood Pressure in Persons With the Metabolic 
Syndrome 1107.144.266A 
Relationship Between Serum Cholesterol Levels and 
Development of Arterial Hypertension in the 
Population of the Brisighella Heart Study 
1133.153.276A 
Stabilization of Plaque Size Accompanied by a Time 
Dependent Decrease in Activated Macrophage 
Content After Vascular Injury in the Apolipoprotein-E 
Null Mouse 1200.142.306A 
Statin Therapy Is Associated With Improved Survival in 
lschemic and Nonischemic Heart Failure 
1085.76.163A 
The impact of Moderate Elevations of Blood Pressure 
and Low-Density Lipoprotein Chlosterol on Coronary 
Heart Disease Risk 1107-140.267A 
The Relationship Between High-Density Lipoprotein 
Cholesterol and Vasomotor Function 1036-l 19.236A 
Theaflavin-Enriched Green Tea Extract Lowers 
Low-Density Lipoprotein Cholesterol 1057-146.243A 
Which Lipid/Lipoprotein Ratio Best Predicts 
Angiographic Coronary Artery Disease? 
1107-l 43.267A 
Cholesterol screening 
Prognostic Value of Simultaneous Assessment of Lipid 
and Inflammatory Markers in Patients With Stable 
Coronary Heart Disease 1036.153.236A 
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Cholesterol-lowering drugs 
Additive Benefits of Pravastatln and Asptrin to 
Decrease Risks of Cardiovascular Disease: 
Randomized and Observatronal Comparisons of 
Secondary Prevention Trials and Their M&r-Analysis 
1095.55526A 
Addltwe Effects of Ramipril and Atorvastatin on 
Inflammatory Cytokines Interferon-y, Tumor Necrosis 
Factor-a, lnterleukin-6. and C-Reactive Protein in 
Diabetic Patients With Congestive Heart Failure 
1181.123301A 
Additive Effects of Statin Combined With Angiotenstn 
Converting Enzyme Inhibitor on Vasomotion in 
Hypercholesterolemic Patients 1083-138.255A 
An Exammation of Atorvastatin Safety When Used in 
Combrnation With Verapamil: Evidence From 44 
Completed Clinical Trials 1026105336A 
Angiotensin Converting Enzyme Inhibition Reduces 
Elevated C-Reactive Protein rn Patients With 
Angiographic Coronary Artery Disease 
849FO-5.391A 
Atorvastatin Improves Myocardial Contractility in 
Moderately Hypercholesterolemtc Patients as 
Assessed by Tissue Doppler imaging During 
Dobutamkte Stress Echocardiography 1140.50442A 
Atorvastatin Inhibits Aortic Valve Calcification rn an 
Experimental Model of Chronic Hypercholesterolemia 
via Nonlipid Lowering Effects 824FO2507A 
Beneficial Effects of Statin Therapy in the 
Atherosclerotic Human Aorta Are Related to Plaque 
Locatton 811%3.259A 
C-Reactive Protein Is Reduced During Ezetimibe 
Coadministration With Simvastatin in Pattents With 
Primary Hypercholesterolemia 876~6316A 
Clinical Pathway Improves Acute Myocardial Infarction 
Quality Indicators 1191-45.366A 
Coadministration of Ezetimibe With Simvastatin 
1010.147.227A 
Correlation Between Statin Therapy Before 
Percutaneous Coronarv Intervention. Periorocedural 
Creatine Kinase-MB R&ease, and Mortality at 
Follow-Up 867-1.77A 
Diabetes and Progression of Coronary Calcium Score 
Using Electron Beam Tomography 
1190MP-170.456A 
Differential Effects of Statins on Hypercholesterolemic 
Patients With Metabolic Syndrome 645-4.292A 
Does Pretreatment With Statins Before Percutaneus 
Coronary Intervention Reduce Myonecrosis? 
10837 143.256A 
Early Short-Term Use of Atorvastatin and Pravastatin rn 
Patients Wrth Non-ST Elevatron Acute Coronary 
Svndrome: Chanqes of Hemostatrc Parameters 
li71-106.362A - 
Effect of Pravastatin on Low-Density Lipoprotein 
Particle Concentratron as Determined by Nuclear 
Magnetic Resonance Spectroscopy: Results From 
the Pravastatm InflammationlCRP Evaluation 
(PRINCE) Trial 1010.150.226A 
Effects of Switching to Rosuvastatin From Atorvastatin 
or Other Statins on Achievement of International 
Low-Density Lipoprotein Cholesterol Goals: 
MERCURY I Trial lOlO-149.227A 
Efficacy and Safety of Pravastatin at 80 mg and 160 mg 
1010.151.226A 
Elevated Soluble Tumor Necrosis Factor Receotor 
Levels in Nonobese Adults With the Atherogonic 
Dyslipoprotememia 1156-l 18.29OA 
Enhanced Mobilization of Crrculatlng Endothekal 
Progenitor Ceils tn Hypercholesterolemtc Patients by 
3-Hydroxy-3-Methylglutaryl Co-A Reductase Inhibitor: 
Vtew Pomt to Two Different Types of Endothelial 
Progenitor Cells 1131-l 38.271 A 
Ezetimibe Coadmwtistered Wrth Atorvastatin Compared 
to Atorvastatin Alone rn the Attatnment of 
Low-Density Lipoprotein Goals Among High-Risk 
Patlents With Hypercholesterolemia 1083.140.255A 
Ezetimibe Coadministered With Low Dose Statins in 
Primary Hypercholesterolemia: Lipid Profiles 
Comparable to High-Dose Statin Monotherapy 
1083-142.255A 
Heterozygous Familial Hypercholesterolemia: 
Coadminrstration of Ezetrmibe Plus Atorvastatin 
1083.141.266A 
Increase I” Rusk Assoctated With a Statln Therapeutic 
lnterchanqe Policv 1095-52526A 
Lipid-LowerTng Therapy With Pravastatin Reduces 
Coronary Plaque Volume: Role of High-Densky 
Lipoprotern Cholesterol Containing Apolipoprotein 
A-l 1177.135.296A 
Patrents After Acute Mvocardial Infarction Have for a 
Prolonged Penod Increased Thermal Heterogeneity 
in Culorit Atherosclerotic Lessons: Additional Effect of 
Statins on Plaque Stabilizatron 1010.148.227A 
Pleiotropic Hemodynamic Action of Statins rn Rats 
Rendered Hypertenswe by lnhibrtion of Nrtric Oxide 
Synthew 832.4.261A 
Predictors of Clinrcal Outcome in Patients Undergoing 
Penpheral Vascular Interventions: Insights From the 
University of Michtgan Peripheral Vascular Disease 
Quality Improvement Initiative (PVD-Ql2) 
1199-17575A 
Safety Efficacy, and Effect on Glucose Levels of 
Once-Dailv Niacin on Patients With Dvsliordemia 
1057.222.246A 
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Simvastatin Preserves Myocardial Function by 
Enhancing Endothelial Nitric Oxide Production in 
Heart Failure 1039-59.151A 
Srmvastatin Restores Contractile Function and 
Reduces Cardiac Remodeling in a Genetic Model of 
Cardiomyopathy 1135-60.16OA 
Six-Month Mortality Rates Are Lower in Patients With 
an Acute Coronary Syndrome Treated With the 
Combtnation of Clopidogrel and a Statin Than in 
Patients Treated With Either Therapy Alone: An 
Analysts From the Global Registry of Acute Coronary 
Events 822-3.361A 
Statln Therapies for Elevated Liprd Levels Compared 
Across Dose Ranges to Rosuvastattn: Low-Density 
Lipoprotein Cholesterol and High-Density Lipoprotein 
Cholesterol Results 876-2.315A 
Statin Therapy Is Associated With Improved Survival in 
lschemic and Nonischemic Heart Failure 
1085.76.163A 
Statins Potentrate the Anticoagulant Effects of Low 
Molecular Weight Heparin 1083-144.256A 
Statins Promote Systemic Antioxidant Effects Through 
Specific Inflammatory Pathways 1181.120.301A 
The HMG-CoA Reductose Inhibitor Atorvastatin 
Prevents Atrial Fibrillation by Inhibiting Inflammation 
in the Canine Sterile Pericarditis Model 1041.1566A 
Tracking Changes in Human Carotid Atherosclerosis 
Using Maqnetic Resonance lmaqina 
119OMP-i71.466A 
_ _ 
Variability in the ABCAI Gene but Not HMG-CoA 
Reductase Predicts Low-Density Lipoprotein 
Lowering Effects of Statins 1083.145.256A 
Circadian rhvthm 
Administration-Time Dependent Effects of Asprrin on 
Blood Pressure tn Untreated Hvpertensive Patients 
1009-l 54.227A 
Circadian Fluctuations in Thrombogenicity in Patients 
Undergoing Primary Angioplasty for Acute Myocardial 
Infarction 1172.92.364A 
Circadian Variation of Blood Pressure in Normotensive 
and White Coat Hypertensive Subjects 
1058-l 29.247A 
Circadian Variation of Plaque Rupture in Patients With 
Acute Myocardial Infarction 1102.185.42A 
Circardian Vanation of QT Dispersion Determined by 
Twelve-Lead Holler Electrocardiography in Patients 
Without Coronarv Arterv Disease 1213.9.135A 
Differences in Outcome oi Primary Angioplasty for 
Acute Myocardial Infarction Dunng Routine Duty 
Hours Versus During Cff-Hours: Is It the Patrent or Is 
It Care? 1097.96.367A 
Evaluation of the Extent and Duratron of the ABPM 
Effect in Patients With Essential Hypertension 
1058.128.246A 
Influence of Chronobiological Variation in the Rusk of 
Acute Aortic Dissection on In-Hospital Mortality 
1154s144.266A 
Prior Treatment With Anqiotensin Convertino Enzvme 
lnhrbitors Influences the Diurnal Variation% Acute 
Mvocardial Infarction Onset 1035-148.237A 
The Circadian Variation of Atrial Defibrillation 
Thresholds 1139~17.116A 
Clinical laboratorv information evetems 
High Body Iron Stores Predispose for Early Vascular 
Modifications in B-Thalassemia Maior Patients 
1033-l 34.234A 
Clinical trials 
Helicobacter Pylori Eradicatton Improves Prognosis of 
Coronary Artery Disease Through a Mechanism Not 
Related With Platelet Activation 1173.89.366A 
A Prospective Randomized Multicenter Trial Comparing 
Distal Protection During Saphsnous Vein Graft 
Intervention With a Filter-Based Device Compared to 
Balloon Occlusion and Aspiration: The FIRE Trial 
820.4.43A 
A Prospective, Randomized Trial of 
Thromboatherectomy During Intervention of 
Thrombotic Native Coronary Artenes and Saphenous 
Vern Grafts: The X-TRACT Trial 820-l 43A 
A Randomized Study of Three Tilt Test Protocols Wrth 
Lonq-Term Follow-Uo bv lmolantable Looo Recorder 
109&20.102A . 
A Simple ECG Method Using High-Risk Infarct Territory 
Is Superior to ECGs Using Summed ST Elevation for 
Assessing Risk rn ST El&on Myocardral Infarction 
872.4.402A 
Administration-Time Dependent Effects of Asprrin on 
Blood Pressure in Untreated Hyoertensw Patrents 
1009.154.227A 
An Optimal Diagnostic Threshold of Minrmum Stent 
Area to Predict Long-Term Stent Patency Following 
Sirolimus-Elutrnq Stent Imolantation: Serial 
Intravascular VI&sound Analysis From the SIRIUS 
Trial 877-l .60A 
Antibody Levels Against Chlamydia Pneumomae and 
Outcome of Roxithromycin Therapy: Results From a 
Substudy of the Randomized Antibtotic Therapy in 
Acute Myocardial Infarction (ANTIBIO) Trial 
1196-i 11.399A 
Assocration of Major Bleeding With Adverse Clinical 
Outcomes and Length of Stay: A TACTICS TIMI 18 
Substudy 1146-108.375A 
Baseline Features and Clinical Results in Patients 
Excluded From Randomization From a Large 
lnternattonal Trial of Reperfusion Strategies in Acute 
Myocardial Infarction: The CADILLAC Registry 
827-2.366A 
Blinded Adjudication of Reinfarctron Following 
Fibrinolysis: Data From the HERO-2 Trial 
1146-l 10.375A 
C-Reacttve Protein Is Reduced During Ezetimrbe 
C&administration With Simvastatin rn Patients With 
Primary Hypercholesterolemia 676.6.316A 
Cardiovascular Safety of Vardenafil in Patients 
Receiving Antihypertensive Medications: A Post-Hoc 
Analysis of Five Placebo-Controlled Clinical Trials 
1133.148.276A 
Case-Base Distance Measurements for the Selection of 
Controls in Case-Matched Studies: Application in 
Coronary tnterventions 1023.52.519A 
Changes rn Plasma Brain Natriuretic Peptrde and 
Norepinephnne Over Time and Subsequent Mortality 
and Morbidity in Heart Failure: Results From 
Val-HeFT 8864.222A 
ClInical Features of Minority Patients in the AFFIRM 
Study 1210-20.130A 
Clinicat Outcome After Prehospital Thrombolysis 
Versus Percutaneous Coronarv Intervention for ST 
Elevation Myocardial Infarction: Results of the START 
in Berltn Pilot Study 1197.194.72A 
Clinical Performance of the WaveletTM Automatic 
Electrogram Template Collection Algorithm 
1139.13.116A 
Coadministration of Ezetimibe With Simvastatin 
1 OlO-147.227A 
Correlates of Qualitv of Life in Advanced Heart Failure: 
Insights From the-Acorn Trial 1206.76.212A 
Cost-Effectiveness Analvsis of a Disease Manaaement 
Program in Chronic Heart Failure: DIAL Trial-r 
G.E.S.I.C.A. Investigators 1022MP-164.517A 
Cost-Effectiveness of Strolimus Druo-Elutina Stents for 
the Treatment of Complex Coronary Stenoses: 
Results From the Randomized SIRIUS Trial 
805.2.32A 
Cryoablatron for Treatment of Paroxysmal Atrial 
Fibrillation: Initial Results of a Prosoective Multicenter 
Clinical Trial 846-5.126A 
Cutting Balloon Atherotomy Is Associated With 
Decreased Stent Utilization 1149-191.65A 
Does a 3-D Strain Analysis Invalidate 2-D Strain? 
Observations rn Hypertensive Left Ventricular 
Hypertrophy From the LIFE Trial Using Magnetic 
Resonance Imaging 101 l-138.229A 
Does the Extent of ST-Segment Depression Predict 
Short- and Long-Term Mortality in Patrents With 
Non-ST Segment Elevation Acute Coronary 
Syndromes? Insights From the GUSTO IV 
822.1.360A 
Does the Magnitude of the Beneficial Effect of 
Beta-Blockers in Chronrc Heart Failure Differ 
Between Diabetic and Nondiabetic Patients? A 
M&a-Analysis of All-Cause Mortality Outcomes From 
Major Chronic Heart Failure Beta-Blocker Trials 
1085-77.163A 
Early Use of Beta-Blockade tn Complicated Myocardial 
Infarctton: The VALIANT Trial 1001.106.322A 
Effect of Carvedilol on Major Cardiovascular Events tn 
Post-Infarction Patients Treated With Angtotensin 
Converting Enzyme Inhibitors: Further Analysis of the 
Capricorn Trial 1071-l 13.346A 
Effect of Ethnicity on Distrust Toward Medical 
Researchers and Willingness to Join a 
Cardiovascular Drug Prevention Tnal 851-i .534A 
Effect of Roxithromyctn on Clinical Cardiovascular 
Events in Patients Undergoing Coronary Angioplasty 
1026-l 00.3364 
Effects of Avasimibe in Claudicants With Peripheral 
Arterial Disease 857.4.304A 
Efficacy and Safety of a Chronotherapeutic 
Graded-Release Diltiazem Hydrochloride 
Formulation Dosed at Bedtime Compared to Placebo 
and to Morning Dosing in Chronic Stable Angina 
Pectoris 1026-l 02.3354 
Efficacy of a Novel P-Selectin Antagonist, rPSGL-Ig for 
Reperfusion Therapy in Acute Myocardial Infarction: 
The RAPSODY Trial 881 FO-4.404A 
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Sildenafil Improves Left Ventricular Systolic Function in 
Patients With Conaestive Heart Failure: The Role of 
Wave Reflections 7 105-l 54.264A 
Stem or Percutaneous Transluminal Coronary 
Anaioplastv for Occluded Coronaw Arteries in 
Pat;ehts With Acute Myocardial Infarction Ineligible for 
Thrombolvsis (STOPAMI-3) Trial 1172-96365A 
Superior Efiicacy of Low Molecular Weight Heparin 
Versus Unfractionated Heparin in Acute Coronary 
Svndromes Without ST Elevation 1171-108.362A 
Mesenchymal Stromal Cell Transplantation Contributes 
to Collateral Response in Tissue lschemia Through 
Release of Arteriogenic Cytokines 1176173.67A 
Nicorandil Preserves Collateral Circulation Even at 
Reduced Systemic Pressure in Comparison With 
Nitroglycerin: Real-Trme Myocardial Contrast 
Echocardiographic Study 1043.50.414A 
TNFa and IL-6 Release During Primary Percutaneous 
Coronary Intervention for Acute Myocardial Infarction 
Is Related to Coronary Collateral Flow 
1123-108.362A 
Elective Coronary Angioplasty and Percutaneous 
Coronary Intervention During Uninterrupted Warfarin 
Theraov 1174-190.63A 
Ezatimibe Coadministered Wrth Low Dose Statins in 
Primary Hypercholesterolemia: Lipid Profiles 
Comparable to High-Dose Statin Monotherapy 
1083-I 42.255A 
Heterozygous Familial Hypercholesterolemia: 
Coadministration of Ezetimibe Plus Atorvastatin 
1083.141.256A 
Hypertension Adverse Experiences Among 
Osteoarthritis Patients Treated With Rofecoxib, 
Celecoxib. or Acetaminophen in the VACT Trials 
1203-123.31OA 
Intection of Monteplase Prior to Percutaneous Coronary 
Intervention Maintains Left Ventricular Function and 
Prevents Left Ventricular Remodeling rn Acute 
Myocardial Infarction Combining Monteplase With 
Angioplasty: COMA Trial 1191.28.367A 
Internet-Based Continuing Medical Education 
Instruction and Live Interactive CME Workshops 
Produce Similar Knowledge Gains of National 
Cholesterol Education Program: Adult Treatment 
Panel Ill Gurdelines 1122.57.626A 
Is There Risk Associated With the Use of Nesrritide for 
Acute Heart Failure? 1085.70.16lA 
lschemia Modified Albumin: A New Biomarker of 
Myocardial lschemia for Early Diagnosis of Acute 
Coronary Syndromes 1048-9734OA 
Niacin Decreases Myocardial Infarctron and Total 
Mortality in Patients With Metabolic Syndrome: 
Results From the Coronary Drug Project 
845-2.29lA 
Occurrence of Transient ST-Segment Elevation During 
Pulmonary Vein Ablation for Paroxysmal Atrial 
Fibrillation in a Prospective Multi-Center Study 
1063-16.95A 
Overlapping Sirolimus-Eluttng Stems: Intravascular 
Ultrasound Analysis From the SIRIUS Trial 
877~5.81A 
Performance of the Thrombolysis in Myocardial 
Infarction Risk Index for Early Acute Coronary 
Syndrome rn the National Registry of Myocardial 
Infarction: A Sample Risk Index Predrcts Mortality in 
Both ST and Non-ST Elevation Myocardial Infarction 
112596.366A 
Pharmacodynamics of Eptifibatrde and Abcrximab in 
Patients With Non-ST Segment Elevation Acute 
Coronaw Syndromes (TAMP) 1124.89.363A 
Tumor Necrosrs Factor Sianalina Not lmoortant for 
TheAssociation of the Heart Failure Score With 
Mortality and Hospitalizatrons in Pacemaker Patlents 
837.2.189A 
The Cyclooxygenase-2 Specific Inhibitor Valdecoxib Is 
Not Associated With an Increased Risk of 
Cardiovascular Thrombotic Events in Arthritis 
Patients 1095-51.525A 
Arteriogenesis but for A%giog&esis i201-153,306A 
Vascular Endothelial Growth Factor Induces Both 
Angiogenesis and Arteriogenesis Independently of 
Nitric Oxide 830.6.26OA 
Computer communication networks 
Divx Compression Allows Medically Lossless lntranet 
or Internet Exchange of Coronary Angiograms 
866-4.538A 
Monitoring and Improving Hypertension Using the 
Veterans Administration Electronic Medical Record: A 
48-Month Review 1058.127.246A 
Practice lmoact and Patient Acceptance of a 
Cardiologist- Operated Web-Based Billing, Coding, 
and Reoort Generation Svstem 866-l .637A 
The Medicine, Angioplasty, or Surgery Study (MASS II 
Registry): A Comparison of Diabetic and Nondiabetic 
Patient’s Outcome in Medical Therapy, Coronary 
Angioplasty. and Bypass Surgery During the First 
Year Follow-Up 1050-I 05.345A 
The RelatIonship Between B-Type Natriuretic Peptide, 
Heart Structure, and Function in 4,300 Patients With 
Heart Failure Enrolled to Val-HeFT 888-2.221A 
The Use of Implantable Loop Recorders in the 
Diagnosis and Management of Syncope 
1090-3.199A Validation of Teleauscultatidh oh ah Internet-Based 
System 1122.54528A 
Wireless (GPRS-Based) Mobile Real-Time Patient 
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Chronic Oral Endothelin-A Receptor Antagonism 
Activates the Renin-Anaiotensin-Svstem With 
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Gender-Related Differences in Neurohormonal Plasma 
Levels 1038-76.149A 
Inhibition of Both Neutral Endopeptidase and 
Endothelin Convertmg Enzyme Lowers Pulmonary 
Pressures in Congestive Heart Failure 
1106.125.266A 
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832-l .260A 
Sildenafil Selectively Improves Endothelium-Dependent 
Microcirculation 1131.135.27lA 
Site Specific Systemic Delivery of Rapamycln With 
Perfluorobutane Gas Mlcrobubble Carrier Reduced 
Neointimal Formation in the Porcine Coronary 
Restenosis Model 1031.200.16A 
Specific Dysregulation of Troponins and Inflammatory 
Marker Genes in Endomyocardial Biopsies From 
Heart Transplant Recipients 1185-87.209A 
Spironolactone Improves Endothelial Function in 
Congestive Heart Failure Patients on Angiotensin 
Converting Enzyme Inhibitors 1177-i 32.295A 
The A376G (A+) Variant of the Glucose-B-Phosphate 
Dehydrogenase Gene Is Associated With Endothelial 
Dysfunction in African Americans 1079-131.249A 
The Beneficial Effect of Optimized Neurohormonal 
Therapy on Exercise Capacity in Heart Failure 
Patients Is Associated With the Restoration of 
Endothelial Function 1206.81.213A 
The Effect of Exercise Training on Endothelial Functw 
in Coronary Artery Disease: Role of Nitric Oxide and 
Endogenous Antioxidants 1104.148.262A 
The Effect of Exercise Training on the Endothelial 
Function of Coronary Artery in Patients With 
Myocardial Infarction 1161-67.199A 
The Molecular Mechanisms of Calcium Dependent 
Tissue-Type Plasminogen Activator Release 
1032-122.231A 
The Relationship Between High-Density Lipoprotein 
Cholesterol and Vasomotor Function 1036.119.236A 
The Role of Endothelial-Derived Hyperpolarizing Factor 
in Tissue-Type Plasminogen Activator Release 
1032.131.233A 
Time Course of Stent Endothekalization After 
Intravascular Radiation Therapy 112%181.48A 
Transcriptional Profiling of the Vascular Smooth Muscle 
Cell Response to Allograft Injury 855-4.210A 
Transplantation of AUtOlOQOUS Endothelial Cells Induces 
A”QiOgs”eSiS in a Sheep Model of Chronic lschemia 
1201-l 22.306A 
Tumor Necrosis Factor-a lmpaws 
Endothelium-Dependent Vasodllatation and 
Stimulates Local Tissue Plasminogen Activator 
Release in Humans: Diverse Vascular Actions of a 
Pleiotropic Cytoklne 856.3.302A 
Tumor Necrosis Factor-a Infusion Impairs Endothelial 
Function and Induces Endothelial and Metabolic 
Insulin Resistance in Humans 856-2.302A 
Upregulation of Arginase Mediates Endothelial 
Dysfunction in Aging Blood Vessels 
1130MP-171.270A 
Endothelium-derived relaxing factor 
Differential Effects of Cyclooxygenase and Nitric Oxide 
Inhibition on Endothelium-Dependent Responses in 
Coronary Arteries From Juvenile and Adult Male Pigs 
1155.148.289A 
Hemodynamic Effects of Aqueous Nitric Oxide 
Solutions Applied Directly Into Human Coronary 
Circulation 1131-l 40.272A 
Metformln Improves Endothelial Function I” Patients 
With Metabolic Syndrome X 1035.146.236A 
Raloxlfene Effect on Endothelial Function Depends on 
Duration of Menopause and Previous Hormone Use 
1035-l 47.236A 
Role of Endothelial Nitric Oxide Synthase in Arterial 
Remodeling in Heart Fallwe 1096-l 12.355A 
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The Role of Endothekal-Dewed Hyperpolarizing Factor 
rn Tissue-Type Plasmmogen Activator Release 
1032.131.233A 
Energy metabolism 
Acute intravenous Ranolazine Improves Left Ventricular 
Functton in Dogs With Heart Failure: A Dose 
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Conditional-Dependent Effects of CVT-4325. a Novel 
Fatty Acid Oxidatton Inhibitor, on Palmitate Utilizatton 
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1061.71.156A 
Mitochondrial Membrane Potential Is Decreased in 
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Matrix Metalloproteinase Inhibition in Transgenic Mice 
With Modified Cardiac Restricted Tumor Necrosis 
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Geometry and Function 809-2.17OA 
Matrix Metalloproteinases and Their Inhibitors in 
Premature Coronary Atherosclerosis: Relation With 
Inflammation and Metabolrc Markers 640.3.262A 
PAPP-A. ProMBR and PAPP-AIProMBP Ratio Are 
Related to the Extent of Angiographfc Coronary 
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Increased Levels of Matrix Metalloproteinass-3 in 
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Correlation With C-Reactive Protein 1194-99.394A 
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Outcome? 1099.194.36A 
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Congenital Heart Disease: Prevalence Rates in a 
Population of 5,363,695 Adults 1192156.490A 
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1072-I 03.349A 
Decreasing One-Year Mortality From Heart Failure in 
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Registry-1988 to 2000 637-6.198A 
Does the Prevalence of Atria Fibrillation Vary by Race 
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Practrce, Outcomes, and Costs of Heart Failure 
(EPOCH) Study 1038-74.149A 
Effect of Ethnicity on Distrust Toward Medical 
Researchers and Willingness to Join a 
Cardiovascular Drug Prevention Trial 851-I .534A 
Increase in Mortality of Patients Discharged With the 
Diagnosis of Acute Myocardfal Infarction Between 
1986and 1996 1126.100.366A 
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Hazardous Waste Sites 1143-156.485A 
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N-T Pro-BNP and the Diagnosis of Heart Failure: A 
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Studres 1013.80.143A 
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Cardiac Autonomic Modulation by Estrogen in Female 
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Electrophys&$ Testing 821.4.lllA 
Estradiol Coated Stems for the Prevention of 
Restenosis in Native Coronary Arteries: Results From 
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1150-l 79.56A 
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Marrow-Derived Endothelial Proaenitor Cells Into 
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Estrogen Is Vasoprotective in Osteopontin Deficient 
Mice 1031-176.15A 
Estrogen Receptor Alpha Gene Polymorphism Is 
Associated With Coronary Artery Disease Severity 
1033-139.235A 
High Endogenous Estrogen Levels Are Predictive of 
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Elderly Postmenopausal Women 1162-86.201 A 
Plasma C-Reactcve Protein Is Not Elevated in 
Physically Active Postmenovausal Women Taktno 
Hormone Replacement Therapy 840.5.263A _ 
Raloxifene Effect on Endothelial Function Deoends on 
Duration of Menopause and Previous Hormone Use 
1035-I 47.236A 
Regulation of Estrogen Receptor Subtypes on Vascular 
Cells 1079.136.250A 
Testosterone Aggravates Cardiac Performance and 
Remodeling in Mice After Myocardial Infarction 
809.3.170A 
Effect of Ethnicity on Distrust Toward Medical 
Researchers and Willingness to Join a 
Cardiovascular Drug Prevention Trial 851-I .534A 
Exercise 
Acute Dynamic Exercise Increases Circulating 
Endothelial Progenitor Cells 1178-137.296A 
Assessment of Left Ventricular Diastolic Function 
Following Completion of a Marathon in a Group of 
Well-Tratned Runners 1161-66.199A 
Autonomic Effects on Heart Rate Recovery in Patients 
With Coronary Artery Disease 1087-63.167A 
Cardiovascular Effects of the Endogenous Nitric Oxide 
Synthase Inhibitor Asymmetric Dimethylarginine 
(ADMA) and Evidence for ADMA Metabolism in 
Humans In Viva 856.5.303A 
Chronotrooic Resoonse to Exercise in Patients With 
Peripheral Arterial Disease Without Classical 
Symptoms of Intermittent Claudtcation 
1081.119.252A 
Effects of Acute Exercise on the Fibrtnolytic and 
Coagulative System in Patients With Chronic 
lschemic Heart Disease Ill i-66.176A 
Evidence of Impaired Left Atrial Function Response to 
Exercise in Hypertrophic Cardiomyopathy Patients 
With Heart Failure 1136-82.165A 
Exercise-induced Expression of Angiogenic Cytokines 
in Normal and Infarcted Hearts 1161.64.199A 
Feasibility of Exercise Rubidium-62 Positron Emrssion 
Tomography Myocardial Perfusion Imaging 
1093-38.428A 
Fitness Versus Activity for Predicting Mortality in Men 
838-3.191A 
High Prevalence of Anxiety rn Coronary Patients With 
Marked Improvements Following Cardiac 
Rehabilitation 1161-65.199A 
Impact of Obesity on Inflammation and Metabolic 
Svndrome in Coronarv Patients and Effects of 
Cardiac Rehabilitation Ill I-63.177A 
Importance of Diastolic and Systolic Hypertensive 
Response to Exercise on Left Ventricular Mass and 
Geometry 1209-63.217A 
Metabolic and Hemodvnamic Parameters Do Not 
Predict Sleep Disordered Breathing in Severe Stable 
Heart Failure 1061-78.156A 
Physrcal Activity Exerts Benefits in Coronary Heart 
Disease Through Autonomic Nervous System 
Modulation Ill I-65.178A 
Physical Training-Induced Reduction of Peripheral 
Monocyte-Related Inflammatory Markers Is 
Associated With Improvement in Endothelial Function 
of Chronrc Heart Failure Patients 1209-61.216A 
Plasma C-Reactive Protein Is Not Elevated rn 
Physically Active Postmenopausal Women Taking 
Hormone Replacement Therapy 840.5.263A 
POStDrandiaf Lipaemia-Induced Endothelial 
Dysfunction’The Protective Effects of High-Density 
Lipoprotein Cholesterol and Aerobic Fitness 
1130MP-189.269A 
Pulse Pressure at Early Stages of Exercise Predicts 
Angiographically Determined Coronary Artery 
Disease Severity 1161.60.196A 
Relationship Between Doppler-Derived Left Ventricular 
Filling Parameters and Exercise Capacity in Patients 
With Hypertrophic Cardiomyopathy 1044.35.414A 
Reported Health Behaviors Long-Term After Coronary 
Artery Bypass Surgery Compared With the General 
Population 1047-58.523A 
Skeletal Muscle Remodeling and Exercise Intolerance 
in Elderly Patients With Diastolic Heart Fatlure 
1088.87.166A 
The Effect of Exercise Trainrng on Endothelial Function 
in Coronary Artery Disease: Role of Nitric Oxide and 
Endogenous Anttoxidants 1104-148.262A 
The Effect of Exercise Training on the Endothelial 
Function of Coronary Artery tn Patients With 
Myocardial Infarction 1161.67.199A 
The Effects of Exercise on Lower Extremity Functtoning 
in Peripheral Arterial Disease Patients Without 
Intermittent Claudication: A Randomized Controlled 
Clinical Trial 857.3.394A 
Tissue Doppler Derived Index (EIEa) Correlates With 
Exercise Capacity in Patients With Hypertrophic 
Cardiomyopathy 1044-36.415A 
Tissue Doppler Imaging Is Superior to Mitral Flow 
Velocities for Predicting Exercise Performance 
1038.79.150A 
Upper Limits and Clinical Stgnificance of Left Atrium 
Dilatation in Trained Athletes 807-4.169A 
Exercise tests 
A Novel Periodic Breathing Index in Awake Patients 
With Heart Failure Predicts Prognosis 1062-88.161A 
Abnormal Peripheral Thermoregulatory Response to 
Exercise Substantially Impairs Exerctse Tolerance 
Among Patients With and Without lschemia on 
Myocardial Perfusion Srngle-Photon Emission 
Computed Tomography 111 I-60.177A 
Akin&a Becoming Dyskinesta During Exercise 
Echocardiography: Prevalence and Relationship to 
Clmical Outcome 1019.32.408A 
Anomalous Origin of the Left Coronary Artery From the 
Pulmonary Trunk: A 25Year Single Institution 
Outcome Study Following Surgical Restoration of 
Dual Coronary Antegrade Flows 1046.160.476A 
Association of Abnormal Heart Rate Recovery and 
Chronotropic Incompetence Wiih Obesity in a Healthy 
Cohort 838.6.191A 
Association of Abnormal Heart Rate Recovery 
Following Exercise Testing and Chronic Obstructive 
Lung Disease 1087-64.167A 
Better Functional Status Among U.S. Than Non-U.S. 
Patients After Percutaneous Coronary Intervention: 
An Effect of Medical Care? 1047-53.521A 
Blood Pressure Response During ABPM and Exercise 
and Cardiac Alternations 1058.130.247A 
Can a Pre-Exercise Test Score Predict Prognosis tn 
Women With a Low Prevalence of Coronary 
Disease? The National Heart, Lung, and Blood 
Institute-Sponsored Women’s lschemia Syndrome 
Evaluation (WISE) Study 838.4.191A 
Cardiopulmonary Exercise Capacity Increases in 
Patients Wtth Atrial Septal Defect Following 
Transcatheter Closure 1021-161.474A 
Clopidogrel Inhibits Exercise-Induced lschemia and 
Platelet Activatfon in Stable Coronary Artery Disease 
829.2.370A 
Comparison of Health-Related Quality of Life (SF-36) 
With Exercise Testing in Patients With Congenital 
Heart Disease 1192-156.490A 
Correlation of Bran? Natriuretic Peptide Release, 
Cardiopulmonary Exercise Testing, and Six-Minute 
Walktng Test in Patients With Heart Failure and 
Cardiac Resynchronization Therapy 1209.60.216A 
Dobutamine Nuclear Myocardial Perfusion Imaging 
Compared to Dobutamine Stress Echocardiography 
as a Prognostic Test for Coronary Artery Disease 
1020-42.411 A 
Doppler Stress Pulmonary Hemodynamics in Mild to 
Moderate Pulmonary Hypertension 1066-31.420A 
Dynamic Diastologic Stress Echocardiography With 
Mintmal Exercise Enables Prediction of Exercise 
Tolerance in Patients With Congestive Heart Failure 
1066.34.421A 
Early Repolarization, Heart Rate Recovery, and Rusk of 
Death 838-1.1984 
Effects of Avasimibe in Claudicants With Peripheral 
Artenal Disease 857.4.304A 
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Low Intensih/ Is Better Than High Intensity Exercise 
Training I” Chronic Heart Failure Patients Concerning 
Pulmonary Ventilation, Brain Natwretic Peptide, and 
Quality of Life Evaluation: A Prospective Randomized 
Study 1136-71.182A 
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Premature doronary Artery Disease 1033-137.234A 
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Fetal Rhabdomyoma: Prenatal Diagnosis. Clinical 
Outcome, and Incidence of Associated Tuberous 
Sclerosis Complex 1119-162.463A 
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Induced Expression of Adhesion Molecules in Human 
Coronary Artery Endothelial Cells 1132.120.273A 
Follow-up studies 
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BetaP-Adreneralc Receotor Polvmorohisms Predict 
Heart FailureProgression in idiopathic Dilated 
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KEY: Abstract Title, Sesston-abstract numberpage number 
654A SUBJECT INDEX JACC March 19.2003 
Magnetic Resonance Imaging and the Diagnosis of 
Right Ventricular Dysplasia in Children: An 
Institutional Exoerience 1046-156.474A 
Matrix Metalloprdteinass Inhibition Limits Remodeling 
and Reaional Svstolic Dvsfunction but Not Mvocvte 
Hypertrophy Foilowing tiyocardial Infarction . 
036~2.37lA 
Myocardial Blood Flow in Patients With Dilated 
Cardiomyopathy: Quantitative Assessment With 
Velocity-Encoded Cine Magnetic Resonance Imaging 
of the Coronary Sinus 1141-33.442A 
Myocardial Hyperenhancement by Magnetic 
Resonance Imaging in Genotyped Hypertrophic 
Cardiomyopathy Patients Identifies Early Disease 
and Correlates With Clinical Risk 1167-40.451A 
Mywardial Infiltration I” Sarcoidosis Demonstrated 
With Delayed Contrast Enhanced Magnetic 
Resonance Imaging 1160-80.197A 
Myocardial Injury After Percutaneous Transluminal 
Septal Myocardial Ablation in Hypertrophic 
Obstructive Cardiomyopathy: Evaluation by Magnetic 
Resonance Imaging 1167-44.452A 
Myocardial Velocity Pattern During lsovolumic 
Contraction Predicts Recovery of Contractile 
Function After Revascularization in Pabents With 
Segmental Dysfunction 410-5.545A 
Pericardial Effusion or Epicardial Fat? Improved 
Discrimination With Phase-Sensitive Inversion 
Recovery Magnetic Resonance Imaging 
111%32436A 
Prediction of the Extent of Myocardial Necrosis and 
Contractile Reserve After Reperfusion Therapy 
Following Acute Myocardial Infarction: Comparison 
Between Mvocardial Contrast Echocardiosraphv and 
Contrast Enhanced Cardiovascular Magnetic 
Resonance 1116MP.204.433A 
Qp/Qs in Atrial Septal Defects by Cardiac Magnetic 
Resonance Imaging Is Comparable to OplQs by 
Cardiac Catheterization 1130A-MP-205.439A 
Quantifying Right Ventricular Regional Systolic 
Function: Tetralogy of Fallot Versus Normals Using 
Magnetic Resonance Imaging 1 -D Myocardial 
Tagging 691.2.496A 
Quantitative Assessment of Atrial Septal Defect 
Closure Using a Hybrid XMR System 
1130A-MP-206.439A 
Quantitative Magnetic Resonance Valve Imaging: An 
Accurate Tool for Evaluating Mitral Stenosis 
1045-34.417A 
Real-Time Magnetic Resonance Imaging for Integrated 
Identification. Targeting, and Injection of Labeled 
Stem Cells to Porcine Myocardial Infarction 
407.2.542A 
Real-Time Magnetic Resonance Imaging Guidance for 
Endograft Delivery in a Porcine Model of Abdominal 
AorticAneurysm -i lOO-196.38A 
Reduction of No-Reflow and Infarct Size bv lntraaortic 
Balloon Counterpulsation in a Randomized Magnetic 
Resonance Imaging Experimental Study . 
407-l 542A 
Regional Diagnosis in Patients Wtth Unstable and 
Stable Angina Pectoris: Nicorandil Stress Myocardial 
Contrast Echocardiography and Magnetic Resonance 
Imaging 819-I .432A 
Right Ventricular Function in Idiopathic Right Ventricular 
Tachycardia Evaluated by Doppler Myocardial 
Imaging: Comparison With Magnetic Resonance 
Imaging 1044-41.416A 
Right Ventricular Systolic Function Improvement After 
Pulmonary Valve Replacement in the Restricted 
Right Ventricle of Repaired Fellot Patients 
831.6.487A 
Simultaneous Evaluation of Myocardial Function, 
Viability, and Mlcrovascular Dysfunction by a New 
Magnetic Resonance Technique 1167-43.46lA 
Spiral Magnetic Resonance Coronary Angiography 
With Real-Time Localization at 3T 
1075A-MP-203.423A 
Stereolithographic Modeling of Congenital 
Cardiovascular Malformations From Magnetic 
Resonance Images 1216-156.493A 
Substitution of Coagulation Factor XIII Partially 
Restores Scar Healing After Myocardial Infarction in 
Factor XIII Knockout Mice 1194.104.395A 
The Role of Cardiovascular Magnetic Resonance in the 
Evaluation of Familial Arrhythmogemc Right 
Ventrwlar Dysplasia/Cardiomyopathy 
1207.82.213A 
The Transmural Extent of Necrosis Modulates the 
Contractile Response of Metabolically Viable 
Myocardium to Dobutamine 1167-3&45lA 
Trackina Chanoes in Human Carotid Atherosclerosis 
UsingMagnetic Resonance Imaging 
1190MP-171.458A 
Vulnerable Plaque Diagnosis by a Self-Contained 
lntravascular~Magn&c Resonance Imaging Probe in 
Ex Vivo Human lnsitu Coronarv Arteries 
1151.197.59A 
Magnetic resonance spectroscopy 
Effect of Pravastatin on Low-Density Lipoprotein 
Particle Concentrabon as Determined by Nuclear 
Maanetic Resonance Spectroscopy: Results From 
thePrsvastatin InflammationICRPEvaluation 
(PRINCE) Trial 1010.150.228A 
Fusion Imaging in Chronic Coronary Artery Stenosis of 
the Rat by Phosphorus Spectroscopy and Magnetic 
Resonance Coronarv Anaioaraphv 
1075A-MP-207.424A; - 
Medical record systems, computerized 
Practice Impact and Patient Acceptance of a 
Cardiologist- Operated Web-Based Billing, Coding, 
and Report Generation System 866-l .537A 
Treatment Patterns and Goal Attainment Among 
Hypertensive Patients With and Without Dyslipidemia 
and/or Diabetes 1203.133.311A 
Validation of the Campus Living With Heart Failure 
Software for Assessment of Quality of Life and 
Psychological Distress in Chronic Heart Failure 
1122.55.528A 
Membrane potentials 
Cardiac Connexin43 Gap Junction Channels 
Participate in the Establishment of Membrane 
Potential and Cell Growth 1186-4.125A 
Metabolism 
Abnormal Skeletal Muscle Mitochondrial Oxidative 
Phosphorylation in Severe Chronic Heart Failure 
1183.64.203A 
Acute Intravenous Ranolazine Improves Left Ventricular 
Function in Dogs With Heart Failure: A Dose 
Escalation Study 1184-79.206A 
Effects of Insulin Resistance on Flow: Mediated Dilation 
of Conduit Vessels 1130MP-163.268A 
Elevated Plasma Xanthine Oxidase Activity in Chronic 
Heart Failure: Source of Increased Oxygen Radical 
Load and Effect of Alloourinol in a Placebo 
Controlled, Double Blinded Treatment Study 
11134.81.207A 
High Body Iron Stores Predispose for Early Vascular 
Modifications in B-Thalassemia Major Patients 
1033-l 34.234A 
Impact of Alpha-Tocopherol on the Hypertrophied Heart 
in a Murine Model of Systemic Carnitine Deficiency: 
The Involvement of 1 ,P-Diacylglycerol 1207.86.214A 
impact of Asynchronous Ventricular Activation 
Sequence on Cytokine Activation and Oxidative 
Stress in Paced Patients 1187.19.129A 
Impact of Obesity on Inflammation and Metabolic 
Svndrome in Coronarv Patients and Eflects of 
Cardiac Rehabilitation 11 ll-63.177A 
Insulin Resistance and Survival in Chronic Heart 
Failure 1061.77.158A 
Mitochondrial Membrane Potential Is Decreased in 
Failing Cardiomyocytes and Is Associated With 
Decreased Cvtochrome Oxidase-Dependent 
Respiration iO60-66.166A 
Persistence of lmoaired Vascular Function Desoite an 
Improved Metabolic ProfIle Following Three h;lonths 
of Significant Weight Loss 1202.147.309A 
Polymorphisms of the CETP, ABC, MTHFR, LPL. and 
PAI-I Genes Predict Intermediate Endpoints but Not 
Angiographic Coronary Disease: Implications for 
Genetic Research 1079-132.249A 
Ranolazine Increases Exercise Performance and 
Decreases Hemoqlobin AiC in Anqina Patients With 
Diabetes 114%91.378A _ 
Relation of the Metabolic Svndrome to Cardiac Markers 
of Preclimcal Disease: The Strong Heart Study 
890.4.320A 
The Rlaht to Left Ventricular Glucose Uptake Ratio 
Predicts Left Ventricular Function Recovery After 
Revascularization in Heart Failure 1093.41.429A 
Uric Acid and Survival in Chronic Heart Failure: 
Validation and Application in Metabolic, Functional, 
and Hemodynamic Staging 1061-83.1594 
Which Features of the Metabolic Syndrome Predict 
Clinical Outcomes (Death/Mvocardial Infarction) in 
Patients With Angidgraphic coronary Artery 
Disease? 822.4.361A 
Which Features of the Metabolic Syndrome Predict the 
Presence of Angiographic Coronary Artery Disease? 
1050.104.344A 
Microcirculation 
A New Model of Coronary Microthrombosis I” Rats and 
the Protective Effect of a New Thrombin Inhibitor 
1024-i 15.331A 
A Novel lnvaslve Assessment of the Coronary 
Microcirculation 1029-187.lOA 
Accuracy of Quantitative Assessment of Collateral 
Blood Flow Estimated by Real-Time Myocardial 
Contrast Echocardiography: Comparison With 
Microsphere Method 1043.46.413A 
Can AnatomIc No-Reflow Be Prevented by 
Pharmacologic Treatment With Adenosine and 
Verapamil? 869.6.4OlA 
Comparison of Magnetic Resonance Imaging and 
Contrast Echocardiography for Semiquantitative 
Myocardial Perfusion Analysis 1045.33.417A 
Coronary Flow Velocity Pattern by Transthoracic Color 
Doppler Echocardiography in Patients With Acute 
Myocardial Infarction Can Predict Myocardial Viability 
Assessed by Thallium Scintigraphy at Six Months 
1091-31.424A 
Effect of Abcixlmab on Myocardial Microcirculation After 
Successful Primary Percutaneous Coronary 
Intervention for Acute ST-Segment Elevation 
Myocardial Infarction 1025MP-167.333A 
Inflammation Is Not Associated With Coronary 
Microvascular Dysfunction in Women With Chest 
Pain 1080.122.251A 
Inhibition of Delta Protein Kinase C Protects Vascular 
Injury and Microwculation From Reperfusion Injury in 
Myocardial Infarction 1145.101.373A 
Intravenous Versus lntracoronaty Myocardial Contrast 
Echocardiography for the Evaluation of No-Reflow 
After Primary Coronary Angioplasty 
1025A-MP-207.412A 
Is Coronary Endothelial Function Impaired Both at the 
Level of Resistance Vessels and at That of Condut 
Vessels in Women With Atypical Chest Pain? 
1131.134.270A 
Is Coronary Thermodilution as Accurate as Doppler 
Velocity for Measuring Coronary Flow Reserve? 
1151.174.59A 
Powerful Microvascular and Myocardial Protection by 
Na+‘H+-Exchange Inhibition and lschemic 
Preconditioning: Evidence for a Causal Link in the 
Rabbit 1145-l 03.373A 
Prediction of Myocardial Infarct Size in Patients With 
Acute Myocardial Infarction by Coronary Flow 
Velocity Patterns Immediately After Percutaneous 
Coronary Intervention 1077-196.29A 
Reduction of No-Reflow and Infarct Size by lntraaortic 
Balloon Counterpulsation in a Randomized Magnetic 
Resonance Imaging Expenmental Study 
407-l .542A 
Simultaneous Evaluation of Myocardial Function, 
Viability, and Microvascular Dysfunction by a New 
Magnetic Resonance Technique 1167.43.46lA 
Tissue Level Perfusion After Primary or Rescue 
Coronary Angioplasty in Acute Myocardial Infarction: 
A Myocardial Contrast Echocardiography Study 
1116MP-207.434A 
Triggered Harmonic Power Doppler Imaging Predicts 
Functional Recovery After Revascularization in 
Patients With Left Ventricular Dysfunction 
1116MP-206.433A 
Women With Cardiac Syndrome X Exhibit Features of 
the Insulin Resistance Syndrome and Impaired 
Peripheral Microvascular Function 1177-I 31.295A 
Mitral regurgitation 
Anomalous Origin of the Left Coronary Artery From the 
Pulmonary Trunk: A 25.Year Single Institution 
Outcome Study Following Surgical Restoration of 
Dual Coronary Antegrade Flows 1046-160.475A 
B-Type Natriurettc Peptide Predicts Left Ventricular 
Response to Surgery in Patients With Severe Mitral 
Regurgitation in Asymptomatic Patients With 
Preserved Left Ventricular Function 1134.25.509A 
Can New Parameters of Flow Propagation Velocity of 
Early Filling Mitral Flow and of E-FPV Detect the 
Severity of Diastolic Dysfunction in Patients With 
Severe Mitral Regurgitation? Usefulness of Flow 
Propagation Velocity and E-FPV Analysis 
1166.29448A 
ContractlIe Response and Mitral Regurgitation After 
Late Withdrawal of Biventricular Pacing 
11 IO-79.176A 
Development of Left Ventricular Remodeling in Mitral 
Regurgitation: Influence of Etiology and Treatment 
1109MP.164.505A 
Does Functional Mitral Regurgitation Improve With 
Isolated Aoftic Valve Replacement? 806.4.503A 
Echocardiographic Classification of lschemlc Mitral 
Regurgitation Based on Mitral Leaflet Motion, Left 
Ventricular Remodeling, and Characteristics of the 
Regurgitant Jet IO&l-21.500A 
Echocardiographic Quantification of Annular Dilatation 
and Papillary Muscle Separation in Patients of 
Functional Mitral Regurgitation: Role of Anterior 
Mitral Leaflet Length~askeference 
1109MP.163.505A 
Effect of Candesartan Cilexetil on Left Ventricular 
Remodeling in Mitral Regurgitation: A Randomized 
Clinical Trial 1084.25.50lA 
Effect of Mitral Regurgitation on Left Atrial Clot end 
Spontaneous Echo Contrast in Patients With Severe 
Mitral Stenosis 1214-38.463A 
KEY: Abstract Title, Session-abstract number-page number 
JACC March 19,2003 SUBJECT INDEX 655A 
Effect of Nonsurgical Heart Failure Therapies on 
Functional Mitral Reauraitatlon: A Meta-Analvsis 
1184-75.205A - - 
Effect of Pulmonary Artery Systolic Pressure on 
MortaliN in Patients Wtth Mitral Regurgitation and 
Normal8ystolic Functton 841-6.5iiA 
Factors Affecting Regresston of lschemic Mitral 
Regurgrtation Following Isolated Coronary Artery 
Bypass Surgery 1108.23.594A 
Forward Stroke Volume Is Preserved Durino Left 
Ventricular Remodeling After Mitral Valve‘kepair 
1204-26515A 
Is Mitral Reauroitation in Conaestive Heart Failure Trulv 
Functions? Evidence for S~nificant Biochemical ’ 
Changes in the Valvular Extracellular Matrix 
1134.23.509A 
Left Ventrtcular Remodeling Differs m Chronic Aortic 
Insufficiency and Mitral Regurgitatton Following 
Surgical Correction 1084.26.502A 
Neurohormonal Activatton Is Associated With Left 
Ventricular Remodeling in Chronic Asymptomatic 
Mitral Regurgitation and Normal Left Ventricular 
Eiection Fraction 1134.24.599A 
New Impella lntracardtac Minipump Supports the 
Acutely Failing Left Heart Signifi&mtty More Effective 
Than lntraortic Balloon Pumoina 1208-67.215A 
Noninvasive Esttmatton of Lek’Ve%tcular End-Systolic 
Etastance During Stress Echocardrography in 
Pattents With Severe Mitral Reaurattation Predicts 
Latent Left Ventricular Dysfunciion 1066.32.420A 
Off-Pump Mitral Valve Repair Using the Coapsys 
Device: A Ptlot Study in a Chronic Pacmg-Induced 
Model of Functional Mitral Regurgitation 
1182-23.513A 
Outcomes After Various Surgical Strategies for Patients 
With Severe lschemic Cardiomyopathy and Moderate 
Mitral Regurgitation 1108.25504A 
Papillary Muscle Dysfunctton Attenuates lschemic 
Mitral Reouraitation in Patients With Localized Basal 
Inferior Left ljentricular Remodeling 1084-22.501A 
Presence of Mitral Annular Calcification Predicts 
Improvement in Mitral Reauraitation After Aortic Valve 
Replacement for Severe no& Stenosis 806-2.502A 
Progression of Mitral Regurgitation in Patrents With 
Mitral Valve Prolapse. A Community Study 
120%25515A 
Serum B-Type Natriuretic Peptide in Patients With 
Chronic Mitral Regurgitation Is Not Elevated 
1134-28569A 
The Effective Regurgitant Oriftce Area Is Predictive of 
Survival in Patients With Organic Mitral Regurgitation 
841.1.510A 
Mitral valve 
Calctfied Rheumatic Heart Valves Are Associated With 
Osteopontin Bone Matrix Expression 1059.2559OA 
Factors Affecting Regression of lschemic Mitral 
Reauraitation Followma Isolated Coronarv Arterv 
Bypass Surgery 1108r23.594A 
Impact of Age on Pathology, Treatment, and Outcome in 
Degenerative Mitral Valve Dtsease 806-1.502A 
Is Mitral Regurgitation in Congestive Heart Failure Truly 
Functional? Evidence for Sionificant Brochemical 
Changes in the Valvular Ext;acellular Matrtx 
1134.23.509A 
Left Ventricular Diastolic Filling Pattern by Passive 
Ventricular Reshaping in Canine Heart Failure 
1208.68.215A 
Left-Sided Valvular Disease tn Carcinotd Syndrome: 
Underestimation Without Repetitive 
Echocardioaraphies 1109MP-172.507A 
Mechanism oiLate Onset lschemic Mitral Regurgrtation 
Followina Dot’s Procedure 1108-22.503A 
Mitral Valve Disease Progression in Shones Complex: 
Are There Echocardiographic Predictors? 
8.54.5.492A 
Mitral Valve Pressure Half-Time Does Not Predict the 
Effective Valve Area m Prosthetic Mitral Valves of All 
Types. A Review of 2,175 Prosthetic Mitral Valves 
1157-25.512A 
One-Year Clinical and Echocardiographic Follow-Up 
After Endocardial Radiofrequency Ablatron for Atrial 
Frbrillation During Mttral Valve Surgery 
1037.25.499A 
Reduction in Mitral Regurgitation After Alcohol Septal 
Ablation I” Patients With Hypertrophic Obstructive 
Cardiomyopathy 1014-83.146A 
Relation of Mitral Annular Calcification to 
Cardiovascular Risk Factors and Cardiovascular 
Mortality in Adults With Type 2 Diabetes: The Strong 
Heart Study 1109MP-169506A 
Systolic Anterior Motion of the Mitral Valve After 
Surgical Repair: Incidence and Natural History 
8063503A 
Utility of Real-Time 3-D Transthoracic 
Echocardiography rn the Evaluation of Mitral Valve 
Disease 801 FO-2.429A 
Mitral valve prolapse 
Development of Left Ventricular Remodeling in Mitral 
Regurgitation: Influence of Etiology and Treatment 
1109MP-164.505A 
Halter Monitoring and Treadmill Testing Assist in 
Prediction of Future Events in Patients With Classic 
Mitral Valve Prolapse 1205.24615A 
Progression of Mitral Regurgitation in Patients With 
Mitral Valve Prolapse: A Communitv Studv 
1205-25.515A 
Mitral valve stenosis 
Effect of Afterload Reduction on Left Atrial Appendage 
Tissue Velocities After Percutaneous Mitral 
Commissurotomy for Mitral Stenosis 1140.45441A 
Effect of Mitral Regurgitation on Left Atrial Clot and 
Spontaneous Echo Contrast in Patients With Severe 
Mitral Stenosis 1214-38.463A 
Preliminarv Reoort on Percutaneous Mechanical Mitral 
Commis&roiomy 1157-24.512A 
Quantitative Magnetic Resonance Valve Imaging: An 
Accurate Tool for Evaluatina Mitral Stenosis 
1045-34.417A 
Short-Term Effect of Oral Anticoagulant Therapy on 
Documented Left Atrial Thrombi in Candidates for 
Percutaneous Transvenous Mitral Commissurotomy 
1032-l 30.233A 
Time Course Changes in Left Atrial Appendage 
Function, Left Atrial Size. and Sponianeou<Echo 
Contrast After Balloon Mitral Valvuloolastv ~ 
1157-23.512A 
Molecular biology 
Cellular Cardiomyoplasty With Bone Marrow Cells 
Improves Cardiac Performance in Heart Failure 
Induced by Healed Infarct in Rats 1135.85.181A 
Genetic Determinants of Nicotine-Induced 
Angiogenesis 804-2.256A 
Glucrxorticoids Suppress Pulmonary Hypertension 
After Cardiopulmonary Bypass by Reducmg 
Endothelin and Neutrophil Adhesion Molecules rn 
Neonatal Lungs 1008-121.223A 
Heme Oxygenase-1 Is Repressed by Bachl: A Novel 
Heme-Binding Transcriptional Repressor in Smooth 
Muscle Cells and Macrophages 875-4.314A 
Inhibition of Delta Protein Kinase C Protects Vascular 
Injury and Microcirculation From Reperfusion Injury in 
Myocardial Infarction 1145-101.373A 
Matrix Mstalloproteinase Inhibition in Transgenic Mice 
With Modified Cardiac Restricted Tumor Necrosis 
Factor Expression: Effects on Left Ventricular 
Geometry and Function 809.2.17OA 
Matrix Remodeling in Human Aortic Valve Disease 
824FO-5.599A 
Mechanism of Sestamibi Retention and Clearance 
From Myocardium and Other Organs 1142-41.444A 
Overexpression of Tumor Necrosis Factor-a in 
Cardiomyocytes Migrates Embryonic Stem Cells 
885-3.313A 
Oxidative Damage and Repair System in Spinal Cord 
lschemia and Reperfusion Injury 1180.152.3WA 
Progression of Hypertrophic Cardiomyopathy to Dilated 
Cardiomyopathy: Three New Mutations in Genes 
Encoding Sarcomeric Proteins With Two Cases of 
Double Heterozygosity 1014.88.147A 
Protein Phosphatases PPl and PPZA Regulate 
Endothelial Nitric Oxide Svnthase Activitv bv 
Modulation of the Enzyme Phosphorylatibn~ 
1152.122.294A 
Pur 8. a Single Stranded DNA Binding Protein 
Represses SRF Mediated Muscle Gene Expression: 
Implications in Impaired Cardiac Muscle Gene 
Expression During Heart Failure 1183.68.294A 
Rapid Electrical Stimulation of Contraction Modulates 
Gap-Junction Protein in Cultured Neonatal Rat 
Cardiomyocytes: Involvement of Mitogen-Activated 
Protein Kinases and Effects of Anoiotensin II 
Receptor Antagonist 825-8.113A 
Regulation of Estrogen Receptor Subtypes on Vascular 
Cells 1079.138.25OA 
Role of DNA-Binding Proteins Interacting With 
-My&n Heavy Chain Gene Repressor Element in 
Cardiac Hypertrophy 113587.182A 
Monitoring, physiologic 
Effect of Diabetes Mellitus on the Predictive Value of 
Myocardial Fractional Flow Reserve 1005-210.24 
Equivalence of Bioimpedance and Thermodilution in 
Measuring Cardi&Output and Index in Patients With 
Advanced, Decompensated Chronic Heart Failure 
Hospttalized in Critical Care 1206.71.211A 
Wireless (GPRS-Based) Mobile Real-Time Patient 
Momtoting 1122-56.529A 
Muscle, skeletal 
Abnormal Skeletal Muscle Mitochondrial Oxidative 
Phosphorvlation in Severe Chronic Heart Failure 
1183:64.203A 
Converting Patients Intolerant of Stmvastatin to 
Atorvastatin Is a Safe Practice and Associated With 
Significant Improvement in Lipid Control and Less 
Creatine Kinase Elevation 1057.223.245A 
Dyspnea-Induced Training of the Diaphragm Augments 
Local Antioxidative Enzyme Actwity in an Animal 
Model of Heart Failure: Implications for Aerobic 
Metabolism 1080-69.156A 
Effects of Beta-Blockade Treatment on Impaired 
Skeletal Muscle Function and Ryanodink Receptor/ 
Calcium Release Channel PKA 
Hyperphosphorylation in Ischemia-Induced Heart 
Failure 1080.62.154A 
Noncultured Autologous Skeletal Muscle Cells Can 
Successfully Engrafl in Ovine Myocardium 
1185-85.299A 
Noninvasive Assessment of Angiogenasis by Contrast 
Ultrasound Imaging With Microbubbles Targeted to 
Alpha-V lntegrins 602-l 430A 
Skeletal Muscle Remodeling and Exercise intolerance 
in Elderly Patients With Diastolic Heart Failure 
1088.87.188A 
Muscle, smooth 
Angiotensin II Type-l Receptor Antagonist Inhibits 
Vascular Phenotypic Change and Remodeling in 
lntramyocardial Arteries by Reducing Oxidative 
Stress Through Upregulation of Superoxtde 
Dismutase 1177-129.294/L 
Decreased Caveolin- Expression in Atheroma: Loss of 
Antiproliferative Control of Vascular Smooth Muscle 
Cells in Human Atherosclerosis 804-5.257A 
Different Cell Death Rates Determine Growth of 
Vascular Smooth Muscle Cells From Human 
Aortocoronary Bypass Vessels: Implications for 
Patency of Radial Artery Grafts 1054-143.241A 
Mental Stress Inhibits the lntimal Ftbromuscular 
Proliferation Through Endogenous Opioid System in 
the Process of Arterial Remodeling 1179.147.296A 
Obligate Role of Macrophage Colony-Stimulating 
Factor for the Development of Neotntimal Thickening 
Following Arterial Injury 808~5.34A 
Rapamycin Inhibits Expression of Minichromosome 
Maintenance Proteins in Vascular Smooth Muscle 
Cells 1031-199.16A 
Reduction of Secondary Vasospasm Limits 
Cardiomyopathy Progression 864.3.218A 
Thrombin Potentiates Platelet-Derived Growth Factor 
Induced Vascular Smooth Muscle Cell Proliferation 
via PI3 Kinase Activation and p27 Downregulatton 
1032-l 26.232A 
Myooardial contraction 
A New Criteria for Positive Dobutamine Atropine Stress 
Echocardiography: New or Worsening Wall Motion 
Abnormalities Occurring During the Recovery Phase 
Only 1092.49.427A 
Changes in Left Ventricular Structure and Function 
Predict the Onset of Hypertension in Adult 
Normotensives With a Family History of Hypertensive 
Disease: A Seven-Year Follow-Up Study 
1133-l 18.276A 
Comparative Evaluation of Longitudinal and Radial 
Myocardial Strain in Ischemia, Infarction, and 
Idiopathic Dilated Cardiomyopathy Using a New 
Tissue Doooler Svstem With Anale Correction 
1065.29.4’18A . 
Conduit Arterial Stiffness Is Associated With lmparred 
Left Ventricular Subendocardial Function 
843.5.453A 
Detection of Acute Myocardial lschemta During 
Pharmacological Stress in Graded Coronarv Artery 
Stenosis: Analysis of Left Ventricular Asynchrony 
Usino Fourier Phase lmaaina 1092-50.427A 
Improvement in Regional aid Global Myocardial 
Oxygen Consumption in Resynchronization Therapy: 
A C-l 1 -Acetate Positron Emission Tomography Study 
1093-43.429A 
Initial Experience With a New Real-Time 3-D 
Ultrasound Imager: Comparison With Conventional 
Echocardiographic Methods 801 FO-5.430A 
Nitric Oxide Reaulation of Mvocardtal Contractilitv and 
Calcium Cycling: Independent Impact of Neuronal 
and Endothelial Nitric Oxide Synthases 
1060-64.155A 
Pregnancy Associated Cardiomyopathy: Clinical Profile 
tn 137 Patients Diaanossd in the United States 
1136.78.184A - 
Pregnancy-Associated Cardiomyopathy: Early Versus 
Late Presentation 1039-60.151A 
Quantifying Right Ventricular Regtonal Systolic 
Function: Tetralogy of Fallot Versus Normals Using 
Magnetic Resonance Imaging 1-D Myocardial 
Tagging 891.2.496A 
Aesynchronization Therapy Produces Greater 
Improvement rn Left Ventricular Function in Patients 
With Pacer Induced Compared to Those With 
lntnnsic Left Bundle Branch Block 1138.3.113A 
KEY: Abstract Tttle, Session-abstract numberpage number 
656A SUBJECT INDEX JACC March 19. 2003 
Striking Systolic Asynchrony in Patients With 
Congestive Heart Failure and Normal QRS Duration: 
Is There a Role for Resynchronization? 833-3.166A 
Myocardial hibernation 
Assessment of Myocardial Viability in Patients With Left 
Ventricular Dysfunction Using Contrast-Enhanced 
Magnetic Resonance Imaging : Comparison to 
201.Thallium Single Photon Emission Computed 
Tomography 1187.42.451A 
Diaonosis of Viable Mvocardium Using Velocity 
Information of Doppler Myocardial Imaging: 
Comparison With Positive Emission Tomography 
1117-37.434A 
Diagnostic Value of Low Dose Dobutamine Stress in 
Addition to the Assessment of Late Enhancement for 
the Prediction of Functional Recovery 883-4.469A 
Evaluation of the Porcine Ameroid Constrictor Model of 
Chronic Myocardial lschemia for Therapeutic 
Anglogenesis Studies 1024-I 11.331A 
Extent and Not Nature of Dvsfunctional Mvocardium Is 
the Main Determinant of B-Type Natriur&ic Peptide in 
Patients With lschemic Left Ventricular Dysfunction 
1013.77.143A 
Flow-Function Relationships in Chronically 
Dysfunctional Myocardlum Revisited: Impact of 
Subendocardial Perfusion and Transmurality of 
Myocardial Necrosis 883-l .489A 
lntramyocardial Delivery of Bone Marrow-Derived 
Mesenchymal Stem Cells Improves Myocardial 
Contractility in a Chronic lschemic Model 
1178-l 38298A 
Low-Dose Dobutamine Gated SPECT to Predict 
Improvement in Left Ventricular Ejection Fraction in 
Patients With lschemic Cardiomyopathy Treated With 
Beta-Blocker Therapy 1020.40.41OA 
Quantitative Assessment of Left Ventricular Myocardial 
Viability During Low Dose Dobutamine Stress 
Echocardiography I” Combination With Color Tissue 
Doppler lmaglng 1189.38.454A 
Significance of ST-Segment Elevation and Chest Pain 
During Exercise Stress Testing for the Assessment of 
Myocardial Viability 1093.44429A 
Simultaneous Evaluation of Myocardial Function, 
Viability, and Microvascular Dysfunction by a New 
Magnetic Resonance Technique II 87-4i.451A 
Strain Rate Analvsis Allows Detection of Differences in 
Diastolic Funciion Between Viable and Nonviable 
Myocardial Segments 843.6.453A 
The Transmural Extent of Necrosis Modulates the 
Contractile Response of Metabolically Viable 
Myocardium to Dobutamine 1187.39.451A 
Myocardial infarction, pathophysiology 
A New Model of Coronary Microthrombosis in Rats and 
the Protective Effect of a New Thrombin InhIbitor 
1024.11533lA 
A Simple ECG Method Using High-Risk Infarct Territory 
Is Sbperior to ECGs Using Summed ST Elevation for 
Assewng Risk in ST Elevation Myocardial Infarction 
872.4.402A 
A Single Troponin I Concentration Measured 12 Hours 
After Onset of Chest Pain Accurately Reflects Infarct 
Size as Measured by Gadolinium-DiPA Late 
Enhancement Magnetic Resonance Imaging 
1170-l 00.36OA 
Acute Hyperglycemia Abolishes lschemic 
Preconditionina: A Possible Mechanism for Adverse 
Outcome of Pailents With Acute Myccardial Infarction 
and Acute Hyperglycemia 1088A-MP-203.345A 
Admission Glucose, Baseline Glucose Control, and 
Mortality After Acute Myocardial Infarction I” Diabetic 
Patients IOZA-MP-204.329A 
Antecedent Hypertension Predisposes to Arrhythmic 
Death After Acute Myocardial Infarction: An Insight 
From Contemporary Survival Studies 1018-l 1.67A 
Association Between Angioscopically Determined 
Parameters of Atherosclerosis and Classical Risk 
Factors of Myocardial InfarctIon 1080.123251A 
Association of Left Ventricular Hypertrophy Regression 
and Heart Rate Reduction With Determinants of 
Myocardlal Oxygen Consumption and Cardiovascular 
Events: The LIFE Studv 889.4.4oOA 
Baseline Creatinine Cleaiance Provides Additional 
Prognostic Information to TIMI Risk Score in Non-ST 
Elevation Acute Coronarv Svndromes 1173.90.366A 
Blinded Adjudication of Reinfamtlon Following 
Fibrinolvsis: Data From the HERO-2 Trial 
1146-l iO.375A 
C-Reactive Protein Levels as an Early Predictor of 
30.Day Mortality in Patients With Acute Myocardial 
Infarction 1048.95.340A 
Changes in Borderzone Curvature Herald Adverse 
Remodeling After Myocardial Infarction: A Contrast 
Echocardiooraohlc Studv 1135.81.181A 
Circadian Flu&&ions in ihrombogenicity in Patients 
Undergoing Primary Angioplasty for Acute Myocardial 
Infarction 1172.92364A 
Circadian Variation of Plaque Rupture in Patients With 
Acute Mvocardial Infarction 1102-185.42A 
Combination of Rapid Heart-Type Fatty Acid Binding 
Protein and Wall Motion Analysis Using 
Echocardiography at Emergency Room Improves an 
Early Diagnostic Value of Acute Myocardial Infarction 
1117~44436A 
Comoarison of Repolanzation and Inflammatory 
Aciivity in Patients With and Without Ventricuiar 
Fibrillation Durina Acute Mvocardial Infarction of a 
Similar Size (CK&OOO U/Ii 1123-l 12.383A 
Comparison of the Importance of Increasing Pathogen 
Burden, Elevated C-Reactive Protein, and the 
Presence of Antibodies to Heat Shock Protein 80 on 
Myocardial Infarction or Death 889-2.4WA 
Concerted Action of Various Angiogenic Factors During 
Acute Myocardial Infarction in Patients: The Three 
Lines of Defense 881 FO-5.405A 
Coronary Flow Reserve Immediately After Reperfusion 
Predicts Infarct Size in Patients With Acute 
Myocardial Infarction Without Diabetes Mellitus 
842-3.81A 
Coronary Flow Velocity Pattern by Transthoracic Color 
Doppler Echocardiography in Patients With Acute 
Myocardial Infarction Can Predict Myocardial Viability 
Assessed by Thallium Scintigraphy at Six Months 
1091.31.424A 
Culprit Coronary Lesion Location Correlates Closely 
With Aortic Root Mechanics Early After Acute 
Myocardial Infarction 1153-l 38.i66A 
Decline in Recurrent lschemlc Events After Mvocardial 
’ Infarction: A PO-Year Community Study 
1072.103.349A 
Detection of Acutely Impaired Microvascular 
Reperfusion Following Infarct Angioplasty With 
Magnetic Resonance Imaging 1187.38.450A 
Diabetes Does Not Add to the Increased Six-Month 
Mortality Associated With Increase in CK-MB After 
Percutaneous Coronary Intervention 1149.192.55A 
Diastolic Ventricular Electromechanical Response to 
Thrombolysis for Acute Myocardial Infarction 
1071-109.347A 
Direct Physiological Evidence of Damage to Collaterals 
During Primary Coronary Angioplasty for Acute 
Myocardial Infarction 1123-l 13.363A 
Early Activation of Matrix Metalloproteinase After 
Myocardial Infarction in Rats 1024.107.330A 
Early Heightened Inflammation Promotes Greater Left 
Ventricular Remodeling Following Anterior Myocardial 
Infarction 1159MP-185.194A 
Elevated C-Reactive Protein Levels and Increased 
High-Density Lipoprotein Size in a Post-Infarction 
Population Is Associated With Higher Risk for Future 
Cardiovascular Events 1038-l 54.236A 
Enhanced Oxidant Stress After Reperfusion Is 
Associated With Persistent ST Elevation Despite 
Patent Infarct-Related Arterv in Acute Mvocardial 
Infarction 1049-l 08.342A ’ 
Estrogen Augments Incorporation of Bone 
Marrow-Derived Endothelial Proqeni:or Cells Into 
Sites of Myocardial NeovascularTzation 407.3.542A 
Evidence of Rioht Ventricular Remodelino After Primarv 
Stenting for r\cute Myocardial Infarction: A Cine 
Magnetic Resonanc& Imaging Study 1045.32.417A 
First-Pass Maanetic Resonance lmaainq Mvocardial 
Perfusion Can Determine Microva&&r tiysfunction 
in Acute Myocardial Infarction: Validation Against 
Angiographic Thrombolysis in Myocardial Infarction 
Frame Count and Myocardial Blush Score 
1187.35.45OA 
Functional Significance of Toll-Like Receptor-2 
Mediated Signaling in the Heart FolIowIng Acute 
IschemiaIlnfarction 838.3.372A 
High-Risk Clinical Features Predict Enhanced 
Post-Infarction Myocardial Apoptosis and the Need to 
Achieve Infarct-Related Artery Patency 410.2.544A 
Hyponatremia Is a Powerful Independent Predictor of 
Short-Term Mortality in Patients With Acute ST 
Elevation Myocardial Infarction 1048.98.340A 
Impact of Diabetes on Clinical, Echocardiographic, and 
Electrocardiographic Characteristics of Myocardial 
Infarction 1088A-MP-204.345A 
Impact of High-Sensitivity C-Reactive Protein on 
Long-Term Mortality of Acute Myocardial lnfarctlon in 
the Reperiusion Era 1002.100.324A 
Impaired Endothelium-Dependent Vasomotion in 
Patients With Recent Myocardial Infarction and 
Hyperhomocysteinemia 1103.134.261A 
Increased Body Mass Index Is Associated With Better 
Short- but Not Long-Term Outcome Following Acute 
Myocardial Infarction Despite an Increased Risk of 
Recurrent Events 1193.57.533A 
Increased Concentrabons of Bone Marrow-Derived 
Stem Cells in Peripheral Blood After Acute 
Myocardial Infarction 889.3.400A 
Increased Levels of Matrix Metalloproteinase-9 in 
Patients With Acute Myocardial Infarction: No 
Correlation With C-Reactive Protein 1194.99.394A 
Infarct Imaging in a Smgle Heart Beat: Could LESS Be 
More? 1187.37.450A 
Infarct Size Needed to Cause Adverse Left Ventricular 
Remodeling in Humans: A Magnetic Resonance 
Imaging Study 883.3.469A 
Influence of Smoking on Manifestation and Clinical 
Outcome of Acute ST Elevation Myocardial Infarction 
in Clinical Practae: Results of the ACOS Registry 
889-1.399A 
Intravenous Versus lntracoronary Myocardial Contrast 
Echocardiography for the Evaluation of No-Reflow 
After Primarv Coronarv Anqioplastv 
1025A-MP-507.412A - 
Left Atrlal Volume: A Powerful PredIctor of Survival 
After Acute Myocardial InfarctIon 1117.38.434A 
Left Ventricular Remodeling After Myocardial Infarction 
Assessed by Three-Dimensional EchocardIography 
1018-50.408A 
Long-Term Prognosis of Patients With Myocardial 
Infarction and Normal Coronary Angiography: Impact 
of Inherited Coagulation Disorders 1123-110.363A 
Molecular Basis of Electrical Remodelino in the Infarct 
Zone 1098-103.354A 
Myocardial lschemia Induced Upregulation of 
Pleiotrophin Gene 1194.98.393A 
N-Terminal Pro-Brain Natriuretic Peptide on Admission 
Has Prognostic Value Across the Whole Spectrum of 
Acute Coronarv Svndromes 872.8.402A 
Nicorandil, a KATp Channel Opener, Facilitates the 
Recovery of Ventricular Contraction After 
Reperfusion Therapy in Acute Myocardial Infarction: 
Multicenter Reaistrv in Japan 1174-l 94.84A 
Nonangiograph&lly ivident Collateral Flow During 
Primary Percutaneous Translumlnal Coronary 
Angloplasty Favors Contractile Recovery 
1098-108.354A 
Platelet Activation as a Predictor of Acute Coronarv 
Syndrome in Patients Who Present to the Emergency 
Department With Chest Pain 1124.90.384A 
Platelet Collagen Receptor Glycoproteln VI as a Novel 
Risk Factor for Myocardial Infarction 878-8.404A 
Predischarae Mvocardial Contrast Echocardiooraohv 
Predicts iong:Term Clinical Outcomes and ieri ’ 
Ventricular Remodeling in Patients With Myocardial 
InfarctIon 121547.466A 
Preprocedure Inflammatory State Predicts 
Periprocedural Myocardial Infarction After Elective 
Percutaneous Coronary Intervention: An EPIC 
Substudy 1051.190.17A 
Prevalent Low-Freouencv Oscillation of Heart Rate Is a 
Powerful Predictor of bostinfarctlon Mortality: 
Comparison of Two Computational Methods 
1184-13.122A 
Prevalent Low-Frequency Oscillation of Heart Rate Is 
the Strongest Risk Stratifier Independent of All 
Available Mortality Predictors in the Placebo 
Population of EMIAT Trial 1115.12.11OA 
Prior Treatment With Angiotensin Converting Enzyme 
lnhlbitors Influences the Diurnal Variation in Acute 
Mvocardial Infarction Onset 1035-148.237A 
Prodromal Anglna Favorably Alters Relationship 
Between Time to Rep&&ion and Outcomes in 
Patients With a First Anterior Acute Myocardial 
Infarction 1195.93.396A 
Proonostic Value of Monoxte Cell Markers Earlv After 
Acute Myccardial Infarcti& 1194-101.394A ’ 
Prolonged but Reversible Sarcolemmal Phosphatidyl 
Serine Expression in Myocardial lschemia 
Represents lschemic Memory and Can Be 
Noninvasively Detected by Radiolabeled Annexin-V 
Imaging 835-5.448A 
Relation of Growth Hormone and Insulin-Like Growth 
Factor-l to Ventricular Remodeling in Acute 
Myocardial Infarction 1170.103.381A 
Relation of Prothrombotic Platelet Polymorphisms to 
the First Manifestation of Coronary Artery Disease in 
Mlddle-Aged Males 1124.93.364A 
Rest Redistribution Imaging: A Novel Standard fol 
Assessing ECG Criteria for Myocardlal Infarction 
1213.8.135A 
Rheumatoid Arthritis Is Not Associated With Myocardial 
Infarction After Controlling for Other Risk Factors 
1200-l 35.305A 
Right Ventricular Behavior in Left Ventricular Infarction 
1071.108.347A 
Simultaneous Evaluation of Myocardlal Function, 
Viability, and Microvascular Dysfunction by a New 
Magnetic Resonance Technique 1187.43.451A 
Substitution of Coagulation Factor Xlll Partially 
Restores Scar Healing After Myocardial Infarction in 
Factor XIII Knockout Mice 1194.104.395A 
Successful Late Reperfusion by Primary Angioplasty 
Reduces Risk of Mechanical Complication ln Patients 
With Acute Myocardial Infarction 1029.194.1lA 
The Clinical Significance of Circulating Levels of 
GranulocytelMacrophage-Colony Stimulating Factor 
in Acute Myocardial Infarction Patients 
1049-l 11.343A 
The Effects of Tumor Necrosis Factor, Angiotensin, and 
Phenylephrine on Myocyte lntegrin IsoformTransition 
KEY: Abstract Title, Session-abstract numberspage number 
JACC March 19,2003 SUBJECT INDEX 657A 
and Cytoskeletal Rearrangement. A Clue to 
Post-Infarct Remodeling 809.5.17lA 
The Prognostic Signillcance of Short-Term 
Measurements of Heart Rate Vanabilitv Assessed 
Early Following Acute Myocardial lnfar&on 
1213-4.134A 
The Take-Tsubo Syndrome (Transient Apical 
Ballooning). A United States Perspectwe 
1188-31.453A 
Time Dewndent Reduction of Mvccardlal Infarct Size 
by En&vascular Hypothermrain an 
Ischemia-Repariusion Porcine Model 
1096-l 13.356A 
Timing and Risk Factors for Enzymatic Myocardlal 
Infarctions in Patients Undergoing Percutaneous 
Intervention: Insights From TARGET 1076.187.26A 
TNFa and IL-6 Release During Primary Percutaneous 
Coronary lnterventlon for Acute Myocardral Infarction 
Is Related to Coronary Collateral Flow 
1123-108.362A 
Turbulence Slope After AtrIal Premature Complexes Is 
Significant Mortality Predictor in Patients After 
Myocardial Infarction 814-4.104A 
Ventricular Endocrine and Wall Motion Function in 
Acute Myocardial Infarction 828FO-6.279A 
Volumetric Assessment of Ulcerated Ruptured 
Coronary Plaques: A Study With Three-Dimensional 
intravascular Ultrasound In VIVO 1080-124.25lA 
Myocardial infarction, treatment 
80.Lead Body Surface Map Compared With Physictan 
and 12.Lead ECG in Detection of Acute MyOcardlal 
Infarction 1115.3.108A 
A New Endpoint to Evaluate the Success of 
Reperfusion Therapy Following ST-Elevation 
Myocardlal Infarction 853-3.392A 
A Prospectwe MultIcenter International Randomized 
Trial Comparing Infarct Artery Stenting Alone With 
Infarct Artery Stentmq Plus Abciximab in Acute 
Myocardial ~nfarction_Principal Report of the 
Abciximab and I;arbostent Evaluation (ACE) Trial 
1025MP-165.332A 
A Risk Score for Predicting Coronary Artery Bypass 
Surgery in Patients With Non-ST Elevation Acute 
Coronary Syndromes 849FO-6.39lA 
A Simple Electrocardiographic Method to Predict 
Patency of the Infarct-Related Artery After Fibrmolytic 
Therapy 1195-l 15.397A 
Acute Hyperglycemia Abolishes lschemic 
Preconditioning: A Possible Mechanism for Adverse 
Outcome of Patients With Acute Myocardial Infarction 
and Acute Hyperglycemia 1068A-MP-203.345A 
Adjunctlve Porous Filter Protection From Distal 
Embolization in Primary Percutaneous Intervention 
for Acute Myocardial InfarctIon 1127-189.46A 
Angiographic and Clinical Outcomes of Patients Treated 
With Primary or Rescue Angioplasty m Saphenous 
Vein Graft for Acute Myocardial Infarction 
1172.98.385A 
Angiographic Assessment of Reperfusion in Acute 
Myocardial Infarction by Myocardial Blush Grade 
1049-108.342A 
Anglographic Predictors of Left Ventricular Ejectlon 
Fraction After Successful Angioplasty in Acute 
Myocardial Infarction: An Angiographic Risk Score for 
Use in the Catheterization Laboratory 1191-29.388A 
Antibody Levels Against Chlamvdia Pneumonia? and 
Outcome of RoxTthromycin Tl&apy: Results From a 
Substudv of the Randomized Antibiotic Theraov in 
Acute Miocardial Infarction (ANTIBIO) Trial ’ 
1196.111.399A 
Aaueous Oxvaen Theraw for ST-Seament Elevation 
ivlyocardiai ifarctlon: ‘AMIHOT Trial Design and 
Praliminarv Results 1197.19572A 
Are the Re&ts of the Multicenter Automatic 
Defibrillator Implantation Trial-It Applicable to Pattents 
Seen at a Tertiary Referral Center? 1064.5.96A 
Baselme Features and Clinical Results m Patients 
Excluded From Randomization From a Large 
International Trial of Reperfusion Strategies in Acute 
Myocardial Infarction: The CADILLAC Registry 
827.2.368A 
Baseline Serum Creatinlne Level Strongly Predicts Risk 
of Procedural Failure of Percutaneous Coronary 
Intervention in Patients With Acute Myocardial 
Infarction: Results From the Japanese Multicenter 
AMI Registry (JAMI) 1172.94.384A 
Beneficial Effects of Direct Call to Emergency Medical 
Services on Time Delays and Management of 
Patients With Acute Myocardial Infarction: Real World 
Data From RICO Database 1147-94.376A 
Benefits and Risks of Abciximab Use I” Primary 
Angioplasty for Acute Myocardlal Infarction: The 
CADILLAC Trtal 1097.95.357A 
Blologlcal Ex-Viva Pre Differentiation of Adult Bone 
Marrow-Derived Mesenchymal Stem Cells for 
Cardiac Repair I” a Chronic Dog Model of Myocardial 
Infarction 809-4.1714 
Catheter-Based Percutaneous Cellular 
Cardiomyoplasty Using Allogeneic Bone Marrow 
Derived Mesenchymal Stem Cells 1176-175.67A 
Changing Sex Differences in Invasive Cardiac 
Procedure Rates Following Acute Myocardial 
Infarction 1121-58.527A 
Clmical and Angiographic Predictors of Cardiac Events 
in Patients With Non-ST Elevation Acute Coronary 
Syndromes Undergoing Percutaneous Coronary 
Intervention in the Current Era: Insights From the 
PRESTO Trial 822-5.36lA 
Clinical Evidence for Benefit of lntracoronary Progenitor 
Cell Therapy on Post-Infarction Remodeling: Results 
of the TOPCARE-AMI Trial 88lFO-2.404A 
Clinical lmpllcations of Myocardial Perfusion Status 
Assessed by Myocardial Blush After Primary 
Angioplasty in Acute Myocardial Infarction: Analysis 
From the CADILLAC Trial 853.2.39lA 
Cltnical Outcomes After Percutaneous Coronary 
Intervention in Rlaht Ventricular Infarction 
1127.193.47A _ 
Clinical Pathway Improves Acute Myocardial Infarction 
Qualitv Indicators 1191-45.388A 
Coagula&n Activation Induced by Fibrinolytlc Therapy 
Is Blunted bv the Combination of a Low-Dose 
Fibrinolytic and a Platelet Glycoprotein Ilb/llla 
Irfhibitor: The GUSTO V Italian Hematologic 
Substudv 1025MP-172.334A 
Cost-Effeciiveness of Prehospital Thrombolysis 
1070-56.524A 
Critical Pathways in the Emergency Department Have 
Improved Treatment Modalities and Outcome for 
Patients With ST Elevation Mvocardial Infarction 
1147.96.377A 
Delays I” Revascularization Are Associated With an 
Increased Risk of Stroke in Patients With Mvocardial 
Infarction 1071-l 10.347A 
Despite Increased Mortality Post Myocardial Infarction. 
Diabetics Have Made Substantial Gams From 
Therapy 1193.54.533A 
Differences m Outcome of Primary Angioplasty for 
Acute Myocardial Infarction During Routine Duty 
Hours Versus During Off-Hours: Is It the Patient or Is 
It Care? 1097-96.357A 
Disparities in the Treatment of Acute Myocardial 
Infarction: Underutilization of Evidence-Based 
Therapw for Patients With Non-ST-Segment 
Myocardial Infarction 1385.4.540A 
Distal Myocardial Protection With lntracoronary 
Propranolol During Percutaneous Coronary 
Intervention Is Widely Applicable 1051.188.17A 
Do Baseline C-Reactive Protein Levels Predict 
Myocardial Salvage After Reperfusion Therapy in 
Patients With Acute Myocardial Infarction? 
1071.116.348A 
Early Postinfarction Ventricular Restraint Prevents 
Adverse Remodeling and Preserves Borderzone 
Contractile Function 809.1.170A 
Effect of a Novel Pharmacological Strategy to 
Counteract Shivering During Endovascular Cooling 
for Acute Myocardial Infarction 1197-l 96.72A 
Effect of Abciximab on Myocardial Microcirculation After 
Successful Primary Percutaneous Coronary 
Intervention for Acute ST-Segment Elevation 
Myocardial InfarctIon 1025MP.167.333A 
Effect of Carvedilol on Major Cardiovascular Events I” 
Post-Infarction Patients Treated With Angiotensin 
Converting Enzyme Inhibitors: Further Analysis of the 
Capricorn Trial 1071-l 13.348A 
Effect of Distal Protection or Thrombectomy on 
Corrected Thrombolysis in Myocardial Infarction 
Frame Counts in Stenting for Acute Myocardial 
Infarction 1097.94.356A 
Effect of Gender on Strategies for Revascularization for 
Cardiogenic Shock 1001.107.322A 
Efficacy of a Novel P-Selectin Antagonist. rPSGL-Ig for 
Reperfusion Therapy in Acute Myocardial Infarction: 
The RAPSODY Trial 881 FO-4404A 
Enhanced Cardiomyocyte Transplantation With 
Vascular Endothelial Growth Factor and IGF 
Transduction in a Mouse Model of Acute Myccardial 
Infarction 1185~8&209A 
Enoxaparin Is Superior to Unfractionated Heparin After 
Fibrinolysis m Acute Myocardial Infarction: 
Meta-Analysis of ASSENT-3, HART-II, and 
ENTIRE-TIMl-23 Trials 1025MP-171.334A 
Erythropoletin Augments Cardiomyocyie Survival and 
Left Ventricular Function After Hypoxia 
1196-I 13.399A 
Excesswe Hospital and One-Year Mortality in Diabetics 
Compared to Nondiabetics With Non-ST Elevation 
Myocardial Infarction in Clinical Practice: Results of 
the ACOS-Registry 1191-27.387A 
Extent of Three-Dimensional Applical Reverse 
Remodeling During Endoventricular Circular Patch 
Plasty (DOR Procedure) for Anterior Left Ventricular 
Aneurysm Predicts the Degree of Global Function 
Improvement lOI&49.408A 
Fractional Flow Reserve of the Infarct-Related Artery 
Early After Myocardial Infarction ldentifles 
Reversibility on Dipyrldamole Sestamibi 
Single-Photon Emission Computed Tomography 
Perfusion Imaging 842-5.62A 
Gender-Specific Risk Factors for Thromboembollc 
Stroke With Acute Mvocardial Infarction 
1146-112.375A ’ 
Glycoprotein llbillla Inhibitors After Full Dose 
Thrombolysis in Rescue Angioplasty for Acute 
Myocardial Infarction: To Give or Not Give? 
1097-I 01.358A 
Glycoprotein llbillla lnhlbitors Are UnderutIlized Among 
Patients Who Undergo Cardiac Catheternation 
Followina Acute Mvocardial Infarction: Observations 
From th;NRMI-4 i 147.95.377A 
Glycoprotein Ilb/llla Receptor Antagomsm in Patients 
With Acute Coronary Syndromes and Prior Coronarv 
Artery Bypass Grafting: Results From PRISM PLUS- 
1124-91.364A 
Heart Failure and/or Left Ventricular Systolic 
Dysfunction Complicating Myocardial Infarction Is 
Common and Accounts for the Majority of In-Hospital 
Myocardial Infarction Mortality: Rewlts of the 
VALIANT Reaistrv 103%71.148A 
Heart Failure F&&g ST Elevation Myccardial 
Infarction: Are We Aggressive Enough? 
1159MP-171.195A 
How Important Is Time to Treatment With Primary 
Percutaneous Coronary Intervention for Acute 
Myocardial Infarction? Results From the CADILLAC 
Trial 827-l .368A 
Impact of Known and Newly Diagnosed Diabetes 
Mellitus After a Myocardial Infarction 
1068A-MP-205.345A 
Impact of Multivessel Coronary Artery Disease on 
In-Hospital Outcome in Patients Treated by 
Immediate Angioplasty for Acute Myocardial 
Infarction 1097-98.3574 
Impact of Multivessel Disease on Recovery of Left 
Ventricular Function After Primary Angioplasty for 
Acute Myocardlal Infarction 1191.49.389A 
Impact of Plaque Characteristics on Myocardial Tissue 
Reperfusion in Acute Myocardial Infarction 
1049.107.342A 
Impact of Time to Reperlusion on Microvascular 
Damage After Primary Coronary Angioplasty for 
Acute Myocardial Infarction 1001-l 10.323A 
Implantation of Bone Marrow Stromal Cells Into 
Ischemic Myocardium Prevents Late Myocardial 
Remodeling 1024-l 16.332A 
Implication of MADIT-II on Unselected Patients 
Following an Acute Myocardial lnfarctlon 1064.2.96A 
Improved Clinlcal Outcomes With Abciximab Therapy in 
Acute Myocardial Infarction: A Systematic Overview 
of Randomized Clinical Trials 1025MP-166.333A 
Improved Efficiency in Both Initial Rep&u&n Therapy 
and Subsequent Acute Myocardial Infarction Care 
Through Commitment to Emergency 
Department-lnltiated Primary Percutaneous 
Coronary Intervention 1001-l 13.323A 
Improved Functional Status and Quality of Life After 
Invasive Management of Non-ST-Segment Elevation 
Acute Myocardial InfarctIon 1196-109.398A 
Increased Risk of Adverse Outcomes With Proximal 
Culprit Artery Lesions m Acute Myocardial Infarction 
1001-I 08.322A 
Influence of Biochemical Markers on Thrombolysis 
Effectiveness Early in the Course of ST-Segment 
Elevation Myocardial Infarction 1191.47.388A 
Influence of Diabetes Mellltus on Intravenous 
Thrombolysis Effectiveness in Patients With ST 
Elevation Myocardlal Infarction 1049-I 10.343A 
Influence of Guidelines and Results From Major Clinical 
Trials on Medical Practice: Findings From the Global 
Registry of Acute Coronary Events (GRACE) 
1022MP.169.518A 
Influence of Patch Material Stiffness on Stroke Volume 
With Surgical Anterior Ventricular Endocardial 
Restoration in lschemic Cardiomyopathy: A Finite 
Element Model Study 110%24.604A 
Influence of Physician Specialty on Care and Outcomes 
of Acute Coronary Syndrome Patients: Results From 
CRUSADE 851.3.534A 
InhIbition of Delta Protein Kinase C Protects Vascular 
Injury and Microcirculation From Reperfus~on Injury in 
Myocardlal Infarction 1145-l 01.373A 
InhibItion of Nuclear Factor Kappa B Activation by 
lntramyocardial Adenovirus-Mediated Gene Transfer 
Attenuates Ventricular Remodeling Followmg 
Myocardial Infarction 1194-l 05.395A 
Initial Results of the GuIdelines Applied in Practice for 
Improving Quality of Care Patients With Acute 
Myocardial Infarction: The Flint-Saginaw Cooperative 
Initiative of the American College of Cardiology 
Foundation, Greater Flint Health Coalition, and 
Michigan Peer Review Organization 1147-92.376A 
lnlection of Monteplase Prior to Percutaneous Coronary 
Intervention Maintains Left Ventricular Function and 
Prevents Left Ventricular Remodeling in Acute 
Myocardial Infarction Combining Monteplase With 
Angioplasty: COMA Tnal 1191.28.387A 
KEY: Abstract Title, Session-abstract numbwpage number 
658A SUBJECT INDEX JACC March 19,2003 
International Patterns in the Care of Acute Myocardial 
Infarction Pabents in the Occluded Arterv Trial (OAT): 
Characteristics of 1,635 Screened Patients 
1147.90.377A 
International Trends in the Use of Primary 
Percutaneous Coronary Intervention 1005A-216.4A 
lntracoronary Beta-Blocker Protects the Distal 
Myocardium During Percutaneous Coronary 
Intervention 880FO-4.64A 
lntracoronarv Hvperoxemic Blood Infusion Following 
Primary P&ianeous Coronary Intervention in _ 
Anterior Acute Mvocardial Infarction Patients: Positive 
Effects on Cardiac Enzyme Kinetic, S%Segment 
Changes, and Left Ventricular Function Recovery 
1049-I 13.343A 
Is COX-2 Inhibitor Use Associated With an Increased 
Rate of Recurrent Events Among Patients With a 
Recent Cardiovascular Event? 1126-102.367A 
lschemia Modified Albumin: A New Biomarker of 
Myocardial lschemia for Early Diagnosis of Acute 
Coronary Syndromes 1046-97.340A 
Lack of Benefit From Cytokine Mobilized Stem Cell 
Therapy for Acute Myocardial Infarction in Nonhuman 
Primates 6361.3714. 
Left Ventricular Remodelino Is the Most Common 
Cause of Systolic Dysfu&ion After Acute Myocardial 
Infarction: Findings From the Stent-PAMI Study 
1159MP-166.194A 
Long-Term Prognosis of Patients With Myocardial 
Infarction and Normal Coronary Angiography: Impact 
of Inherited Coagulation Disorders 1123-l 10.363A 
Low-Molecular-Weight Heparin Alone and With Ilb/llla 
lnhlbitors in Patients With Renal Failure and Non-ST 
Elevation Acute Coronary Syndromes: Insights From 
the Global Registry of Acute Coronsiry Events 
1026.101.335A 
Lower Preprocedural Hemoglobin Level Is Associated 
With Increased Risk of In-Hospital Mortality Following 
Percutaneous Coronary Intervention 671-5.639A 
Magnitude and Impact of After Hours Treatment Delay 
in Patients Undergoing Primary Angioplasty for Acute 
Myocardial Infarction: The CADILLAC Trial 
1005.190.1A 
Management and In-Hospital Outcome for Patients 
With Acute Myocardial Infarction in Contemporary 
Practice: Japan Acute Myocardial infarction (JAMI) 
Study--Prospective Multicenter Observational Cohort 
Study in Japan 1193.56.633A 
Management and Outcomes of Patients With Acute 
Cor&ry Syndromes and Gastrointestinal Bleeding 
1146-I 06.374A 
Marked Mortality Risk of Renal Insufficiency in Patients 
Undergoing Primary Angioplasty for Acute Myocardial 
Infarction 1172-93.364A 
Matrix Metalloproteinase Inhibition Limits Remodeling 
and Reoional Svstolic Dvsfunction but Not Mvocvte 
Hypertriphy Foilowing dyocardial Infarction ’ ’ 
636-2.371A 
Mechamsms of Lumen Enlargement During Stenting of 
Acute Myocardial Infarction Lesions: A Volumetric 
Intravascular Ultrasound Study 642.4.61A 
Mid-Term Results of Thrombus Extraction in Patients 
With ST Elevation Myocardial Infarction: One Center 
Experience With the X-SIZER Catheter System 
1097.93.366A 
Multiple Lesion Coronary Intervention Is Associated 
With Higher Mortality in Primary Angioplasty for 
Acute Myocardial Infarction: The Stent PAMI Trial 
627-4.36SA 
Multivessel Percutaneous Intervention for ST-Segment 
Elevation Myocardial Infarction: The Mayo Clinic 
Experience 1001.206.324A 
My&dial Tissue Replacement With Extracellular 
Matrix Scaffolds 1182-26614A 
Neovasculature of the Infarct Scar: Need to Expand 
Angiogenic and Vasculogenic Components 
1194-l 03.394A 
Novel Gene Therapy for Post-Myocardlal Infarction 
Ventricular Arrhythmias 616.1.105A 
Opening the Window of Facilitated Percutaneous 
Coronary Intervention in Acute Infarction: The Role of 
Combined Ilb/llla Inhibition and Thrombolytic 
Therapy 1025MP-170.334A 
Outcome AHer Urgent Percutaneous Coronary 
Interventions in ASSENT-3 1191.46.369A 
Outcome of Patients With Acute Myocardial Infarction 
Admitted to Hospitals With and Without Facilities for 
Primary Percutaneous Coronary Intervention: Data 
From the AMCFlorence Registry 1097-102.366A 
Outcomes Based on Time to Angiography in Patients 
With Non-ST Elevation Acute Coronary Syndromes 
1173.114.366A 
Outcomes in Patients Requiring Bail-Out Abciximab 
During Primary Intervention in Acute Myocardial 
Infarction: Analysis From the CADILLAC Trial 
1025MP.169.333A 
Outcomes Using Stress Myocardial Perfusion Imaging 
in Patients With and Without Troponin Elevations 
1195-I 16.397A 
Patency of Infarct Related Artery Influences In-Hospital 
Outcome of Patients Undergoing Facilitated 
Percutaneous Coronary Intervention for Acute 
Mvocardial Infarction 1 lSl-50.36OA 
Patients After Acute Myocardial Infarction Have for a 
Prolonged Period In&eased Thermal Heterogeneity 
in Culprit Atherosclerotic Lesions: Additional Effect of 
Statins on Plaque Stabilization lOlO-146.227A 
Percutaneous Coronary Intervention During the Index 
Hospitalization Is Associated With Reduced 
Re&rrent Myocardial Infarction and Improved 
Survival Followino Thrombolvtic Administration 
1196-106.396A _ 
Percutaneous Endocardlal Versus Selective Coronary 
Venous Cellular Delivery: Comparisons of Transplant 
Efficiency, Distribution, and Efficacy in Reducing 
Infarct Size and Improving Myocardial Function 
1176.174.67A 
Performance of the Thrombolysis in Myocardial 
Infarction Risk Index for Early Acute Coronary 
Syndrome in the National Registry of Myocardial 
Infarction: A Simple Risk Index Predicts Mortality in 
Both ST and Non-ST Elevation Myocardial Infarction 
1125-96.365A 
Performance of the Thrombolysis in Myocardial 
Infarction ST Elevation Myocardial Infarction Risk 
Score in Elderly Patients 1112-66.160A 
Plasma PAI-I Antiaen Concentration Predicts Clinical 
Outcome of Thrimbolytic Treatment of Acute 
Myocardial Infarction 1032.125.232A 
Possible Beneficial Effects of Adenosine as Adjuvant 
Therapy to Thrombolytic Treatment in Patients With 
an Acute Anterior Myocardial Infarction and 
Depressed Left Ventricular Funchon 1071-l 12.347A 
Prediction of Mvocardial Infarct Size in Patients With 
Acute MvocaLdial Infarction by Coronary Flow 
Velocity &terns lmmediatelj After Per&taneous 
Coronarv Intervention 1077-196.29A 
Predictorsand Long-Term Mortality of Atrioventricular 
Block After Acute Myocardial Infarction Treated With 
Thrombolysis 1071.107.346A 
Predictors and Sequelae of Subacute Thrombosis After 
Percutaneous Intervention in Acute Myocardial 
Infarction: The CADILLAC Trial 653-6.393A 
Predictors of Treatment Delay in Patients With Acute 
Mvocardial Infarction Underooina Primarv 
Angioplasty: An Analysis From ti;e CADILLAC Trial 
1147-93.376A 
Prehospital ThrombolyticlAbciximab Therapy in 
Comparison to Facilitated Percutaneous Coronary 
Intervention After Combined Prehospital 
Thrombolysis in Acute Myocardial Infarction 
1025MP-164.332A 
Preintervention Restoration of Coronary Flow in 
Patients With ST Elevation Acute Myocardial 
Infarction Is Associated With Better Anglography and 
Clinical Outcomes 1124-92.364A 
Preprocedutal Lesion Morphology as Assessed by 
Intravascular Ultrasound Predicts Thrombolysis in 
Myocardial Infarction Frame Counts Following 
Percutaneous Coronary Intervention for the 
Infarct-Related ArteN 642-2.6lA 
Primary Angioplasty Reduces Mortality in Elderly 
Patients With Riaht Ventricular Infarction 
1071.114.346A- 
Primary Coronary Angioplasty After Transfer Versus 
On- Site Thrombolvsis in Acute Mvocardial Infarction: 
A Me&-Analysis 1172.95.364A 
Primarv Percutaneous Intervention in Patients With 
Prior’Coronary Artery Bypass Grafting Admitted With 
Acute Myocardlal Infarction: Results of the 
ALKK-Reaistrv 1197-167.71A 
Prodromal +ingina Favorably Alters Relationship 
Between Time to Reoerfusion and Outcomes in 
Patients With a First’Anterior Acute Myocardial 
Infarction 1195.93.396A 
Prognostic Value of the Absolute Degree of 
ST-Segment Elevation of the ECG at Baseline and 
After Primary Angioplasty: Analysis From the 
CADILLAC Trial 1001-I 12.323A 
Prospective Study of Primary Percutaneous 
Intervention and Abciximab in Patients With ST 
Elevation Myocardial Infarction Complicated by 
Cardioaenic Shock 1196-l 07.396A 
Protection Against Reperfusion Injury With ITF-1697 in 
Acute Myccardial Infarction: The PARI-MI Trial 
661 FO-3.404A 
Quality of Care for Patients With Peripheral Vascular 
Disease During Acute Coronary Syndromes: Insights 
From the Global Registry of Acute Coronary Events 
(GRACE) 1061-116.2524 
Racial Differences in Acute Repelfusion Therapy Use in 
Patients Hospitalized With Acute Myocardial 
Infarction: A Regional Phenomenon 
1022MP-170.516A 
Randomized Trial of Primary Angioplasty Versus 
Prehospital Hibrinolysis in Acute Myocardial 
Infarction: One-Year Survival Results 827-6.369A 
Real-Time Magnetic Resonance Imaging for Integrated 
Identification. Targeting, and Injection of Labeled 
Stem Cells to Porcine Myocardial Infarction 
407-2.542A 
Reduction in Hospital Mortality by First Day 
Percutaneous Coronary Intervention for Non-ST 
Elevation Myocardial Infarction in Diabetics: Results 
of the ACOS-Registry 1196-I 08.396A 
Reduction of Hospital Mortality in Patients With ST 
Elevation Myocardial Infarction Receiving 
Glycoprotein llbillla Antagonists: Results of the 
ACOS Registry 1025MP-166.333A 
Reduction of No-Reflow and Infarct Size by lntraaortic 
Balloon Counterpulsation in a Randomized Magnetic 
Resonance lmagmg Experimental Study 
407-l .542A 
Regional Variations in Treatments and Outcomes of 
Reinfarction in the HERO-2 Trial 1071-I 11.347A 
Relationship Between Time of Day/Day of Week and 
Outcomes in Patients Undergoing Primary 
Percutaneous Coronary Intervention for Acute 
Myocardial Infarction 885-6.641A 
Relationship Between Time to Treatment, 
Electrocardiographic ST-Segment Resolution, and 
Outcomes With Primary Percutaneous Coronary 
Intervention for Acute Myocardial Infarction: Results 
From the CADILLAC Trial 1049.109.342A 
Safety and Efficacy of an Accelerated Streptokinase 
Regimen in Combination With Enoxaparin in the 
Prehospital Management of the ST Acute Myocardial 
Infarction (ASENOX-2) Study 1198.112.399A 
Safety and Efficacy of Sirolimus-Eluting Stent (cypher) 
in Acute Myocardial Infarction: A substudy of the 
Rapamycin-Eluting Stent Evaluation at Rotterdam 
Cardiology Hospital (RESEARCH) Study 
1052.186.2lA 
Safety and Feasibility of Autologous Myoblast 
Transplantatwn in Patients Undergoing Coronary 
Artery Bypass Grafting: Results From the United 
States Experience 848FO-5.360A 
Safety of Adjunctive Glycoprotein Ilb/llla Blockade 
During Rescue/Early Percutaneous Coronary 
Intervention Following Full-Dose Fibrinolyiic Therapy 
for Acute Myocardial Infarction 1025MP-163.332A 
Safety of an Early Discharge Strategy Following 
Primary Intervention With Adjunctive Glycoprotein Ilbl 
llla Inhibition: The CADILLAC Trial 871-2.636A 
Serial Changes in CK-MB Are Superior to Myoglobin for 
Rapid Identification of Myocardial Infarction 
1195.90.395A 
Sex Differences in Elderly Patients--Use of Coronary 
Revascularization After Acute Myocardial Infarction: 
A Tale of Two Therapies 1112.84.179A 
Simultaneous Inhibition of lntegrin Alpha V Beta 3 
Potentiates the Effect of Platelet Glycoptotein Ilb/llla 
Antagonism on Infarct Size Reduction in Acute 
Coronary Thrombosis 1025A-MP-204.4llA 
ST Elevation Myocardial Infarction Caused by 
Spontaneous Distal Embolization From Unstable 
Lesions: Frequency and Sequelae of a Distinct 
Pathophysiological Entity 1170.104.36lA 
ST-Segment Elevation Resolution as a Predictor of 
Mortality in Patients With Thrombolysls in Myocardial 
Infarction Ill Flow in the infarct Artery After Primary 
Angioplasty: The CADILLAC Trial 853.4.392A 
Stent or Percutaneous Transluminal Coronary 
Angioplasty for Occluded Coronary Arteries in 
Patients With Acute Myocardial Infarction Ineligible for 
Thrombolysis (STOPAMI-3) Trial 1172-96.3864, 
Stenting and Platelet Glycoprotein llbillla Inhibitors 
Improve Electrocardiographic ST-Segment 
Resolution After Primary Percutaneous Coronary 
Angioplasty for Acute Myocardial Infarction 
853-5.392A 
Surgical Implantation of Bone Marrow Cells May 
Reverse Perfusion and Wall Motion Abnormalities in 
Patients With Previous Myocardial Infarction and 
Dominance of Scar 1004-98.326A 
Temporal Trends of One-Year Reinfarction and Mortality 
Rates Following Primary Angioplasty in High-Risk 
Acute Myocardial lnfarctlon Patients 1174.19664A 
The Benefit of Early Use of Lipid-Lowering Drugs at 
Discharge in Patients With Acute Coronary 
Syndromes Is Greater in Patients With Heart Failure 
1036-l 17.237A 
The Effect of Age on Early Death and Stroke Rates in 
Patients With Heart Failure After Acute Myocardial 
Infarction 1112.85.179A 
The Effect of Combination Use of Ticlopidine and 
Aspirin on 30-Day Mortality in Patients With Acute 
Myocardial Infarction 1071.106.346A 
The Effect of Exercise Training on the Endothelial 
Function of Coronary Artery in Patients With 
Myocardial Infarction 1161.67.199A 
The Effect of Left Ventricular Surgical Remodeling on 
Three-Dimensional Myocyie Orientation Using 
Magnetic Resonance Diffusion Tensor Imaging 
1204.21.614A 
The Impact of Admission to Primary Versus Tertiary 
Care VA Medical Centers on Outcomes Following 
Acute Coronary Syndromes: The VA Access to 
Cardiology Study 1193-53.533A 
KEY: Abstract Title, Session-abstract numbwpage number 
JACC March 19,2003 SUBJECT INDEX 659A 
The Impact of Implanting Cardioverter-Defibrillators an 
Patients Who Meet the MultIcenter Automatic 
Defibrillator Implantation Trial-II Cnteria on the Health 
Care System at a Tertiary Referral Center 
1217.53.536A 
The Role of Myocardlal Revascularization Surgery and 
Percutaneous Coronary Intervention in the 
Long-Term Follow-Up of Elderly Patients With 
Myocardial Infarction 111%82.179A 
The Sianificance of Early ST-Seament Resolution After 
Treaiment With Asp& in Pat&s Assigned to 
Primary Angioplasty 1171-l 13.3834 
The Vasopeptidase Inhibitor, Omapatrilat, Increases 
Survival, Improves Cardiac Function, and Attenuates 
Ventricular Remodeling After Coronary Artery 
Ligation in Insulin Resistant Zucker Fatty Rats 
1191.30.366A 
Thrombectomv With Distal Protection Prior to Stentina 
Is a Novel sirategy to Obtain Optimal Reperfusion i; 
Patients With Acute Mvocardial Infarction 
1097.92.356A 
Thrombolytic Therapy but Not Primary Angioplasty Is 
Associated With an Earlv Hazard in Patients >75 
Years Old With Acute Myocardial InfarctIon: Results 
of the PPRIMM75 Registry 1040.84.153A 
Time Dependent Reduction of Mvocardial Infarct Size 
by Endovascular Hypothermlajn an 
Ischemia-Reoerfuslon Porcine Model 
1096-l 13.35bA 
Transepicardial Autologous Bone Marrow 
Transplantation in a Porcine Nonreperfused 
Myocardial Infarction Model: Angiogenesls or 
Myogenesls? 117%139.296A 
Transthoraclc Doppler Echocardiographic Assessment 
of lntramyocardial Artery Flow and Coronary Flow 
Velocity Pattern Predict Wall Motion Recovery 
Following Acute Myocardial Infarction 852.6.46OA 
Treatment and Outcomes of Eastern European Patients 
With Acute Coronary Syndromes I” a Multinational 
Randomized Clinical Trial 1193-51.532A 
Treatment With Eolerenone. an Aldosterone Antaaonist 
Improved Ven&ular Remodeling and Functlon‘bost 
Myocardial Infarction 1135-88.182A 
Trends in Door to Balloon Times Amona Hiah-Risk 
Patients UndergoIng Primary Angiopisty 
1005-211.2A 
Trimetazidine-Mediated Cardioprotection During 
lschemia Is Mediated by Mltochondrial Respi&ory 
Chain’s Comolex I Activitv 1145.100.373A 
Unraveling the kpectrum o<Left Bundle Branch Block in 
Acute Myocaridal Infarction: Insights From ASSENT 3 
1125.99.366A 
Use of Glycoprotein Ilb/llla Receptor Blockers Before 
and During Percutaneous Coronary Intervention for 
Acute Coronary Syndromes Versus Stable Angina I” 
Consecutive Patients in Europe: Results of the 
International SHAKESPEARE Registry 
1001.111.323A 
Use of Mvocardial Contrast Echocardioaraohv in 
Identi&a Patients With Failed Repe&$ion After 
Throiboksis in Acute Myocardial Infarction: 
Comoarison With TIMI Mvocardial Perfusion Grade 
and Clinical Markers of Reperfusion 
1025A-MP-203.41 IA 
Usefulness of Concordant ST Elevation and Vl-3 ST 
Depression in Risk Stratifying Patients With 
Presumed Acute Myocardial Infarction and Left 
Bundle Branch Block 1164.16.122A 
Warfarin Therapy Improves Clinical Outcome of 
Kawasaki Disease Patients With Giant Coronary 
Aneurysm 1143-l 55.485A 
Which Is the Best Streotokinase Reaimen in ST Acute 
Myocardlal Infarctioi7 A Prosper&e Study 
1191.46.366A 
Yyocardial stunning 
Assessment of Myocardlal Viability in Patients With Left 
Ventricular Dysfunction Using Contrast-Enhanced 
Magnetic Resonance Imaging : Comparison to 
201-Thallium Single Photon Emission Computed 
Tomography 1167-42.451 A 
Diagnosis of Viable Myocardwm Using Velocity 
Information of Doppler Myocardial Imaging: 
Comparison With Positive Emission Tomography 
1117-37434A 
Flow-Function RelatIonships in Chronically 
Dysfunctional Myocardium RevisIted: Impact of 
Subendocardial Perfusion and Transmurality of 
Myocardial Necrosis 883.1.469A 
Myocardial Velocity Pattern During lsovolumic 
ContractIon Predicts Recovery of Contractile 
Function After Revascularization in Patients With 
Segmental Dysfunction 410.5.545A 
Oxygen Free Radical Scavengers Reverse Alterations 
to MultIpIe Proteins Observed FolIowIng Myocardial 
Stunning 1145.102.373A 
Myocarditis 
Comparing Long-Term Survival and Frequency of Heart 
Transplantation in Patients With Suspected Versus 
Biopsy-Proven Myocarditis: A 15-Year Prospective 
Follow-Up 816.5.172A 
Coxsackie-Adenovirus-Receptor Induction Is 
Associated With Enteroviral and Adenoviral Infection 
in Acute Myocarditls and Dilated Cardiomyopathy 
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Modulating Mltogen-Activated Protein Kinases 
865-4.313A 
Blockade of Preconditionina by Sulfonvlureas Can Be 
Overcome by Activation of PKC and-p38MAPK 
1123-107.362A 
Bone Marrow Derived Cardiomyocytes Are Present in 
Adult Human Heart 410.1644i 
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N-Terminal Pro-Brain Natriuretlc Peptlde on Admission 
Has Prognostic Value Across the Whole Spectrum of 
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Pro-Brain Natriuretic Peptlde Predicts Severe 
Cardiovascular Events in Patients With Heart 
Disease 828FO-3.276A 
Proanostic Value of Brain Natriuretlc Peotide and 
C&diac Troponin T in Patients With &firmed 
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Acute Increases in Methylated Arginines in Obstructive 
Sleep Apnea: Implications for Cardiovascular Risk 
847-4.293A 
Additive Effects of Statin Combined With Angiotensin 
Converting Enzyme Inhibitor on Vasomotion in 
Hypercholesterolemic Patients 1083-l 38.255A 
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Reactive Oxygen Specres Are Involved in 
Smoking-Induced Dysfunction of Nitnc Oxide 
Biosynthesis and Upregulation of Endothelial Nitric 
Oxide Synthase in Human Coronary Artery 
Endothelial Cells 1103-133.26lA 
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Persistence of Impaired Vascular Function Despite an 
Improved Metabolic Profile Following Three Months 
of Significant Weight Loss 1202.147.309A 
Pulmonary Artery Systolic Pressure in 
Echocardiographically Normal Subjects 81 l-l .257A 
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Interleukin-6 Predict Outcome in Elderly Patients 
With Stroke 1162.85.200A 
Plasma Noreoineohrine Predicts 12.Year Surwal in 
Patients ‘&h deduced Ejection Fractions From the 
Studies of Left Ventricular Dysfunctton (SOLVD) 
1013-71.141A 
Possible Beneficial Effects of Adenosine as Adjuvant 
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Prostaglandin El Induces Vascular Endothelial Growth 
Factor-A in Human Adult Cardiac Myocytes and 
Coronarv Artery Smooth Muscle Cells 
1054-l 4i.240d 
Prosthetic valves 
Increased Presence of Pathogen Burden and of 
Circulatorv Precursor Cells in Prosthetic CornDared to 
Native Degenerated Aortlc Valves 1059-21&A 
Mitral Valve Pressure Half-Time Does Not Predict the 
Effective Valve Area in Prosthetic Mitral Valves of All 
Types: A Review of 2,175 Prosthetic Mitral Valves 
1157.25,512A 
Transesophageal EchocardIography Improves Risk 
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Monitoring of the Internal Thoracic Impedance: A Novel 
Method to Detect Pulmonary Edema Before 
Appearance of Clinical Signs 1206-73.2llA 
New Impella Intracardiac Minipump Supports the 
Acutely Failing Left Heart Significantly More Effective 
Than lntraortic Balloon Pumping 120%67.215A 
The Role of Cardiac Power and Systemic Vascular 
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Outcome of Pulmonary Valve Replacement in Adults 
After Tetralogy Repair 631.5487A 
Right Ventricular Diastolic Funcbon Before and After 
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Systemic Markers of Inflammation Do Not Predict 
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808-4.34A 
Echocardiography: Prevalence and-Relationship to 
Clinical Outcome 1019.32.406A 
Preinterventional Levels of C-Reactive Protein and 
Platelet Function in Patients With Stable Angina 
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Major Adverse Cardiovascular Events at Six Months 
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Angiographic and Hemodynamic Correlates of 
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Continuous Monitoring Treadmill Exercise Stress 
Echocardiography: Utility in the Detection of 
Coronary Artery Stenosis 1117-35.434A 
Can Myocardial Contrast Echocardiography, Ustng 
Triggered Replenishment Imaging, Be an Alternate to 
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The Endothelial Nitric Oxide Synthase (Glu298Asp and 
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The Frequency and Consequences of Angiographic 
Aneurysms After Sirolimus-Eluting Stems: Results 
From SIRIUS 1030.181.13A 
The Impact of Sirolimus-Elutina Stents in Diabetics: 
Cardiac Troponin I Release After Dobutemine Stress 
Echocardiography in Patients With Coronary Artery 
Disease 1092-45.426A 
Change in Doppler Left Ventricular Inflow Pattern by 
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Delay in Transition From Seamental Contraction to 
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The Impact of Sirolimus-Eluting Stents on the Outcome 
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The Volume of Embolic Particles Retrieved via Distal 
Prolonged Antiplatelet Therapy After Coronary 
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Qualitative Assessment of Coronarv Lesions Treated 
With Sirolimus-Eluting Stents: S&al Intravascular 
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Randomized Intravascular Ultrasound Comparcson 
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Three-Dimensional Intravascular Ultrasound 
Assessment After the Implantation of 
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Three-Year Clinical and Quantitative Angiographic 
Follow-Up After Carotid Artery Stenting 
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R&xatlon Activity (TT) Reliably Predicts Changes in 
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Outcome in Patients With Viable Myocardium 
1108.28.564A 
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Regional Diagnosis in Patients With Unstable and 
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PLAATOTM (Percutaneous Left Atrial Appendage 
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1018~29.466A 
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Myocardium 1142.42.444A 
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Sinale Center Exoerience With Transcatheter Patent 
F&amen Ovald Closure for Paradoxical Embolism 
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Thromboembolic Events During Long-Term 
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Time Course of Morbidity and Mortality After a 
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Ventricular Remodeling After Mitral Valve Repair 
1204-26.515A 
Sudden death 
A Multicenter Study of Heart Failure as a Predictor for 
Internal Cardioverter Defibrillator Shocks 
10641.95A 
Chronic Subthreshold Electrical Stimulation of the Left 
Stellate Ganglion and a Canine Model of Sudden 
Cardiac Death 
825s4.112A 
Factors Associated With Increased Risk of Sudden 
Death in Youna Patients With Hvoertroohic 
Cardiomyopathy 1014-87.147A’ 
Implantable Cardioverter Defibrillator Lead 
Complications and Laser Extraction in Children and 
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Nuclear Perfusion Scintigraphy es a Gatekeeper for 
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Prolonged QRS Duration and Cardiac Death in 
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Sex Selection in Unexplained Sudden Cardiac Death 
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to Familial Sudden Death 8i8-3.105A 
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Time Course of Morbidity and Mortality After a 
Myocardial Infarction Complicated by Left Ventricular 
Systolic Dysfunction or Heart Failure 1217.56636A 
Superoxide dismutase 
Angiotensin II Type-l Receptor AntagonIst Inhibits 
Vascular Phenotypic Change and Remodeling in 
lntramyocardial Arteries by Reducing Oxidative 
Stress Through Upregulation of Superoxide 
Dismutase 1177-l 29.294A 
Supraventricular tachycardia 
KEY: Abstract Title, Session-abstract number-page number 
JACC March 19,2003 SUBJECT INDEX 679A 
Angiotensm Converting Enzyme Inhibitors Do Not 
Prevent SuoraventricularTachvarrhvthmias: Evidence 
From the S’OLVD Trial 121 IM-P-1&13lA 
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National Trends of Lower Target Intensity Among 
Elderly Patients Taking Warfarin: The Anticoagulatton 
Consortium to Improve Outcomes Nationally 
(ACTION) Studv 1040-85.153A 
PI&ma van Willebrand Factor, Soluble 
Thrombomodulin. and Fibrin D-Dim% Levels in 
Acute-Onset No&beumatic Atrial Fibrillation 
1210-2.13OA 
Relation Between Left Atrial Appendage Function and 
Abnormal Hypercoagulability in Patients With Atrial 
Flutter 1214-39.453A 
Right Atrial Thrombus: A Comparison Between Freely 
Mobile and Partially Mobile Thrombus 
1006-I 26.224A 
Safety of Lwo Molecular Weight Heparin After 
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